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Résumé 
 
La fumée du tabac est un aérosol extrêmement complexe constitué de milliers de 
composés répartis entre la phase particulaire et la phase vapeur. Il a été démontré que les 
effets toxicologiques de cette fumée sont associés aux composés appartenant aux deux 
phases. Plusieurs composés biologiquement actifs ont été identifiés dans la fumée du tabac; 
cependant, il n’y a pas d’études démontrant la relation entre les réponses biologiques 
obtenues via les tests in vitro ou in vivo et les composés présents dans la fumée entière du 
tabac. Le but de la présente recherche est de développer des méthodes fiables et robustes de 
fractionnement de la fumée à l’aide de techniques de séparation analytique et de techniques 
de détection combinés à des essais in vitro toxicologiques. 
 Une étude antérieure réalisée par nos collaborateurs a démontré que, suite à l’étude 
des produits de combustion de douze principaux composés du tabac, l’acide chlorogénique 
s’est avéré être le composé le plus cytotoxique selon les test in vitro du micronoyau. Ainsi, 
dans cette étude, une méthode par chromatographie préparative en phase liquide a été 
développée dans le but de fractionner les produits de combustion de l’acide chlorogénique. 
Les fractions des produits de combustion de l’acide chlorogénique ont ensuite été testées et 
les composés responsables de la toxicité de l’acide chlorogénique ont été identifiés. Le 
composé de la sous-fraction responsable en majeure partie de la cytoxicité a été identifié 
comme étant le catéchol, lequel fut confirmé par chromatographie en phase liquide/ 
spectrométrie de masse à temps de vol.  
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 Des études récentes ont démontré les effets toxicologiques de la fumée entière du 
tabac et l’implication spécifique de la phase vapeur. C’est pourquoi notre travail a ensuite 
été focalisé  principalement à l’analyse de la fumée entière. La machine à fumer Borgwaldt 
RM20S® utilisée avec les chambres d’exposition cellulaire de British American Tobacco 
permettent l’étude in vitro de l’exposition de cellules à différentes concentrations de fumée 
entière du tabac. Les essais biologiques in vitro ont un degré élevé de variabilité, ainsi, il 
faut prendre en compte toutes les autres sources de variabilité pour évaluer avec précision 
la finalité toxicologique de ces essais; toutefois, la fiabilité de la génération de la fumée de 
la machine n’a jamais été évaluée jusqu’à maintenant. Nous avons donc déterminé la 
fiabilité de la génération et de la dilution (RSD entre 0,7 et 12 %) de la fumée en 
quantifiant la présence de deux gaz de référence (le CH4 par détection à ionisation de 
flamme et le CO par absorption infrarouge) et d’un composé de la phase particulaire, le 
solanesol (par chromatographie en phase liquide à haute performance). 
 Ensuite, la relation entre la dose et la dilution des composés de la phase vapeur 
retrouvée dans la chambre d’exposition cellulaire a été caractérisée en utilisant une 
nouvelle technique d’extraction dite par HSSE (Headspace Stir Bar Sorptive Extraction) 
couplée à la chromatographie en phase liquide/ spectrométrie de masse. La répétabilité de 
la méthode a donné une valeur de RSD se situant entre 10 et 13 % pour cinq des composés 
de référence identifiés dans la phase vapeur de la fumée de cigarette. La réponse offrant la 
surface maximale d’aire sous la courbe a été obtenue en utilisant les conditions 
expérimentales suivantes : intervalle de temps d’exposition/ désorption de 10 ±0.5 min, 
température de désorption de 200°C pour 2 min et température de concentration 
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cryogénique (cryofocussing) de -75°C. La précision de la dilution de la fumée est linéaire 
et est fonction de l’abondance des analytes ainsi que de la concentration (RSD de 6,2 à 17,2 
%) avec des quantités de 6 à 450 ng pour les composés de référence.  Ces résultats 
démontrent que la machine à fumer Borgwaldt RM20S® est un outil fiable pour générer et 
acheminer de façon répétitive et linéaire la fumée de cigarette aux cultures cellulaires in 
vitro.  
 Notre approche consiste en l’élaboration d’une méthodologie permettant de 
travailler avec un composé unique du tabac, pouvant être appliqué à des échantillons plus 
complexes par la suite ; ex : la phase vapeur de la fumée de cigarette. La méthodologie 
ainsi développée peut potentiellement servir de méthode de standardisation pour 
l’évaluation d’instruments ou de l’identification de produits dans l’industrie de tabac. 
 
Mots-clés: Machine à fumer Borgwaldt RM20S®, acide chlorogénique, chambre 
d’exposition cellulaire, système d’exposition, fractionnement, chromatographie en phase 
gazeuse, HSSE, test in vitro du micronoyau, chromatographie en phase liquide, 
spectrométrie de masse, désorption thermale, phase vapeur, fumée entière de cigarette. 
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Abstract 
 
Tobacco smoke is an extremely complex aerosol composed of thousands of 
constituents distributed amongst the particulate and vapor phases. Toxicological effects 
have been linked to compounds present in both of these phases. Many biologically active 
compounds have been identified within tobacco smoke; however, there is a lack of studies 
correlating specific in vitro or in vivo biological responses to components within whole 
tobacco smoke. The goal of this research was to develop reliable and robust smoke 
fractionation methods using analytical separation and detection techniques in combination 
with in vitro toxicological assays.  
In a previous study by our collaborators, toxicological assessment of the particulate 
phase combustion products of twelve individual tobacco components revealed that the 
combustion products of chlorogenic acid were the most cytotoxic using the in vitro 
micronucleus test. Therefore, a preparative liquid chromatography method was developed 
in this work to fractionate the combustion products of chlorogenic acid to assess the 
bioactivity of these fractions and to identify the compounds responsible for the toxicity 
observed. The sub-fraction responsible for the most cytotoxic response comprised catechol, 
which was identified by liquid chromatography/time-of-flight mass spectrometry.  
Emerging studies have highlighted the toxicological significance of whole tobacco 
smoke and specifically the vapor phase, which shifted our focus to whole smoke analyses. 
The Borgwaldt RM20S® smoking machine in combination with British American 
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Tobacco’s in vitro cell exposure chamber allow for the generation of fresh cigarette smoke 
in various doses and delivery to cell cultures. In vitro biological assays have a high degree 
of variability, thus, all other sources of variability must be accounted for to accurately 
assess toxicological endpoints; however, the reliability of dose delivery of the instrument 
had not been assessed until now. We have determined the reliability (RSD from 0.7-12%) 
of smoke generation and dilution by quantifying two reference standard gases (CH4 by 
flame ionization detection and CO by infrared absorption) and the tobacco particulate phase 
marker, solanesol (by high performance liquid chromatography-ultraviolet absorption 
detection).  
The relationship between dose and diluted vapor phase components found within the 
exposure chamber was then characterized by developing a headspace stir-bar sorptive 
extraction-gas chromatography/mass spectrometry method. The method repeatability gave 
an RSD from 10-13% for five reference compounds identified in the vapor phase of 
cigarette smoke. The maximal peak area response was obtained using the following 
experimental conditions: exposure-to-desorption time interval of 10 ± 0.5 min, desorption 
temperature of 200 °C for 2 min, and a cryofocussing temperature of -75 °C. The dilution 
precision was found to yield a linear response of analyte abundance and was observed to be 
a function of concentration (RSD from 6.2-17.2 %) with quantities of 6-450 ng for the 
reference compounds. The findings obtained suggest the Borgwaldt RM20S® is a reliable 
tool to generate and deliver repeatable and linear doses of cigarette smoke to in vitro cell 
cultures.  
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Our approach began with designing the methodology to work with an individual 
tobacco component, which could then be applied to a more complex sample, e.g., the vapor 
phase of cigarette smoke. The methodology developed can potentially serve as standardized 
methods for the assessment of instrumentation or screening of products for the Tobacco 
Industry. 
 
Keywords : Borgwaldt RM-20S® smoking machine, chlorogenic acid, exposure chamber, 
exposure system, fractionation, gas chromatography, headspace stir-bar sorptive extraction, 
in vitro micronucleus test, liquid chromatography, mass spectrometry, thermal desorption, 
vapor phase, whole cigarette smoke. 
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1 General Introduction and Research Objectives 
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1.1 Overview 
Tobacco smoke is a complex mixture composed of thousands of components, 
distributed between the particulate and vapor phases. Extensive work has been carried out 
on the identification of compounds present in tobacco and its smoke due to its biological 
activity. Many biologically active compounds have been identified within tobacco smoke; 
however, there is a lack of studies correlating specific in vitro or in vivo biological 
responses to components within whole tobacco smoke due to its complex nature i.e., the 
number and diverse range of compounds simultaneously distributed in the two phases. The 
general hypothesis that guided this work was as follows: the development of reliable and 
robust smoke fractionation methods makes it possible to assign toxicological effects to 
specific cigarette smoke components by using sophisticated analytical separation and 
detection techniques in combination with reliable toxicology assays. The novelty in this 
approach lies in the union of chemical characterization and toxicological studies in parallel. 
This thesis describes the development of methods for chemical characterization of tobacco 
smoke components, specifically the combustion products of chlorogenic acid, which is the 
most abundant tobacco leaf polyphenol (Chapter 3), and the vapor phase of cigarette smoke 
(Chapters 4 and 5). To prepare those readers who may be unfamiliar with this field of 
study, an introduction of some aspects to tobacco science is made in Chapter 1, which is 
concluded with the objectives of the research. The specific techniques used during 
fractionation and chemical analysis are described in detail in Chapter 2. In vitro 
toxicological assays have a high degree of variability, thus, all other sources of variability 
must be reduced or accounted to accurately assess toxicological endpoints. The 
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methodology developed (Chapters 4-5) can potentially serve as standardized methods for 
the assessment of instrumentation (Chapter 4) or screening of tobacco products (Chapter 3, 
5) for the Tobacco Industry.   
    
1.2 Tobacco 
Tobacco used in cigarettes is a product processed from the leaves of the Nicotiana 
genus, namely Nicotiana tabacum L. (typically used in North America) and Nicotiana 
rustica subgenera plant species (Tso, 1999). Similar to other types of plants, the chemical 
constituents (i.e. sugars, alkaloids, N2 and cellulose) vary based on leaf positioning and 
environmental factors, such as soil type and nutrient levels (Tso, 1999). Many plants in the 
Solanaceae family contain nicotine (Fig. 1-1), a powerful neurotoxin; however, Nicotiana 
tabacum L. contains higher levels of nicotine than most plants. Tobacco plants are grown 
and cultivated in a similar procedure to other agricultural products. In addition to seeding 
and cultivation, curing, aging, fermentation, blending and manufacturing processes take 
place prior to cigarette production. 
N
N
 
Figure 1-1: Structure of nicotine, a naturally occurring tobacco alkaloid. 
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1.2.1 Curing Process 
Following cultivation, the leaves undergo a “curing” process (air, flue, sun or fire) 
that involves biochemical and chemical changes. Curing involves three stages which results 
in hydrolysis of starch and other components. The first is a biochemical process applied to 
tobacco leaf by controlling temperature and relative humidity, referred to as “yellowing”. 
The second is a “fixing color” stage, which is followed by the third “drying process” 
involving dehydration to preserve leaves. Two of the most common types of curing 
processes are air- and flue-curing. Air-cured tobacco is hung in ambient, well ventilated 
areas and allowed to dry for a period of four to eight weeks (Palmer et al., 1999). Air-cured 
tobacco is lower in sugar and higher in nicotine compared to using other types of curing 
and is typically used for Burley, Maryland and cigar tobaccos (Table 1-1). Flue-curing is a 
heat-driven process involving the slow ramping of temperature for a period of one week 
and is used for Virginia tobacco (Peedin, 1999). Flue-cured tobacco is higher in sugar and 
contains moderate levels of nicotine (Table 1-1). 
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Table 1-1: Typical composition of cigarette tobaccos: representative analyses of cigarette tobaccos (leaf web after aging, moisture-free basis) (Leffingwell, 1999).1 
        
Component (%)1 Flue-cured Burley Maryland Oriental2 
   type 13 type 31 type 32   
Total volatile bases as ammonia 0.282 0.621 0.366 0.289 
Nicotine 1.93 2.91 1.27 1.05 
Ammonia 0.019 0.159 0.13 0.105 
Glutamine as ammonia 0.033 0.035 0.041 0.02 
Asparagine as ammonia 0.025 0.111 0.016 0.058 
α-Amino nitrogen as ammonia 0.065 0.203 0.075 0.118 
Protein nitrogen as ammonia 0.91 1.77 1.61 1.19 
Nitrate nitrogen as NO3 trace 1.7 0.087 trace 
Total nitrogen as ammonia 1.97 3.96 2.8 2.65 
pH 5.45 5.8 6.6 4.9 
Total volatile acids as acetic acid 0.153 0.103 0.09 0.194 
Formic acid 0.059 0.027 0.022 0.079 
Malic acid 2.83 6.75 2.43 3.87 
Citric acid 0.78 8.22 2.98 1.03 
Oxalic acid 0.81 3.04 2.79 3.16 
Volatile oils 0.148 0.141 0.14 0.248 
Alcohol-soluble resins 9.08 9.27 8.94 11.28 
Reducing sugars as dextrose 22.09 0.21 0.21 12.39 
Pectin as calcium pectate 6.91 9.91 12.41 6.77 
Crude fiber 7.88 9.29 21.79 6.63 
Ash 10.81 24.53 21.98 14.78 
Calcium as CaO 2.22 8.01 4.79 4.22 
Potassium as K2O 2.47 5.22 4.4 2.33 
Magnesium as MgO 0.36 1.29 1.03 0.69 
Chlorine as Cl 0.84 0.71 0.26 0.69 
Phosphorus as P2O5 0.51 0.57 0.53 0.47 
Sulfur as SO4 1.23 1.98 3.34 1.4 
Alkalinity of water-soluble ash3 15.9 36.2 36.9 22.5 
 
1In % except for pH and alkalinity.  
2Blend of Macedonia, Smyrna and Samsun types.  
 3Milliliters of 1 N acid per 100 g tobacco. 
                                                 
1 Quantification of an amino acid is commonly carried out by measuring the ammonia concentration of the α-amino group of that particular amino acid. 
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1.2.2 Aging Process 
Freshly cured tobacco is not immediately processed since its smoke is pungent and 
irritating (Leffingwell, 1999). During aging, leaf tobacco is stored for days or even months 
on a farm to improve the aroma and texture of the leaves. In addition, leaves are separated 
based on physical imperfections, color, thickness, length, stalk position etc. Depending on 
the specific recipe, the tobacco is blended and cigarettes or other products can be 
manufactured.   
1.2.3 Types of Tobacco 
The most common types of tobacco are Burley, Virginia and Oriental. These main 
types are divided into grades based on where the tobacco is grown, which part of the plant 
it is taken from and other plant characteristics. Virginia, normally a flue-cured tobacco, is a 
brighter tobacco because it turns to a yellow/orange color during the curing process. This 
process causes degradation of chlorophyll and most carbohydrates are converted into 
simple sugars (Leffingwell, 1999). Virginia tobacco contains between 1-3.5 % nicotine and 
5-25 % sugars (Leffingwell, 1999). In Canada, Virginia blends do not contain flavors or 
additives.  Burley tobaccos typically undergo an air-curing process under ambient 
conditions in which the leaves turn brown with very low sugar levels. This type of tobacco 
is treated with sugars to replace those lost during the curing process and is combined with 
other types of tobacco or flavors prior to consumption. Oriental tobacco, also known as 
Turkish tobacco, is sun-dried, and contains small leaved plants, because it is grown in soil 
with limited supplies of nitrogen and water.  
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1.2.4 Consumption 
Tobacco is generally consumed in smokable and smokeless forms, such as 
cigarettes, cigars, chewing tobacco, pipe smoking, snuff (dry smokeless form of tobacco, 
snorted through the nose) and snus (smokeless form of tobacco consumed by placing sachet 
under the upper lip). In this study, only smokable forms were analyzed.  
1.3 Composition of Tobacco and Tobacco Smoke 
Leaf tobacco consists of over 2000 components and upon partial combustion 
generates a complex aerosol containing more than 5000 components distributed between 
particulate and vapor phases (Rodgman et al., 2009a, Rodgman et al., 2009b).  
1.3.1 Leaf Chemistry 
The physical and chemical properties of leaf tobacco vary with genetics, 
agricultural practices, soil type and nutrients, weather conditions, plant disease, stalk 
positioning, harvesting and curing procedures (Leffingwell, 1999). The tobacco leaf is 
comprised of carbohydrates (starch, sugars, sugar esters, glucosides, cellulose, 
hemicelluloses and pectin), nitrogen containing compounds (proteins, amino acids, 
ammonia, nitrates and alkaloids including nicotine, cotinine, nornicotine, myosmine, 
nicotyrine, anabasine and anatabine), plastid pigments (chlorophylls and carotenoid 
pigments such as β-carotene, violaxanthin, lutein and neoxanthin), isoprenoids (degraded 
caratenoid products, acyclic isoprenoids and N-demethylated-derivatives such as solanesol 
and neophytadiene, carbocyclic diterpenoids, cembranoids, labdanoids and their degration 
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products), phenolics (polyphenols such as chlorogenic acid, rutin, scopoletin and scopolin, 
lignin and others), sterols (sterols, steryl esters and esterified steryl glucosides) and 
inorganics (Baker et al., 2003, Leffingwell, 1999). The Krebs cycle is responsible for the 
metabolic carbon-nitrogen balance in plants, of which, carbon dioxide is provided from the 
photosynthesis process and inorganic nitrogen is absorbed from the soil. Therefore, where 
nitrogen supply is abundant, protein, amino acid and nicotine are produced in abundance 
(i.e. cigar and burley tobaccos). Conversely, where nitrogen supplies are limited (i.e. 
Oriental Tobacco), there is an accumulation of acetate in the Krebs cycle which results in 
the formation of terpenoids, carbohydrates, aromatic acids and resins. An intermediate 
nitrogen level is required for a flue-cured type tobacco (Table 1-1) (Leffingwell, 1999).  
Many types of compounds are common to leaf tobacco and tobacco smoke (Table 1-2). 
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Table 1-2: Number of compounds identified in tobacco and in smoke (Weeks, 1999) . 
        
Classes of 
Chemicals 
in 
Tobacco in Smoke 
common 
to both 
  (#) (#) (#) 
Carboxylic acids 450 69 140 
Amino acids1 95 18 16 
Lactones 129 135 39 
Esters 529 456 314 
Amides and 
imides 205 227 32 
Anhydrides 10 10 4 
Aldehydes 111 106 48 
Carbohydrates 138 30 12 
Nitriles 4 101 4 
Ketones 348 461 122 
Alcohols 334 157 69 
Phenols 58 188 40 
Amines 65 150 37 
N-Heterocycles: 
Pyridines 63 324 46 
Pyrroles and 
indoles 9 88 3 
Pyrazines 21 55 18 
Nonaromatic 13 43 7 
Ethers 53 88 15 
Hydrocarbons 184 429 114 
Inorganics and 
metals 105 111 69 
 
1 Refers to natural and non-standard amino acids. The latter are constituents of proteins and biologically 
active peptides. 
 
1.3.2 Distillation, Pyrolysis and Combustion 
During a puff, air is drawn into a cigarette through the burning zone and 
mainstream smoke (produced during the puff) is formed (Fig. 1-2). In addition, sidestream 
smoke is formed (during smolder) by a natural convection flow of air at the burning zone. 
Many chemical and physical processes occur while a cigarette is burning since tobacco is in 
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the presence of varying amounts of oxygen and temperatures (ambient up to 950 °C) 
(Baker et al., 2003). The burning process can be broken down into heat producing 
combustion and endothermic pyrolysis/distillation, yielding organic smoke products. 
Combustion is defined as the sequence of chemical reactions between a fuel and an oxidant 
and involves the production of heat and conversion of various compounds, whereas, 
pyrolysis is the chemical decomposition of organic materials by heat in the absence of 
oxygen. Distillation is the separation of components in mixtures based on differences in 
their volatilities in a boiling mixture. As a result of the burning process, other processes 
that may occur are: pyrosynthesis, sublimation and condensation. Pyrosynthesis occurs at 
high temperatures and is the fusion of simple compounds into complex ones. Sublimation is 
the phase transition from solid to gas, without becoming a liquid and condensation is the 
transition from gas to liquid or solid.  
Temperature and heating rate of tobacco are extremely important during smoke 
generation. When air is drawn into the cigarette, oxygen is consumed by combustion with 
carbon-rich tobacco (at temperatures between 700-950°C), releasing carbon monoxide, 
carbon dioxide, water and heat. Downstream, pyrolysis occurs at between 200-600 °C with 
low oxygen levels. As the aerosol is drawn out of the pyrolysis zone, it rapidly cools as the 
diluted air enters (Baker et al., 2003).  
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Figure 1-2: The burning cigarette and processes occurring during puffing (top) and during smoldering 
(bottom) (Baker, 1999). 
1.3.3 Cigarette Smoke Chemistry 
Fresh cigarette smoke is extremely complex, dynamic and reactive because of its 
physical properties and chemical composition. It’s complexity has been compared to other 
widely studied mixtures, such as air (pollution) and diesel engine emissions (Borgerding et 
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al., 2005). As an aerosol, tobacco smoke components are distributed between the 
particulate and vapor phases. The chemical composition of whole mainstream smoke from 
an American blended cigarette (specific blend details not available, similar in composition 
to Ky3R4F, which is specified in section 1.4.2), smoked under standard conditions (35 mL 
puff for a 2 second duration, once every minute) is estimated in Table 1-3 (Dube et al., 
1982). Additionally, the yields of various compounds found in mainstream cigarette smoke 
are listed in Table 1-4. 
Table 1-3:  Approximate chemical composition of whole mainstream smoke (Baker, 1999).  
Constituent
individual
Air
N2 62
O2 13 75.9
Ar 0.9
Vapor Phase
Water 1.3
CO2 12.5
CO 4
H2 0.1
CH4 0.3
Hydrocarbons 0.6
Aldehydes 0.3
Ketones 0.2 19.6
Nitriles 0.1
Heterocyclics 0.03
Methanol 0.03
Organic acids 0.02
Esters 0.01
Other compounds 0.1
Particulate Phase
Water 0.8
Alkanes 0.2
Terpenoids 0.2
Phenols 0.2
Esters 0.2 4.5
Nicotine 0.3
Other alkaloids 0.1
Alcohols 0.3
Carbonyls 0.5
Organic acids 0.6
Leaf pigments 0.2
Other compounds 0.9
}
by phase
% by Weight
}
}
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Table 1-4: Some typical mainstream yield ratios for plain, unfiltered cigarettes of various types, smoked under standard smoking machine conditions (Baker, 1999). 
            
Substance Yield1 Substance Yield1 Substance Yield1 
Small molecules Phenols Aza-arenes 
Carbonyl sulphide 18-42 µg Phenol 60-140 µg Quinoline 0.5-2.0 µg 
HCN 160-500 µg Cresols (o-, m-, p-) 11-37 µg Isoquinoline 1.6-2.0 µg 
CO 10-23 mg Catechol 100-360 µg Benzo[h]quinoline 10 ng 
Hydrazine 20-40 µg Hydroquinone 110-300 µg Indole 16-38 µg 
Methane 600-1000 µg 
Acetylene 20-40 µg Acids Hydrocarbons 
Nitrogen oxides 100-600 µg Formic acid 210-490 µg Isoprene 330-1100 µg 
CO2 20-50 mg Acetic acid 270-810 µg Benzene 36-68 µg 
H2O (gas phase) 3-14 mg 3-Methylvaleric acid 20-60 µg Toluene 100-200 µg 
NH3 50-130 µg Lactic acid 60-170 µg Limonene 15-50 µg 
N2 (generated) <10 µg Benzoic acid 14-28 µg Neophytadiene 66-230 µg 
Phenylacetic acid 11-38 µg 
Neutral heteroatom organics Succinic acid 70-140 µg Polynuclear aromatic hydrocarbons 
Acetonitrile 160-210 µg Glycolic acid 40-130 µg Naphthalene 2.6 µg 
Benzonitrile 5-6 µg Pyrene 45-140 ng 
Acetamide 70-100 µg Amines, pyridines, alkaloids Benzo[a]pyrene 9-40 ng 
Methyl chloride 150-600 µg Methylamine 12-29 µg Anthracene 24 ng 
n-Propylamine 1.6-3.4 µg Phenanthrene 77 ng 
Aldehydes, ketones and alcohols n-Butylamine 0.5-1.5 µg Fluoranthene 60-150 ng 
Acetaldehyde 0.5-1.2 mg Aniline 360 ng 
Propionaldehyde 175-250 µg Pyridine 16-46 µg Nitrosamines† 
Acetone 100-250 µg 3-Ethenylpyridine 11-30 µg N-nitrosodimethylamine 10-40 ng 
Acrolein 60-100 µg Methylpyrazine 2-5 µg N-nitrosodiethylamine nd-25 ng 
2-Butanone ~ 30 µg Pyrrole 16-23 µg N-nitrosopyrrolidine 6-30 ng 
2-Furaldehyde 15-43 µg Nicotine 0.8-2.3 mg N-nitrosodiethanolamine 0-70 ng 
Furfuryl alcohol 18-65 µg Myosmine 13-33 µg N'-nitrosonornicotine 0.2-3 µg 
Cyclotene* 3-5 µg Nicotyrine 4-40 µg NNK‡ 0.1-1 µg 
Pyranone** 13-150 µg Anatabine 2-20 µg N'-nitrosoanatabine 0.3-5 µg 
2,3-'Bipyridyl 16-22 µg 
Phytosterols Inorganic constituents 
β-Sitosterol 59 µg Cadmium 100 ng 
Campesterol 43 µg Nickel 20-80 ng 
Cholesterol 22 µg     Zinc 60 ng 
 
*2-Hydroxy-3-methyl-2-cyclopentanone.  
** 5,6-Dihydro-3,5-dihydroxy-2-methyl-4H-pryan-4-one.  
† Data in the literature on levels of volatiles and nitrosamines may be in error, due to artifact formation during the extraction procedure.  
‡ 4-(methylnitrosamino)-1-(30pyridyl)-1-butanone. Nd = not detected 
1 Yield refers to µg/cig mainstream smoke 
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There is no definitive way to separate and differentiate the particulate and vapor 
phases. Some components partition between the two phases, depending on time, 
temperature and smoke dilution (Baker, 1999). Based on the latter, it is generally accepted 
that the portion of smoke that passes through a Cambridge filter pad (CFP) at room 
temperature is defined as the vapor phase (volatile and semi-volatile compounds). The 
portion that is retained by the CFP is referred to as the particulate phase (semi-volatile and 
non-volatile compounds) or “total particulate matter” (TPM). Another common term used 
is “tar”, which is defined as the weight of TPM minus the weight of nicotine and water. 
The CFP (glass fiber, 44 mm in diameter) retains cigarette smoke particles larger than 0.1 
µm in diameter with an efficiency of approximately 99.9 % (Adam et al., 2006, Baker, 
1999). This efficiency is based on the nature and quantity of the sample, flow through the 
filter, temperature and moisture level (Baker, 1999).  
1.4 Standard Reference Cigarette Samples 
For research purposes, international standard reference cigarettes are manufactured 
by the Kentucky Tobacco Research & Development Center. The first blend was 
manufactured in 1974 and is referred to as Ky1R1. Blends vary based on composition of 
tobacco used, i.e., percentage of Virginia flue-cured, Burley, Maryland, Oriental etc. Other 
blends include: Ky1R3F (blend used by the National Cancer Institute produced in 1974), 
Ky1R4F (low nicotine blend produced in 1983), Ky2R4F (similar to Ky1R4F blend but 
produced in 2002) and Ky1R5F (ultra-low nicotine blend produced in 1989) have been 
produced. Currently, the batch of cigarettes that is available is referred to as Ky3R4F 
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(similar to Ky1R4F blend but produced in 2006) and is a blend of Virginia flue-cured 
(35.41 %), Burley (21.62 %), Oriental (12.07 %), Maryland (1.35 %), Reconstituted (29.55 
%), Glycerin (2.67 %) and an “Isosweet” sugar (6.41 %) (University of Kentucky, 2010a). 
The Ky3R4F was the only references cigarette used throughout this work. 
 
1.5 Cigarette Smoke Sample Collection 
1.5.1 Smoking Protocol (International Organization for Standardization)  
The cigarette smoking process is highly variable between different smokers as well 
as between different smoking sessions for the same individual. Factors that influence the 
smoking behavior include human, social and environmental variables. The yield and 
composition of smoke compounds depends on the physical dimensions of the cigarette, 
puff volume (20-80 cm3), the shape of the puff profile (i.e. the pressure/flow relationship), 
which dictates a puff duration (0.8-3 s), the number and frequency of puffs (typically 20-
100 s) and residual butt length (19-28 mm) left at the end of smoking (Baker, 1999, 
Borgerding et al., 2005). Paper type is an additional variable that may effect smoke 
composition.  
A standard set of smoking procedures was implemented by government and 
industry and included employing a 35 cm3 puff for a 2 second duration, every minute, 
while maintaining a butt length of 23 mm (International Organization for Standardization, 
1999). These parameters were implemented to promote consistency in research (mainly 
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product comparisons) using automated smoking machines by the US Federal Trade 
Commission (FTC), International standard organization (ISO), Cooperation Centre for 
Scientific Research Relative to Tobacco (CORESTA) and Tobacco Institute of Japan 
(TIOJ).  Due to the variation and higher intensity in smoking behavior between individual 
smokers, this smoking regime can not be used to predict consumer yields (Côté et al., 
2010). 
1.5.2 Particulate Phase Collection  
Extensive work has been carried out on phenols, terpenes and alkaloids among 
other particulate phase constituents, based on their biological/toxicological significance. As 
stated above, the most common technique for collecting the particulate phase of cigarette 
smoke is by using a CFP to trap total particulate matter (TPM) generated by a smoking 
machine. The CFP, a glass fiber filter, traps the particles ≥0.1 µm with >99 % efficiency 
(Baker, 1999). The particulate phase is subsequently extracted from the CFP using a 
solvent (Misra et al., 2010). Other techniques that are used to trap the particulate phase 
include: electrostatic precipitation, jet impaction and the use of solid adsorbents (activated 
charcoal, silica gels, molecular sieves and tenax) (Baker, 1999, Dube et al., 1982, Wynder 
et al., 1967). 
1.5.3 Vapor Phase Collection  
Volatile organic compounds, hydrocarbons, carbon monoxide, methane, aldehydes 
and nitrosamines are among the compounds of biological interest, found in the vapor phase 
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of cigarette smoke. Collection of the vapor phase is quite challenging and has been 
achieved by employing sampling bag methods, cryogenic/cold traps, impingers, solvent 
traps, adsorbent traps, direct injection methods,  and solid-phase microextraction (SPME) 
related techniques (Omori et al., 1999, Ye, 2008, Dube et al., 1982, Wynder et al., 1967, 
Borgerding et al., 2005). These techniques all have their own specific advantages and 
limitations. Gas bags allow for the exposure of whole smoke, without preconcentration and 
can average smoking from a number of cigarettes; however, smoke ageing may occur 
(which includes degradation of some compounds) and some compounds may deposit on the 
bag itself (Dong et al., 2000, Omori et al., 1999, Chen et al., 2003). Impingers and traps 
under the use of cryogenic conditions may provide an alternative that is easy to use an 
internal standard and average smoking from a number of cigarettes; however, solvents are 
used and can cause interferences with some analytes and typically have a complex setting 
and time-consuming experimental work (Dong et al., 2000, Darrall et al., 1998, Byrd et al., 
1990). Direct injection methods provide un-aged smoke to be analyzed, where degradation 
of analytes are minimized; however, reproducibility and quantitation are challenging due to 
only sampling a fraction of a puff (Takanami et al., 2003, Adam et al., 2009). SPME and 
related techniques allow for solvent-free method, rapid pre-concentration and sorption in 
one step, homogeneous sampling and high reproducibility; however sensitivity can be low 
since these techniques are limited by the volume of the sorptive phase and quantitation may 
be challenging (Polzin et al., 2007, Ye, 2008, Buszewski et al., 2009).  
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1.6 Cigarette Smoke Sample Analysis 
Tobacco smoke has been extensively characterized using many experimental 
approaches, including detailed chemical analyses of the smoke using chromatographic 
instrumentation coupled with a variety of detection techniques, analysis of smoke from 
precursor “doped” cigarettes, studying aerosols, investigating pyrolysis from fundamental 
perspectives, studies involving isotopically labeled compounds, fractionation studies, 
investigating mass transfer inside the cigarette and computer modeling of the formation 
processes and their interactions (Baker, 1999, Swain et al., 1969, Chen et al., 2003, Dong et 
al., 2000, Adam et al., 2009, Adam et al., 2006, Baggett et al., 1974, Wynder et al., 1967, 
Stedman, 1968, IARC, 1986, Borgerding et al., 2005, Polzin et al., 2007).  
1.7 Toxicology of Tobacco Smoke 
It is important to note that the “toxicology of tobacco smoke” is an extremely broad 
and complex subject and that the content of this chapter is limited to the literature provided. 
1.7.1 Health Implications of Tobacco Use  
The use of tobacco has been recorded across the world since the 10th century or 
earlier (Hoffmann et al., 1998a). It was in the 1920’s that adverse health effects began to be 
more prevalent and the first paper linking tobacco use and cancer was published in the late 
1920s (Lickint, 1929). It was not until 1964 that the United States Surgeon General issued a 
report on Smoking and Health (US Surgeon General, 1964), suggesting a relationship 
between smoking and cancer, which was confirmed in the 1980s (US Surgeon General, 
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1982). At present, some of the known risks associated with tobacco use include: stroke, 
heart attack, chronic obstructive pulmonary disease (COPD), emphysema and various 
forms of lung, mouth and pancreatic cancers (Hoffmann et al., 2001b, U.S. Department of 
Health and Human Services, 1989).  
1.7.2 Toxicologically Relevant Constituents Present in Tobacco Smoke   
During the smoking process, a complex mixture is inhaled into the respiratory tract 
and chemical, physical and physiological phenomena occur. There are a few important 
factors to consider when evaluating cigarette smoke toxicity. Some of these key factors 
include the complex nature of cigarette smoke, potential changes of the smoke material 
during collection and the analysis itself.  
The toxicity of cigarette smoke is thought to be a function of the concentrations of 
individual toxicants present in smoke. A set of compounds referred to as the “Hoffmann 
analytes” were reported by Hoffmann in the 1990s (Hoffmann, 1993, Hoffmann et al., 
1998b, Hoffmann et al., 1997). The Hoffmann analytes are summarized in Table 1-4 and 
the structures of some of these compounds are presented in Fig 1-3 and 1-4 (Hoffmann et 
al., 2001b, Hoffmann et al., 1997, Hoffmann, 1993, Hoffmann et al., 2001a, Hoffmann et 
al., 1990, Hoffmann et al., 1998b, Rodgman et al., 2003, Rodgman et al., 2009b). A more 
recent list of 149 toxicants potentially found in cigarette smoke was published in 2003 
(Rodgman et al., 2003). Various tobacco smoke components have been established as 
tumor promoters, carcinogenic and/or co-carcinogenic (Borgerding et al., 2005). Few 
toxicological studies have been carried out on specific Hoffmann analytes or other 
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biologically active smoke constituents that produce in vitro or in vivo biological responses 
from whole smoke (Borgerding et al., 2005, Rodgman et al., 2003). In fact, toxicological 
data is available for roughly 5% of the number of components present in tobacco smoke 
(Rodgman et al., 2003, Rodgman et al., 2009b).  
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Table 1-5: Summary of lists of toxicants by Hoffmann et al. from 1986 to 2001 (Hoffmann et al., 2001b, 
Hoffmann et al., 1997, Hoffmann, 1993, Hoffmann et al., 2001a, Hoffmann et al., 1990, Hoffmann et al., 
1998b, Rodgman et al., 2003, Rodgman et al., 2009b). 
 
Group Hoffmann Analyte Group Hoffmann Analyte Group Hoffmann Analyte
Polycyclic Benz[a ]anthracene N-Heterocyclic AαC Phenols Phenol
aromatic Benzo[b ]fluoranthene Amines MeAαC m+p+o- Cresol
hydrocarbons Benzo[j ]fluoranthene Glu-P-1 Catechol
Benzo[k ]fluoranthene Glu-P-2 Resorcinol
Benzo[a ]pyrene PhIP Hydroquinone
Chrysene IQ Methyleugenol
5-Methyl-chrysene MeIQ Caffeic acid
Dibenz[a,h ]anthracene Trp-P-1 Chloroaromatic DDT
Dibenzo[a,e ]pyrene Trp-P-2 Compounds DDE
Dibenzo[a,h ]pyrene Aldehydes and Formaldehyde Polychlorodibenzo-p -dioxins
Dibenzo[a,i ]pyrene Ketones Acetaldehyde Polychlorodibenzofurans
Dibenzo[a,l ]pyrene Propionaledhyde Inorganic Hydrazine
Indeno[1,2,3-cd ]pyrene Butyraldehyde Compounds Hydrogen sulfide
Aza-arenes Pyridine Crotonaldehyde Arsenic
Quinoline Acrolein Beryllium
Dibenz[a,h ]acridine Acetone Cadmium
Dibenz[a,j ]acridine 2-Butanone Chromium (VI)
7H -Dibenzo[c,g ]carbazole Volatile 1,3-Butadiene Cobalt
N-Nitrosamines N -Nitrosodimethylamine Hydrocarbons Isoprene Nickel
N -Nitrosoethylmethylamine Benzene Mercury
N -Nitrosodiethylamine Toluene Lead
N -Nitrosodi-n -propylamine Styrene Polonium-210
N -Nitrosodi-n -butylamine Miscellaneous Acetamide Selenium
N -Nitrosopyrrolidine Organic Acrylonitrile Additional Nicotine
N -Nitrosopiperidine Compounds Acrylamide Compounds Carbon monoxide
N -Nitrosodiethanolamine 1,1-Dimethyl-hydrazine Ammonia
N -Nitrososarcosine Maleic hydrazide Nitrogen oxides
N' -Nitrosonornicotine Methanol Hydrogen cyanide
4-(N -Methylnitrosamino)- Methyl isocyanate
1-(3-pyridyl)-1-butanone Nitromethane
N '-Nitrosoanabasine 2-Nitropropane
N '-Nitrosoanatabine Nitrobenzene
N -Nitrosomorpholine Vinyl chloride
Aromatic Amines Aniline Ethyl carbamate
2-Toluidine Ethylene oxide
2,6-Dimethyl-aniline Propylene oxide
1-Napthylamine Di(2-ethylhexyl)phthalate
2-Napthylamine Furan
3-Amino-biphenyl Benzo[b ]furan
4-Amino-biphenyl  
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Figure 1-3: Hoffmann analytes, structures of phenolic compounds found primarily in the particulate phase of cigarette smoke (Rodgman et al., 2003). 
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Figure 1-4: Hoffmann analytes, structures of volatile carbonyls (aldehydes and ketones) and hydrocarbons found primarily in the vapor phase of cigarette smoke 
(Rodgman et al., 2003). 
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1.7.3  Traditional Approaches: in Vitro Assays   
Historically, biological testing of cigarette smoke has been based on smoke 
generation procedures intended for product comparisons. Cigarette smoke in vivo studies 
involve the exposure of cigarette smoke to rodents via inhalation (Baumgartner et al., 
1980) or cigarette smoke condensates to rodents by using skin painting carcinogenesis 
testing (Walaszek et al., 2007). This chapter has been limited to three particular in vitro 
bioassays used throughout the tobacco industry which have been developed by CORESTA 
and implemented by Health Canada (Health Canada, 2004a, Health Canada, 2004c, Health 
Canada, 2004b). These tests are the in vitro micronucleus test (IVMNT), neutral red uptake 
assay and Ames test and are all based on the exposure of cells to the particulate matter 
extracted by DMSO from a CFP. 
The IVMNT is an in vitro genotoxicity and cytotoxicity assay used to detect 
compounds that induce the formation of micronuclei (i.e. small membrane bound DNA 
fragments) in the cytoplasm of mammalian cells at the interphase. Following exposure of 
cells to a genotoxic agent, the cells are stained with a fluorescent dye and the percentage of 
observed micronuclei is reported2. The frequency of micronuclei is visually determined and 
compared between samples and controls to determine the relative genotoxicities. 
Furthermore, the cell viability (cytotoxicity) can also be visually determined by comparing 
samples and controls for relative survivals. In this thesis work, only the IVMNT was used, 
therefore, this assay is further described in Chapter 2.   
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The neutral red uptake assay (NRU) is an in vitro technique used to assess the 
cytotoxic potential of chemical compounds. It is a cell viability chemo-sensitive assay 
based on the ability of viable cells to incorporate and bind neutral red, a supravital dye. 
Since the neutral red dye is taken up by the lysosomes (containing digestive enzymes), the 
assay examines the cellular membrane activity and energy status. In the presence of toxic 
agents, a decrease in the uptake of the dye occurs.  The samples are assessed by measuring 
their optical densities at 540 nm (absorption maxima of neutral red dye) and are compared 
relative to the sample control. Therefore, viable and damaged cells can be differentiated.     
The Ames test is an in vitro technique used to assess the mutagenic potential of 
chemical compounds. This test uses Salmonella typhimuriun bacterial strains that carry 
mutations in genes involved in histidine synthesis and require histidine for growth. The test 
is based on the mutant’s ability to grow on a histidine-free medium. The bacteria are grown 
in the presence of limited histidine. When the histidine is depleted, only mutated bacteria 
that are able to produce histidine will survive. Following a 48 hour incubation period, the 
mutagenicity of a substance is proportional to the number of colonies observed. A positive 
test is indicative of a compound’s mutagenicity and potential carcinogenicity.   
1.7.4 Current Approaches: Whole Smoke Exposure Systems   
A major drawback associated with traditional in vivo and in vitro exposure 
procedures is the inability to simultaneously expose cigarette smoke particulate and vapor 
phases to cells. Studies indicate that the vapor phase of cigarette smoke plays a major role 
                                                                                                                                                    
2 The determination of percent of % micronuclei is given in detail in Chapter 2 and 3. 
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in the toxicological responses (Bombick et al., 1997c, Bombick et al., 1997b, Phillips et al., 
2004, Wieczorek et al., 2006, CORESTA, 2005). Thus, exposure to whole cigarette smoke 
(including both phases) should give a comprehensive description of cigarette smoke 
toxicity.  
Developments in the last decade have introduced smoke generation systems, such as 
the Borgwaldt RM20S® smoking machine (Phillips et al., 2005), Burghart Mimic Smoker-
01® (Scian et al., 2009a, Scian et al., 2009b), the Vitrocell Smoking Robot VC 10® 
(Aufderheide et al., 2000) and the development of novel in vitro exposure systems such as 
British American Tobacco’s (BAT) exposure chamber (Phillips et al., 2005) and the 
CULTEX system (Aufderheide et al., 2000). These systems allow for the generation of 
fresh cigarette smoke in various dilutions (or doses) and direct delivery to cell cultures. The 
ability to introduce smoke diluted over a wide range is required for in vitro cell culture 
investigations because of the high sensitivity of these biological systems. Only the 
Borgwaldt RM20S® smoking machine was available to us and its operation and assessment 
are described in detail in Chapter 4.  
1.8 Research Objectives 
Tobacco smoke is a complex mixture composed of more than 5000 components, 
simultaneously distributed between the particulate and vapor phases (Rodgman et al., 
2009a, Rodgman et al., 2009b). Based on the health implications of tobacco smoke, many 
studies have been conducted to identify the components present in tobacco and its smoke 
(Rodgman et al., 2009a, Rodgman et al., 2009b, Dong et al., 2000, Omori et al., 1999, 
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Chen et al., 2003, Darrall et al., 1998, Adam et al., 2006, Polzin et al., 2007, Baggett et al., 
1974, Baker, 1999). Furthermore, lists have been prepared containing biologically active 
components found within smoke (Hoffmann, 1993, Hoffmann et al., 1998b, Hoffmann et 
al., 1997, Rodgman et al., 2003). In terms of toxicological testing, the majority of studies 
has been carried out on extracts of tobacco smoke particulate or vapor phases (Bombick et 
al., 1997a, Wynder et al., 1969). Nevertheless, there is a lack of studies correlating specific 
in vitro or in vivo biological responses to components within whole tobacco smoke 
(Borgerding et al., 2005, Rodgman et al., 2003) due to its complex nature i.e., the number 
and diverse range of compounds simultaneously distributed in the two phases. Therefore, 
the general hypothesis that guided the current work was as follows: the development of 
reliable and robust smoke fractionation methods makes it possible to assign toxicological 
effects to specific cigarette smoke components by using sophisticated analytical separation 
and detection techniques in combination with reliable toxicology assays. The novelty in 
this approach lies in the union of chemical characterization and toxicological studies in 
parallel. 
Given the complex nature of tobacco smoke, its simplification prior to analysis is 
required. One approach used to assess the composition and toxicity of cigarette smoke is to 
study the combustion of individual components found in leaf tobacco. This approach 
reduces the complexity of a whole smoke experiment and allows the development of a 
strategy to assess individual components or their respective combustion products, for 
application to the study of whole smoke. A previous study that applied this approach 
(Préfontaine et al., 2006),  and which inspired the research described in Chapter 3, was 
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based on the toxicological assessment of the particulate phase combustion products of 
twelve individual tobacco components using the IVMNT. The particulate phase 
components were targeted based on the available methodology, instrumentation and 
expertise required. Twelve major tobacco constituents were chosen for this study by 
Préfontaine et al.: lignin (LIG), chlorogenic acid (CLO in this figure only), malic acid 
(MAL), RUBISCO (RUB), tryptophan (TRY), tyrosine (TYR), glycine (GLY), proline 
(PRO), pectin (PEC), glucose (GLU), starch (STA) and cellulose (CEL). Additionally, two 
tobacco reference blends used in the tobacco science industry were assessed: CK36 and 
1R4F. Based on the IVMNT results (Fig. 1-5), the combustion products of chlorogenic acid 
and lignin were found to be the most cytotoxic of the twelve sets of combustion products 
tested. Lignin is a complex biopolymer found in tobacco and chlorogenic acid is the most 
abundant polyphenol in tobacco. It is important to point out that chemical characterization 
(i.e., identification) of the products generated by combustion of any one of the 12 starting 
compounds was not carried out. Chlorogenic acid was therefore chosen for further 
investigation based on its higher cytotoxic response and simpler structure than lignin. 
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Figure 1-5: Cytotoxicity results (IVMNT) from the exposure of cells to the combustion products of twelve tobacco constituents (Préfontaine 
et al., 2006).
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 Our first objective was to identify the components or groups of components 
resulting from the combustion of chlorogenic acid, responsible for the cytotoxicity results 
obtained from the IVMNT (Préfontaine et al., 2006). Therefore, the challenge was to 
develop a method to further differentiate the combustion products of chlorogenic acid and 
test portions of them to identify the bioactive compounds by combining chromatography 
and toxicological assays. LC/MS was employed because separation and accurate mass 
identification were required, given the complexity of this type of unknown sample. 
Development of a method to characterize the combustion products of a single tobacco 
component like chlorogenic acid (less complex than whole tobacco smoke products), as 
presented in Chapter 3, provided us with a methodology that could potentially be applied to 
whole tobacco smoke products. 
 Emerging studies have highlighted the biological significance of whole tobacco 
smoke vapor phase volatiles and semi-volatiles (Bombick et al., 1997b, Bombick et al., 
1997c, Phillips et al., 2004, CORESTA, 2005, Wieczorek et al., 2006). One of the main 
drawbacks for the assessment of the vapor phase and whole smoke has been a lack of 
techniques available to tackle the in vitro toxicological characterization. Recent 
advancements have led to the development of smoke generation systems, such as the 
Borgwaldt RM20S® smoking machine and novel in vitro exposure systems, such as British 
American Tobacco’s (BAT) exposure chamber. These systems allow for the generation of 
fresh cigarette smoke in various doses and delivery to cell cultures. The instrumentation 
was introduced in our laboratory during the work on chlorogenic acid. Even if the study of 
combustion products from individual tobacco constituents can provide insight into their 
contribution to overall cigarette smoke toxicity, the study of whole cigarette smoke is more 
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representative of smoker exposure to the complex mixture generated during smoking. Thus, 
our objectives shifted to whole smoke analyses versus solely the particulate phase. In vitro 
cell culture studies had been carried out on the instrument mentioned above and a positive 
dose-response relationship was observed for cells exposed to cigarette smoke by the NRU 
assay (Phillips et al., 2005). Doses of smoke were based on dilutions of smoke in air (v/v) 
that had been previously correlated to the quantity of TPM deposited on a CFP (Phillips et 
al., 2005). However, the reliability of dose delivery from this type of instrumentation was 
not assessed and the model has been criticized as an unreliable model for toxicological 
testing. In general, in vitro and in vivo toxicological testing data have high variability, 
primarily based on the heterogeneity of the cell or tissue culture being exposed. Therefore, 
our second objective was to assess the reliability of the instrumentation in terms of 
repeatability, reproducibility and accuracy of the smoke generation and dilution for this 
type of system using standard reference gases and a cigarette particulate phase marker. This 
study is described in Chapter 4.  
Once the smoke generation instrument was deemed reliable for cell exposure 
studies, our third objective was to develop a method to chemically characterize the vapor 
phase components generated by the Borgwaldt RM20S® within the exposure chamber 
itself, at a biologically significant dose. This characterization involved the collection of the 
vapor phase components after cigarette smoke dilution and transfer to the chamber to 
evaluate the dose linearity, as described in Chapter 5. Collection was achieved by stir-bar 
sorptive extraction and GC/MS was employed because separation and accurate mass 
identification were required, given the complexity of this type of unknown sample. By 
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assessing the reliability of smoke delivered to the exposure chamber by this instrument, the 
in vitro toxicological data generated by using this model can be more precisely correlated 
to the dose. Furthermore, developing a method to characterize the biologically active 
smoke vapor phase components can serve as a standard method for assessment of similar 
types of instrumentation and provide a screening tool to assess relative smoke bioactivity 
for potential harm reduced tobacco product comparisons.     
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2 Experimental Methodology 
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2.1 Smoke Generation Techniques 
2.1.1 Generation of Partial Combustion Products from Individual 
Tobacco Components using the John Payne Tar Combustion 
Simulator 
A John Payne Tar Predictor apparatus is commonly used to simulate partial (or 
complete) combustion of various samples, ranging from individual tobacco components to 
spiked tobacco mixtures. The samples generated can be analyzed for their chemical 
composition or tested for their respective biological activities. The sample is inserted in a 
quartz tube that is automatically driven into the instrument’s furnace (Fig. 2-1). Quartz 
tubes are used because of their thermal resistance, which in turn allows for samples to be 
burned at temperatures mimicking the combustion of a cigarette (up to 950 °C). 
Experimental conditions detailed in Chapter 3 (e.g., combustion temperature, sample size 
and flow rate) are carefully chosen to attempt to mimic the cigarette smoking process, since 
they are key factors contributing in the types and quantities of products formed (Chen, 
2004).  
During the partial combustion process (Fig, 2-2), atmospheric air is drawn through 
the quartz tube at constant air flow, forming smoke that passes through a CFP of diameter 
55 mm, thereby trapping the TPM of the smoke. Silicone grease was used to prevent 
leaking of smoke from the tubing at specific locations. Following the partial combustion 
process, the CFP holder is blocked on both ends to reduce loss of the semi-volatile 
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components. The particulate phase on the CFP is then extracted with a solvent to produce 
concentrated extracts for further chemical or biological analysis.  
The John Payne Tar Predictor was used in this study (Chapter 3) to partially 
combust pure chlorogenic acid in order to generate partial combustion products for further 
toxicological analyses. This type of instrumentation was chosen based on its ability to 
partially combust pure substances at a range of temperatures, in substantial quantities for 
further testing as well as its its accepted use in the Tobacco Industry.
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Figure 2-1: Schematic of the John Payne Tar Predictor combustion simulator used to generate partial combustion products of pure tobacco components or other 
samples. The quartz tube contains the sample to be combusted in the furnace for a fixed duration and temperature at a given air flow rate and the CFP collects the 
particulate phase as the smoke passes through. 
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Figure 2-2: Photograph of the cross-section of the furnace during partial combustion of an individual tobacco constituent by the John Payne Tar Predictor.
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2.1.1.1 Chlorogenic Acids and its Combustion Products: Application of the John 
Payne Tar Predictor 
 Phenolic components are important contributors to aroma, taste and toxicity. 
Phenolic compounds present in tobacco smoke are typically products of the thermal 
degradation of polyphenolic compounds. Some of the major polyphenolic compounds in 
tobacco are: chlorogenic acids (0.31- 4.3 %), rutin (0.15- 1.8 %) and scopoletin (0.003- 
0.012 %) (Wynder et al., 1967). Chlorogenic acid isomers are bio-synthesized 
(esterification reaction) from quinic acid and caffeic acid (Fig. 2-3) and are classified as 
convertogenic3 and/or clastogenic4 (Stich et al., 1981). 
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Figure 2-3: The product of quinic acid and caffeic acid, chlorogenic acids (class of isomers). 
                                                 
3 Convertogenic is defined as mitotic gene conversion at the gene locus trp 5 of a Saccharomyces cerevisiae 
D7 strain, resulting in the induction of tryptophan prototrophs. 
4 Clastogenic is defined as capable of causing chromosomal breakage. 
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The partial combustion of chlorogenic acid has been investigated under various 
temperatures (ambient to 800 °C) and has been found to generate benzene, phenol, benzoic 
acid and vinyl catechol among other bioactive products (Fig. 2-4) (Sharma et al., 2002b, 
Baker, 1999, Schlotzhauer et al., 1981). Vinyl catechol, a co-carcinogen5, is one of the 
major compounds observed in the combustion products of chlorogenic acid and between 
200-300 μg is present in the particulate phase of cigarette smoke (Schlotzhauer et al., 1981, 
Hoffmann et al., 1983). Other studies indicates that catechol hydroquinone and benzene 
(also combustion products of chlorogenic acid) inhibit human T cell lymphocyte 
proliferation (Li et al., 1997, Snyder et al., 1993). Moreover, the combustion products of 
chlorogenic acid have been shown to be cytotoxic6, genotoxic7, based on (IVMNT) results 
(Préfontaine et al., 2006, Kaur et al., 2009).  In these  studies, the John Payne Tar Predictor 
was used to generate the partial combustion products of the various tobacco constituents, 
including chlorogenic acid. 
 
 
 
 
 
                                                 
5 Co-carcinogenic is defined as a compound that promotes the effects of a carcinogen. 
6 Treatment of cells to a cytotoxic compound results in cell necrosis, losing membrane integrity resulting in 
cell lysis, or apoptosis, programmed cell death.  
7 Genotoxicity describes damage (deletion) to a cells genetic material affecting its integrity. Genotoxic 
substances may be mutagenic or carcinogenic, causing genetic mutations or tumor development. 
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Figure 2-4: Some of the partial combustion products of chlorogenic acid. 
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2.1.2 Generation and Dilution of Cigarette Smoke by the Borgwaldt 
RM20S® Smoking Engine in Combination with BAT’s Exposure 
Chamber for in Vitro Cell Culture Exposures 
The Borgwaldt RM20S® (Fig. 2-5) is an automatic smoking machine that generates 
and dilutes fresh cigarette smoke for in vitro cell culture investigations (Borgwaldt KC, 
2010). It has a rotary based engine that can simultaneously smoke four types of cigarettes 
for several hours, depending on the smoking regime used. Each cigarette corresponds to a 
specific port, syringe and exposure chamber (A-D); the machine smokes the cigarette, 
dilutes and delivers the smoke into the chambers. By incorporating a CFP before the 
exposure chamber, which is a modification we made specifically for the study, the 
particulate phase is trapped, resulting in the exposure of only the vapor phase to the cells. 
The instrument has an incorporated anemometer, allowing for controlled air flow, as well 
as an electrical lighter, butt detector and butt extractor. The latter allows several cigarettes 
to be smoked in sequence at a given port. The Borgwaldt RM20S® can be used with BAT’s 
exposure chamber (Fig. 2-6) to enable cells or tissues to be exposed to the diluted smoke 
(i.e. doses) generated by the Borgwaldt RM20S®. Within the chamber, the cells or tissues 
lie on porous Transwell® inserts and are exposed to smoke at the air-liquid interface 
(Thorne et al., 2009, Phillips et al., 2005). The ability to introduce smoke diluted over a 
wide range is required for in vitro cell culture investigations because of the high sensitivity 
of these biological systems.  
The Borwaldt RM20S® was used to generate and dilute smoke for reliability studies 
(Chapter 4) involving the measurement of solanesol in cigarette particulate phase and for 
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chemical characterization studies involving the measurement of various cigarette vapor 
phase components present within the BAT exposure chamber (Chapter 5). This type of 
instrumentation was chosen based on its ability to expose cells to whole smoke and on its 
increasing popularity and potential use in the Tobacco Industry.  It is important to underline 
that in the studies presented in Chapter 4 and 5, no live cells were used.   
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Figure 2-5: Schematic of the Borgwaldt RM20S® instrument in combination with BAT’s exposure chamber (on left side of figure) used to generate and dilute 
cigarette smoke for in vitro cell or tissue culture exposures.  Exposure chambers A and B are exposed to whole cigarette smoke versus C and D which are exposed to 
vapor phase only in the figure. 
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Figure 2-6: The BAT exposure chamber (Patent Publication Number WO 03/100417, (Thorne et al., 2009). 
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2.2 Sample Collection Techniques 
2.2.1 Extraction and Enrichment of Organic Compounds by using Stir-
bar Sorptive Extraction (SBSE) or Headspace Stir-bar Sorptive 
Extraction (HSSE) 
SBSE is a similar technique to SPME except the sorptive phase (i.e. PDMS) is on a 
glass-coated magnetic stirring bar for improved extraction/enrichment of analytes from 
aqueous samples. SBSE is based on the approximation that the partitioning coefficients 
between PDMS and water (KPDMS/W) are proportional to the octanol/water coefficients 
(Ko/w). Thus, the only parameter governing recovery of the analyte from the sample is the 
ratio of partitioning constant and phase ratio between PDMS on the stir-bar and the water 
sample. The theoretical recovery (RTH) can be determined by the following: 
α
α
+
==
1)(
)(
O
PDMS
TH
M
MR                                                                        (Equation 2.1) 
                                        where: βα
WOK /
=                                     
                                                   
PDMSofvolume
waterofvolume
=β               
 
                        PDMS in thepresent  analyte of mass  M(PDMS) =  
             waterin thepresent  originally analyte ofamount   totalM  (O) =  
 
SBSE used to sample the vapor phase is referred to as headspace stir-bar sorptive 
extraction (HSSE). Basically, it is a static mode of operation carried out by suspending the 
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stir-bar in the vapor phase, which is in equilibrium (or not) with a solid or liquid matrix. 
For quantification, full equilibrium is not essential, i.e. as in SPME. For example, as long 
as the stirring period for a sample and standards are carried out for a similar fixed period, 
calibration may be accurate; depending on the sample being analyzed, some exceptions 
may apply. Approaching extraction equilibrium is preferred for maximum sensitivity 
(Baltussen et al., 1999). As with SBSE and for SPME, analyte recovery is achieved through 
thermal desorption combined online with GC analysis of desorbed analytes. The preferred 
detection method is by MS, which offers a high sensitivity and specificity. 
A commercially available product, the Twister™ stir-bar (Fig. 2-7), is coated with 
PDMS. This stir-bar can be placed in a sample (gaseous or liquid) and either magnetically 
agitated to provide stirring or left static. Upon contact with the sample, it absorbs and 
concentrates compounds onto its PDMS phase. Subsequently, it can be directly transferred 
to a thermal desorption system (TDS) then a cooled injection system (CIS, a programmable 
inline temperature concentration and injection technique), which is directly coupled to a 
GC/MS. Due to the amount (volume) of the PDMS coating, it is proven to be more 
sensitive (i.e. provides a higher enrichment factor) than conventional SPME. Typical SBSE 
devices, such as the Twister™, consist of a magnetic stirring bar encased in a glass sheath 
that is coated with a ≤ 1 mm film of PDMS and can contain between 55-219 µL of PDMS 
(compared to ≤ 0.5 µL in SPME) depending on the length of the stir-bar, which is between 
1-2 cm. 
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Figure 2-7: Schematic of a Twister™ stir-bar used for SBSE and HSSE applications. 
 
HSSE was used for the chemical characterization studies involving the 
measurement of various cigarette vapor phase components present within the BAT 
exposure chamber. This technique was chosen based on the types of components present 
within the smoke sample (i.e. volatiles and semi-volatiles), the high sensitivity compared to 
SPME in order to analyze very dilute cigarette smoke and the physical size allowing it to be 
placed within the exposure chamber well.  
2.3 Description of Techniques used for the Separation and 
Identification of Smoke Constituents 
2.3.1 Chromatographic techniques: LC, HPLC and GC 
HPLC/TOFMS and LC/MSD were employed for the chemical characterization 
studies of the partial combustion products of chlorogenic acid in the particulate phase 
(Chapter 3). Based on the nature of the analytes (phenolic compounds), reversed phase 
chromatography with a non polar stationary phase (C18 or ether linked phenyl stationary 
  
48
 
phases used in Chapter 3 and Appendix B) and a mobile phase organic solvent such as, 
methanol was applied. Reversed phase separation involves using a stationary phase that is 
less polar than the mobile phase and is the most commonly used mode. 
GC/MS was employed for the chemical characterization of cigarette smoke vapor 
phase components (Chapter 5). The components of interest were relatively non-polar semi-
volatile and volatiles species. For this type of analysis by GC, elution is a function of 
volatility or boiling point. The stationary phase used was non polar and consisted of (5%-
phenyl)-methylpolysiloxane (DB5-MS). 
2.3.2 Fractionation by LC 
Preparative scale LC is a non-destructive technique that can be used for 
fractionation of samples for further analysis or purification purposes. The sample (can 
exceed injections > 20 μL) is injected and migrates through a column (dimensions used in 
Chapter 3: 250 mm × 22 mm and 100 mm × 21.2 mm) composed of a stationary phase and 
mobile phase. Larger stationary phase particles are used and thus lower pressure for the 
mobile phase, allowing higher sample volumes to be injected. Fractions are collected at the 
column outlet. Separation of the sample occurs based on its partition between the mobile 
and stationary phases, in an identical manner to HPLC. Preparative LC uses the same types 
of detector as HPLC (except with MSD). The sample exits the detector and is collected as 
fractions into different tubes. These fractions can be further separated or analyzed for their 
chemical or toxicological properties. With MSD, which is a destructive technique, a small 
portion of the effluent exiting the column is split off the main stream for detection.    
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2.3.3 UV Absorbance Detection 
Ultraviolet absorbance detection is the most common LC detection method because 
most solutes absorb light in the 180-350 nm wavelength range. Some of the compounds 
that absorb light in the UV range include those containing double bonds (π electrons) and 
unshared electrons. Simple detection systems use a mercury lamp, which has an intense 
line emission at 254 nm. More sophisticated instruments use a deuterium, or xenon lamp, 
which emit over ultraviolet and visible wavelengths, or a tungsten lamp for the visible 
region only, combined with a monochromator to select the specific wavelength for 
molecular absorption  (Harris, 2006).   
LC/UV was employed for the fractionation studies of the partial combustion 
products of chlorogenic acid (Chapter 3). This type of instrumentation was used because it 
allowed for a large-scale injection generating sufficient fractionation volumes for the 
subsequent toxicological testing. In addition, the types of solutes present in the samples 
generated (phenolic type compounds) absorb well at the 254 nm wavelength, so a mercury 
lamp detector could be used. LC/UV was used for the Borgwaldt RM20S® instrument 
reliability studies (Chapter 4), involving the quantification of solanesol (which absorbs well 
at 254 nm) in TPM.  
2.3.4 Mass Spectrometry Detection (MSD) 
Mass spectrometry is a technique that provides identification of the molecular mass 
and possibly information concerning the structure of a given analyte(s). For small organic 
molecules, the accuracy of the molecular mass can be measured within 5 ppm, depending 
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on the detector (i.e. to 0.001 amu for an analyte of mass 200 g/mol), which is often 
sufficient to confirm the molecular formula of a compound, depending on the complexity 
of the sample. Mass spectrometry is both qualitative and quantitative and is used for a large 
range of compounds. The technique is based on ionization of molecules to produce charged 
species that are separated according to their mass-to-charge (m/z) ratios and then detected 
with a high sensitivity electron multiplier or microchannel plate. 
Given the complexity and unknown composition of the samples in this study, 
accurate mass measurement providing the empirical formula for given analytes was 
required in order to identify the compound(s) of interest without the use of standards (i.e., ± 
5 ppm provided by a TOFMS). In addition, MSD allows to monitor a wide range of 
compounds (m:z’s). HPLC/TOFMS (equipped with an electrospray ionization source and 
referred to as simply LC/TOFMS in Chapter 3) was employed for the chemical 
characterization studies of the partial combustion products of chlorogenic acid in the 
particulate phase. LC/MSD (equipped with a quadrupole analyzer) was also used to 
identify the products that were responsible for the bioactivity assessed by the IVMNT 
(Chapter 3).  
GC/MS (equipped with a electron impact ionization source and quadrupole 
analyzer) was employed for the chemical characterization studies of the cigarette smoke 
vapor phase generated, diluted and delivered by the Borgwaldt RM20S® and within the 
BAT exposure chamber (Chapter 5). This type of instrumentation was used because the 
target compounds which were present in cigarette smoke vapor phase were volatiles and 
semi-volatiles. Due to the complexity of cigarette smoke, in terms of types and number of 
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products, interest in volatile aromatic compounds and other volatiles/semi-volatiles 
species, GC/MS has been commonly used for the separation and identification of cigarette 
smoke products (Torikaiu et al., 2005, Moldoveanu et al., 2007, Nanni et al., 1990).   
2.3.5 Quantification by Flame Ionization Detection (FID) 
FID which is usually coupled to GC, is used for the analysis of hydrocarbons and 
other flammable compounds. It is very sensitive and its response is linear with carbon 
content of a given analyte across a wide range of concentrations, thus, it is often coupled to 
GC.  
The sample comprised of organic compounds enters the FID and components are 
pyrolyzed at the temperature of a hydrogen/air flame. Pyrolysis produces positively 
charged ions and electrons that conduct electricity through the flame. The ions are repelled 
towards the collector plates (tabular electrodes) that are connected to an ammeter. Upon 
hitting the plates, the ions induce a current that is detected by the ammeter. The signal is 
then amplified, integrated and displayed. Therefore, the current measured corresponds to 
the proportion of reduced carbon atoms in the flame. The pyrolysis products are vented 
through an exhaust port. The FID is mass sensitive rather than concentration sensitive.  
A mini FID (not coupled to GC) was employed in the Borgwaldt RM20S® 
instrument reliability studies (Chapter 4), involving the quantification of a CH4 standard 
gas. This method was used because it is routinely used for hydrocarbon analyses and it was 
readily available in our laboratory. 
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2.3.6 Quantification by Infrared Detection (IR) 
IR spectroscopy is based on absorption of light in the infrared region of the 
electromagnetic spectrum and can be used to identify compounds or sample composition 
because of the narrow spectral bands achieved. Gases can be directly injected into IR 
spectrometers. The emission source is split into two beams (one passes through the sample, 
the other through the reference). The beams are both reflected back to the detector and two 
absorbance (or transmittance) signals are compared.  IR spectroscopy is based on the fact 
that molecules have specific frequencies corresponding to discreet energy levels, at which 
its atoms vibrate and thus absorb light at exactly these energy levels. 
An IR detector was employed in the Borgwaldt RM20S® instrument reliability 
studies, involving the quantification of a CO standard gas. This type of detector was used 
because CO is active in the IR region, but is not detected by FID, and it was readily 
available in our laboratory. 
2.4 The in Vitro Micronucleus Test (IVMNT) used to Assess the 
Relative Bioactivity of Chlorogenic Acid Combustion 
Products 
As mentioned in the previous section, the IVMNT in a short-term in vitro 
genotoxicity and cytotoxicity assay. Genotoxicity testing evaluates the effects of a 
particular test substance on DNA (DNA damage), which has been linked to carcinogenesis 
and arteriosclerosis (CORESTA, 2002). Chromosomal aberrations and gene mutations are 
  
53
 
key results of DNA damage (Heddle et al., 2010). Cytotoxicity is measured by cell 
viability (takes into account cell death by apoptosis and necrosis) and is a critical step in the 
disease process associated with carcinogenesis and emphysema (CORESTA, 2002). This 
assay has the advantages of avoiding the use of in vivo rodent toxicological testing, being 
applicable to various cell types, providing genotoxic and cytotoxic information 
simultaneously, being sensitive to tobacco smoke, fast and easy to perform compared to 
traditional tests (OECD, 2004). The major drawbacks related to this assay include: that it 
can not assess both vapor and particulate phases, simultaneously; solvents used to prepare 
extracts may cause interferences; and as with other in vitro biological assays, there can be a 
high variability between samples based on the heterogeneity of cell cultures (20 % RSD). 
The IVMNT can detect compounds that induce the formation of micronuclei (i.e. 
small membrane bound DNA fragments) in the cytoplasm of mammalian cells at the 
interphase. The compounds that induce the formation of micronuclei are referred to as 
clastogenic (cause chromosomal loss) or aneugenic (interfere with normal chromosomal 
segregation) (CORESTA, 2002, OECD, 2004). The micronuclei may result from acentric 
fragments (chromosomes that do not contain a centromere-structural modification) or 
chromosomes that do not migrate with the rest of the chromosomes during anaphase of the 
cell cycle (CORESTA, 2002, OECD, 2004).   
A fixed number of cells (5×105 cells) are harvested in 25 cm3 flasks one day prior to 
exposure. The general procedure for the IVMNT begins with a 3 hour exposure of cells 
(mammalian cells such as: V79 Chinese hamster fibroblast cells; or human lymphocytes) to 
the test substance (CORESTA, 2002, OECD, 2004). Following exposure, cytochalasin B is 
added to block cell division, but not nuclear division. Cells are grown long enough to 
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undergo nuclear division and observe binucleated  interphase cells (OECD, 2004). Those 
interphase cells that have undergone chromosomal damage, will contain additional 
micronuclei. The cells are harvested, fixed to glass slides, stained with a fluorescent dye 
(acridine orange) and microscopically analyzed for the presence of micronuclei. Positive 
(mitomycin C, a clastogen) and negative controls (1 % solvent, i.e., DMSO) are included in 
every experiment. DMSO is typically used as the solvent for samples in in vitro assays and 
cigarette smoke total particulate matter, due to its excellent solvent properties for polar and 
non-polar compounds. At the 1 % concentration, DMSO does not interfere with the assay 
(Misra et al., 2010). A positive test result is indicated by a dose-response relationship 
different than that of the negative control and is comprised of usually 3 test concentrations 
(OECD, 2004).  
Slides are scored at 400× magnification according to Fenech’s criteria (Fenech et 
al., 2003).   
Micronucleus
Binucleated 
cell with one 
micronucleus
Mono-nucleated 
cell 
 
Figure 2-8: Photograph of fluorescently stained cells (binucleated cell with one micronucleus on left and a 
mono-nucleated cell on the right) obtained from the IVMNT assay. 
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The percentage of micronuclei, which is a measure of genotoxicity, is determined 
by first selecting 1000 binucleated cells and then counting the number of these having at 
least one micronucleus detected, as follows: 
100
cells dbinucleate of No. Total                   
imicronucle more or one  withcells dbinucleate of No.
  ei Micronucl% ×



=       (Equation 2-2) 
       
The percentage of inhibition of cell proliferation was calculated by first determining 
the Cytokinesis-Block Proliferation Index (CBPI) as follows:  
[ ]



 +
=
 cells mitotic  -  cells No. Total                           
cells nucleated -multi and -tetra tri-, of No.2  cells dbinucleate No.
CBPI           (Equation 2-3) 



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

= 100
control  solventCBPI mean
dose  sampleCBPI mean
 -100  ionproliferat cell of  Inhibition %            (Equation 2-4) 
 
The average and relative standard deviation (RSD) for the percentages of micronuclei 
and inhibition of cell proliferation are generally calculated from duplicate experiments. 
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3.1 Abstract 
Chlorogenic acid is the most abundant polyphenol found in the tobacco plant. The 
biological effects of its combustion products remain largely unknown. In this study, 
chlorogenic acid was burned at 640 oC for 2 min and the particulate matter of the smoke 
was collected onto Cambridge filter pads followed by selective extraction in five different 
solvents. Various fractions of the chlorogenic acid combustion products were tested for 
induction of micronuclei in V79 Chinese hamster fibroblast cells. Over 40 compounds were 
identified in the dimethyl sulfoxide (DMSO) extract by high performance liquid 
chromatography coupled to electrospray time-of-flight mass spectrometry (HPLC/TOF-
MS). The DMSO extract was then fractionated into three major fractions by preparative 
LC. The fraction inducing the highest degree of toxicity was further separated into four 
sub-fractions. The sub-fraction responsible for the most toxic response was determined to 
contain catechol as its major component. The overall reproducibility of the combustion, the 
extraction procedure and the chemical characterization of the compounds responsible for 
the toxicity in the chlorogenic acid smoke were evaluated by LC/TOF-MS.  
 
3.2 Introduction 
Tobacco consists of over 2000 components and upon combustion generates more 
than 7000 compounds (Rodgman et al., 2009b). Due to the highly complex nature of 
tobacco smoke, the exact mechanisms of toxicity are still unknown. For instance, a number 
of lists of cigarette smoke toxicants have been published in recent years, some of which 
have begun to estimate the relative toxicity of  the compounds found in tobacco smoke 
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(Rodgman et al., 2003). However, these approaches are unable to account for the 
complex chemical profile and potential interactions that may occur in cigarette smoke. 
Many studies have been carried out on whole tobacco smoke in efforts to determine the 
correlation between tobacco smoke components and their biological effects (Hoffmann et 
al., 1997, Jansson et al., 1986, Paschke et al., 2002).  
An alternative approach is to study the individual components found in leaf tobacco, 
which upon combustion generate a variety of bioactive species. Among the major groups of 
constituents found in tobacco, the polyphenol group accounts for about 10 % of the leaf dry 
weight (Stedman, 1968, Huber, 1989). Among the polyphenols, chlorogenic acid (CGA) 
(3-[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-1,4,5-
trihydroxycyclohexanecarboxylic acid) is the most abundant single constituent. It 
represents about 1 – 3 % or higher of leaf dry weight of the tobacco plant (Runeckles, 
1963, Wynder et al., 1967). Several studies have identified components found in smoke 
from the combustion of CGA (Sharma et al., 2002a, Schlotzhauer et al., 1982, Sakuma et 
al., 1982, Schlotzhauer et al., 1992), and other studies have identified CGA as well as some 
of its combustion products as being genotoxic and carcinogenic (Stich et al., 1981, Li et al., 
1997, Gopalakrishna et al., 1994). Combustion of CGA principally generates pyrocatechol 
(more commonly known as catechol), phenol, hydroquinone, quinide, benzene and benzoic 
acid. Some of these phenolic compounds were reported to be toxic (Schlotzhauer et al., 
1992, McCue et al., 2003, Robertson et al., 1991) whereas catechol and phenol were 
reported to enhance carcinogenic processes induced by other compounds such as 
polynuclear aromatic hydrocarbons (Hoffmann et al., 1983). 
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A few groups have reported toxicological data on individual components found in 
tobacco smoke (Li et al., 1996, Li et al., 1997, McCue et al., 2003, Préfontaine et al., 2006, 
Poirier et al., 2001). A previous study (Préfontaine et al., 2006) indicated that of twelve 
tobacco components tested, the combustion products of the two polyphenols, CGA and 
lignin contained the most bioactive components, evaluated by the in vitro micronucleus test 
(IVMNT). The IVMNT is an in vitro genotoxicity test used to identify chemicals that 
induce the formation of small, membrane-bound deoxyribonucleic acid fragments, called 
micronuclei, in the cytoplasm of interphase mammalian cells (Health Canada, 2004b, 
Health Canada, 1999, OECD, 2004, CORESTA, 2002). CGA is the least complex and most 
readily available of the two above polyphenolic compounds found in tobacco, therefore, it 
was chosen for further investigation. The objective of the current study was to identify the 
toxic compounds resulting from the combustion of CGA under atmospheric conditions. The 
so-called incomplete combustion conditions were adopted to mimic the process occurring 
during the burning of a cigarette. A strategy to partially combust, extract, fractionate and 
concurrently evaluate the chemical composition and relative toxicity of the combustion 
products of CGA by in vitro toxicological assays was designed. Our approach combines 
analytical chemistry and in vitro toxicology to expand knowledge on the toxicity of smoke 
constituents generated from the partial combustion (i.e., burning) of one single tobacco 
component, chlorogenic acid.  
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3.3 Experimental  
3.3.1 Chemicals and reagents  
All standards and reagents used for the combustion reproducibility study were 
supplied by Sigma–Aldrich (St. Louis, MO, USA) and were of ≥ 99.0 % purity unless 
otherwise indicated: hydroquinone (123-31-9), phenol (108-95-2), m-cresol (108-39-4), p-
cresol (106-44-5), o-cresol (95-48-7), pyrocatechol (120-80-9), resorcinol (180-46-3), 3,4-
dihydroxybenzoic acid (90-50-3), caffeic acid (331-39-5), trans-cinnamic acid (140-10-3), 
ferulic acid (1135-24-6), 2,5-dihydroxybenzoic acid (490-79-9), p-hydroxybenzoic acid 
(99-96-7), 1,2-cyclohexanedione (765-87-7) at 97 %, p-coumaric acid (501-98-4) at 98 % 
and CGA (CAS 327-97-9) at ≥ 95 % purity. Glass wool (Pyrex brand wool filtering fiber) 
was purchased from Corning (Big Flats, NY, USA). The HPLC grade solvents used for the 
filter extraction and the CGA combustion reproducibility study were dimethyl sulfoxide 
(DMSO), methanol (MeOH), dichloromethane (DCM), ethyl acetate (EA), acetonitrile 
(ACN), acetic acid and formic acid, all purchased from Fisher Scientific (Whitby, Canada) 
and used without further purification. Water used for the filter extraction was either 
distilled water purified using a Milli-Q system (Millipore, Billerica, MA, USA), which 
consisted of a carbon cartridge, two high-capacity mixed ion exchange cartridges and a 
0.45 µm filter (Chromatographic Specialties, Brockville, Canada) or HPLC grade water 
from Fisher Scientific. Formic acid for HPLC/MS studies was obtained from Fluka (Buchs, 
Switzerland). Benzoic acid (65-85-0) at 99.5 % purity was supplied by Laboratoire MAT 
(Beauport, Canada). Appropriate ventilation measures and protection of researchers were 
employed for all manipulations that involved the use of organic solvents and compounds 
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known or suspected to be toxic. The operation of all instruments used in this study was 
carried out according to the safety procedures recommended by the manufacturers.  
3.3.2 Sample preparation  
Aliquots composed of 0.5 g CGA dissolved in 5 mL of MeOH were mixed with the 
aid of a vortex then deposited onto a matrix of 0.5 g of glass wool in individual Petri 
dishes. To evaporate the MeOH, the sample was stored for at least 72 h in a conditioned 
room at 22.5 oC with 60 % relative humidity. Following the storage period, the corrected 
mass of CGA adsorbed on the matrix was determined to ±1.0 mg by subtracting the glass 
wool matrix and Petri dish mass (includes CGA adsorbed onto the Petri dish) from the total 
mass of the sample (mass of matrix, CGA aliquot and Petri dish).   
3.3.3 Partial combustion of CGA and collection/extraction of the 
particulate phase  
The CGA sample adsorbed onto the glass wool matrix was transferred from the Petri 
dish and packed (7.5 cm bed length) into a quartz combustion tube (outer dimensions: 26.5 
cm × 1.2 cm, wall thickness: 1 mm). A John Payne Tar Predictor (JPTP) (John Payne 
Machinery Spares, Winchester, UK) apparatus was used to burn CGA and collect the 
particulate phase of its smoke. The quartz tube that contained the CGA sample was 
automatically driven into the furnace where the burning process was conducted at 640 oC 
±10 oC for 2 min. During this time, atmospheric air was drawn through the quartz tube at 
1.8 L/min, forming smoke that passed through the Cambridge filter of diameter 55 mm 
(Borgwaldt, Richmond, VA, USA) which trapped the particulate phase of the smoke, or 
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total particulate matter (TPM). Full combustion in air, by definition, should render all 
organic compounds to CO, CO2 and H2O. Therefore, to be accurate, the burning process 
employed here results in partial or incomplete combustion of CGA. Silicone grease was 
used to avoid leaking of smoke from the tubing at specific locations.  
To allow for deposition of the particulate phase, each Cambridge filter was set aside 
for a period of 15 – 60 min. The Cambridge filter was weighed to ±0.1 mg before and after 
the burning process to determine the mass of collected TPM. The particulate matter 
collected on the Cambridge filter was extracted under vacuum, using a Büchner funnel, by 
adding drop-wise a specific volume of solvent as follows. For DMSO extraction, the 
volume of DMSO used was that needed to obtain a final concentration of 15 mg/mL of 
TPM, assuming 100 % extraction efficiency9. For the other solvents, the extraction volume 
was fixed at 10 mL per filter to obtain a suitable volume for the subsequent biological 
assay. The extraction solvent was then evaporated using a rotary evaporator (except when 
water was used) (Rotavapor-R, Büchi, Switzerland) followed by lyophilization (FreeZone 
4.5 L Benchtop Freeze Dry System, Labconco, Kansas, MO, USA). The dry particulate 
matter (DPM), which refers to the residue remaining after the evaporation of the extraction 
solvent, was reconstituted in DMSO to give a final concentration of 15 mg/mL of DPM for 
the water, MeOH and EA extracts and 5 mg/mL for the DCM extract. A more dilute 
solution of the DCM extract was necessary to maintain a manageable volume since very 
little DPM was obtained. For each different solvent a new set of Cambridge filters with 
collected material from CGA burning was utilized. An “extract” resulted from pooling the 
  
63
 
extraction solutions of three Cambridge filters unless otherwise stated. Extracts were 
then aliquoted into 1.5 mL vials and stored in the dark at -80 oC. All toxicity and 
chromatography experiments using the extracts were performed in duplicate, unless stated 
otherwise. 
3.3.4 Mammalian cell cultures  
The cellular lineage used for the IVMNT assay was an internationally registered V79 
Chinese hamster cell line (lung fibroblast) obtained from the European Collection of Cell 
Cultures (V79 86041102 lot 04/C/016). Cells were cultured in complete culture medium 
(Dulbecco Modified Eagle Medium, DMEM; Gibco, Grand Island, NY, USA) 
supplemented with 10 % (v/v) heat-inactivated fetal bovine serum (FBS) and 0.5 % (v/v) 
penicillin/streptomycin (50 units/mL, 50 µg/mL), both from Gibco. Cells were re-
suspended by trypsinization (0.1 % trypsin, 1.06 mM EDTA; Gibco) at 37 oC. 
Subcultivation of cells was performed two times per week ((1.0–2.0) × 105 cells) into a 
75 cm3 Corning flask.  
3.3.5 In Vitro Micronucleus Test (IVMNT)  
The IVMNT was performed with V79 Chinese hamster fibroblast cells without 
metabolic activation (S9 fraction). Cells were grown in 25 cm3 flasks at a concentration of 
5.0 × 105 cells/mL in 10 mL of DMEM for 24 h. The culture medium was then replaced by 
the DMSO-dissolved extracts added to DMEM at the following concentrations to which the 
                                                                                                                                                    
9 DMSO is an aprotic polar solvent with a polarity index of  7.2 and is an excellent solvent for polar organic 
compounds, acids, alkalis and mineral salts. Thus, it is likely that DMSO has an extraction efficiency less 
than 100 % for some of the non-polar compounds found in the particulate phase of tobacco smoke.  
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cells were exposed for three hours: 5, 10, 15 and 20 µg of DPM (or TPM) per mL of 
DMEM. The positive control was mitomycin C (MMC, 0.8 µg/mL; Sigma–Aldrich) and 
the negative control was DMSO (1 % (v/v) in DMEM). After the 3 h exposure, cells were 
rinsed twice with Hanks’ Balanced Salt Solution (HBSS, Gibco) and re-incubated for 17 h 
in DMEM containing 3 µg/mL cytochalasin B (which blocks cellular division, but does not 
block nuclear division). Cells were harvested by trypsinization, re-suspended in culture 
medium at 1.0 × 105 cells/mL and centrifuged onto microscopic slides at 1200 rpm for 8 
min using a Cytospin 3 (Shandon, London, UK). Slides were then air dried, fixed in 90 % 
methanol (9 min at -20 oC) and stained with Acridine Orange solution for 30 s 
(12.5 mg/100mL of 1×-PBS; Sigma–Aldrich). Finally, slides were scored at 400× 
magnification according to Fenech’s criteria (Fenech et al., 2003). The percentage of 
micronuclei, which is a measure of genotoxicity, was determined by first selecting 1000 
binucleated (BN) cells and then counting the number of these having at least one 
micronucleus detected, as follows: 
 
100
cells BN of no. Total                   
imicronucle more or one  withcells BN of No.
 
ei%Micronucl
×



=
 
 
where a micronucleus is defined as a particle surrounded by distinct borders, having a 
maximum of one third the size of the main nucleus and lying inside the cytoplasm (Frieauff 
et al., 1998). The percentage of inhibition of cell proliferation was calculated by first 
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determining the Cytokinesis–block Proliferation Index (CBPI) (Fenech et al., 2003) as 
follows:  
[ ]



 +
=
 cells mitotic  -  cells of no. Total                           
cells nucleated -multi of No.2  cells BN No.
CBPI  
where multi-nucleated cells are those having three or more nuclei 
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The average and relative standard deviation (RSD) for the percentages of micronuclei and 
inhibition of cell proliferation were calculated from duplicate experiments.  
3.3.6 Reproducibility study of the CGA combustion  
The precision of the combustion of CGA was evaluated by HPLC using a Waters 
2695 Separation Module with a Waters 715 Ultra Wisp automatic injector (Milford, MA, 
USA). Detection was achieved with a Waters 2475 Multi wavelength fluorescence (FL) 
detector. The instrument was controlled by ChemStation Plus Family software version 
A.08.03 (Agilent Technologies). Separation was achieved on a Spherisorb, ODS2 
analytical column (5 µm particles, 150 mm × 4.6mm) from Waters. 
Reproducibility of the combustion method was determined by comparing the quantity 
of selected phenolic compounds obtained from four different combustions (Health Canada, 
1999, Risner et al., 1990), but using only 25% of the TPM from each. A quarter of each 
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Cambridge filter (one per combustion) was extracted with 10 mL of 1% (v/v) aqueous 
acetic acid for 30 min on an orbital shaker. The four extracts from the four combustions 
were each filtered through a 0.45 µm filter, of which, 2 mL was collected for analysis by 
HPLC/FL. The volume of each extract injected was 10 µL. Separation was achieved by 
gradient elution (0–100 % ACN in 1 % (v/v) aqueous acetic acid over 46 min) at a mobile 
phase flow rate of 1.2 mL/min. The total run time was 66 min. Quantification was achieved 
by external calibration as follows. A stock solution of 1.00 mg/mL of each standard 
compound was prepared in 1 % (v/v) aqueous acetic acid. From the stock solutions, six 
working solutions, ranging from 0 to 50 µg/mL, were prepared in 1 % (v/v) aqueous acetic 
acid, filtered through a 0.45 µm filter and transferred into 2 mL amber vials. A 20 µL 
volume of each working solution was injected in duplicate and a standard calibration curve 
was made by plotting the concentration of the working solutions versus their respective 
peak areas.  
3.3.7 Reproducibility study of the extraction with DMSO and DCM  
HPLC/MS was used to assess the precision of the DMSO and DCM extraction 
procedure. The instrument consisted of an 1100 HPLC system (Agilent Technologies, 
Waldbronn, Germany) directly interfaced with an Agilent electrospray ionization single 
quadrupole mass spectrometer (LC/MSD). Injections of 5 µL (75 μg of product per 
injection) of DMSO or DCM extracts (the latter having been re-suspended in DMSO) were 
made onto an Eclipse XDB-C18 analytical column (5 µm particles, 150 mm × 4.6mm) 
from Agilent Technologies. Separation was achieved using a gradient elution of 0–80% 
MeOH in 0.1 % (v/v) aqueous formic acid over 24 min at a flow rate of 0.5 mL/min. The 
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total run time was 30 min. For mass spectrometric detection, ions were generated in 
negative electrospray mode with 4000 V applied on the capillary. The fragmentor was set 
at 70 V and the drying gas (N2) was heated at 300°C and run at 10 L/min. Spectra were 
acquired from m/z 75 to m/z 575 at a rate of 0.94 s/cycle. The reproducibility of the method 
of extraction by DMSO and DCM was determined by comparing the peak areas (for 
duplicate injections) of the following 13 phenolic reference compounds consistently found 
in the 4 different DMSO extracts: catechol, hydroxyquinone, 4-methyl catechol, 4-vinyl 
catechol, 2-hydroxybenzoic acid, 4-hydroxybenzoic acid, 4-ethyl catechol, 1-(3,4-
dihydroxyphenyl) ethanone, p-coumaric acid, coumaric acid, hydrocaffeic acid, quinic acid 
and caffeic acid methyl ester. 
3.3.8 Analytical separation of the DMSO extract  
Accurate mass-based identification of several products found in the DMSO extract 
was achieved using an Agilent 1100 HPLC system directly interfaced with a 6120 series 
electrospray ionization time-of-flight (TOF) mass spectrometer from Agilent Technologies. 
The LC/TOF-MS instrument was controlled by Agilent Mass Hunter software, and the data 
was processed by Analyst QS software (Agilent Technologies/Sciex). Samples were diluted 
1:100 in HPLC grade water and 2 µL aliquots (0.3 μg of product per injection) were 
injected onto the Eclipse XDB-C18 analytical column. The chromatographic separation 
was performed in gradient mode (0–80 % MeOH in 0.1 % v/v, aqueous formic acid over 45 
min) at a flow rate of 0.5 mL/min. The total run time was 60 min. For MS detection, ions 
were generated in negative electrospray mode with 4000 V applied on the capillary. The 
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fragmentor was set at 200 V and the heated drying gas (N2 at 350°C) was run at 12 
L/min. Spectra were acquired from m/z 50 to m/z 1000 at a rate of 0.94 s/cycle. 
3.3.9 Preparative fractionation of the DMSO extract10  
The LC system used for preparative fractionation of the DMSO extract consisted of a 
Gilson 215 LC Handler with 156 UV-VIS absorbance detector (Middletown, WI, USA) 
directly interfaced with an LCQ single quadrupole mass spectrometer from Thermo Fisher 
Scientific (Waltham, MA, USA). The instrument was controlled by XCalibur software, 
version 1.3 (Thermo Fisher) and Gilson Unipoint software. DMSO extracts (15 mg/mL) 
were injected (1.8 mL) and separations were performed on a Prevail C18 preparative 
column (5 µm particles, 250 mm × 22mm) from Alltech (Lexington, KY, USA) by gradient 
elution (0–80 % MeOH in 0.1 % (v/v) aqueous formic acid over 20 min) at a flow rate of 
15 mL/min. The total run time was 30 min and the UV signal was recorded at 254 nm 
concomitant to monitoring the MS signal. Fractions of 8 mL each were collected every 39.1 
s into borosilicate disposable culture tubes (10mm × 100mm; Fisher Scientific) and then 
pooled to give three major fractions spanning the following time intervals: 0-14.2 min, 
14.2-23.5 min and 23.5-30 min. A second injection of 1.8 mL (27 mg) was treated 
identically and pooled with the corresponding major fractions from the first injection in 
round bottom flasks. The three (pooled) fractions were reduced in volume using a rotary 
evaporator for approximately 10 min at 30 oC under a moderate rotation speed. The flasks 
were then immersed and rotated in acetone/dry-ice to induce uniform sample freezing. 
Finally, the remaining liquids were lyophilized overnight and re-suspended in 50% MeOH 
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(aq), transferred into pre-weighed vials which were again rotavapped, lyophilized and 
weighed to obtain the correct mass for each fraction. The quantities of the products 
obtained were, 39.5, 22.5 and 7.9 mg respectively, for the first through third pooled 
fractions. The fractions were stored at -80 oC in clear glass vials. Approximately 29 % 
more material was collected than was injected (69.9 mg collected versus 54 mg injected, by 
calculation). This discrepancy is probably due11 to residual DMSO in the first fraction that 
can not be entirely evaporated by lyophilization. 
3.3.10 Chemical characterization and separation of fraction 2  
The LC/TOF-MS described above, which is a high resolution system, was used for 
the chemical characterization of the most bioactive fraction of the DMSO extract. This was 
achieved by first using the lower resolution LC/MSD system (see section in 
Reproducibility studies) to optimize the separation of a test mixture representative of 
fraction 2, comprised of the following seven standards: caffeic acid, benzoic acid, p-
coumaric acid, p-hydroxybenzoic acid, trans-cinnamic acid, 4-hydroxy-3-methoxycinnamic 
acid and 2,5-dihydroxybenzoic acid. This test mixture was injected onto four different 
stationary phases: Synergi Polar-RP (4 µm, 150mm × 4.6mm), Synergi Hydro-RP (4 µm, 
150mm × 4.6mm), Gemini C18 (5 µm, 150 × 4.6mm) and Gemini C6-Phenyl (5 µm, 
150mm × 4.6mm), all from Phenomenex (Torrance, CA, USA). Separations were carried 
out under nine different gradient elution conditions by varying the initial MeOH 
concentration as follows: 10, 15, 20, 25, 30, 35, 40, 45 and 50 %, in 0.1 % (v/v) aqueous 
                                                                                                                                                    
10 A detailed experimental flow chart is given in Appendix A. 
11 Assumption made. 
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formic acid, with the gradient applied up to 75 %, over the first 24 min in each case. The 
best gradient conditions were transferred to the higher resolution LC/TOF-MS instrument 
and applied to the separation of fraction 2 components. Samples were first diluted 100-fold 
in 50 % MeOH (aq) to make them compatible with the dynamic range of the LC/TOF-MS, 
then injections of 2 µL (corresponding to 0.3 μg of product) were made on the four 
columns listed above. The total run time was 30 min at a flow rate of 0.5 mL/min. 
3.3.11 Preparative sub-fractionation of fraction 2 
To sub-fractionate “fraction 2” of the DMSO extract by preparative LC, an injection 
of 2.0 mL was made on the instrument described for preparative fractionation of the DMSO 
extract. Samples (4.24 mg/mL in 75%, v/v, MeOH (aq)) were injected in duplicate and 
separations were performed on an AXIA packed Synergi Polar-RP preparative column (4 
µm particles, 100 mm × 21.2mm) from Phenomenex. A Polar-RP security guard prep 
cartridge (15mm × 21.2 mm) from Phenomenex was installed upstream of the preparative 
column. The chromatographic separation was performed in gradient mode (15–75% MeOH 
in 0.1 %, v/v, aqueous formic acid over 20 min) at a flow rate of 6 mL/min. The total run 
time was 30 min and the UV signal was monitored at 254 nm concomitant with the MS 
signal. Fractions of 4 mL each were collected every 19.8 s into borosilicate disposable 
culture tubes (10mm × 100mm; Fisher Scientific) and then pooled to give four large sub-
fractions spanning the following time intervals: 12.0-15.2, 15.2-16.4, 16.4-21.2 and 21.2-30 
min. Each pooled sub-fraction was placed in a round-bottom flask and was treated as 
described above during the first fractionation step. The amounts of product obtained for the 
first through fourth pooled sub-fractions were 2.16, 1.49, 5.87 and 9.07 mg respectively. A 
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small portion of (major) fraction 2 of the DMSO extract was used for control studies. 
Samples were kept at -80°C in clear glass vials until utilization.  
3.3.12 Chemical characterization of sub-fraction 1 
The LC/TOF-MS system described above was used for the accurate mass 
identification of products present in the sub-fraction displaying the highest toxicity. 
Samples were diluted 1:100 in 50 % (v/v) MeOH (aq) and injections of 2 µL aliquots were 
performed on the Polar-RP column (4 µm, 150 mm × 4.6mm) followed by separation by 
gradient elution (0–80 % MeOH in 0.1%, v/v, aqueous formic acid over 24 min) at a flow 
rate of 0.5 mL/min. The total run time was 15 min. 
3.3.13 Statistical analysis  
The results for the combustion reproducibility study were tested for comparison of 
linearity between different groups of either extracts or fractions using the analysis of 
covariance (ANCOVA) method. For comparison between the DMSO extracts, the 
percentages of micronuclei (genotoxicity) and inhibition of cell proliferation were taken as 
the direct quantitative variable, the dose of exposure as the quantitative dependent 
covariable and the extraction solvent was taken as the qualitative covariable for two 
replicates. ANCOVA compares the dose–response linearity between each extract. 
Significant differences between extracts were determined by the Duncan’s multiple 
comparison test and were considered significant when p < 0.05. Toxicological data 
obtained from the IVMNT for the different solvent extracts and fractionation studies were 
analyzed using XLSTAT software, version 7.5 (Addinsoft Brooklyn, NY, USA).  
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Analysis of variance (ANOVA) was used to evaluate the toxicity results where the 
dose, the CGA extracts, the fractions and the sub-fractions were all considered as factors. 
The dose by extract/fraction interaction was also included in the model. In order to assess 
differences between the CGA extracts/fractions for the different doses, the dose by extract 
interaction was investigated using multiple comparisons. More specifically, the 
extracts/fractions were analyzed by the Fisher least significant difference multiple 
comparison test with a Bonferroni correction to type 1 error to ensure that the overall risk 
was kept under α = 5%. In all cases, the background level of genotoxicity generated by the 
control solvent (1% DMSO) was subtracted from the micronuclei percentage values for all 
samples. As a result of the statistical analysis, the data were grouped as follows: A, B or C. 
Samples sharing the same letter, i.e., lie within the same group, are not statistically 
different.  
 
3.4 Results and discussion 
The various toxicological studies carried out on tobacco smoke have been generally 
related to the combustion products of whole tobacco (Frenesius, 1985, Rodgman, 2003, 
DeMarini, 2004).  The aim of our study was to characterize the toxicity of the combustion 
products of one individual tobacco component, CGA, which is the major polyphenolic 
component of tobacco. A few toxicological studies have reported on the genotoxicity of 
CGA (Stich et al., 1981) and its incomplete combustion products (Schlotzhauer et al., 
1992, Hoffmann et al., 1983, Préfontaine et al., 2006). In addition, some chemical studies 
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have been published on the identification of CGA combustion products (Sharma et al., 
2002a, Sakuma et al., 1982). However, no previous study on relating genotoxicity to the 
chemical composition of the combustion products of CGA has been made. The combustion 
conditions used in this study were chosen based on the range of temperatures found during 
the combustion of cigarettes, which occur between 300 °C and 900 °C and higher (Baker, 
1981). The precision of our chemical analyses required a robust and reproducible means of 
simulating the partial combustion of CGA, which was why the JPTP apparatus was 
employed. Furthermore, this study was carried out at a single combustion temperature of 
640 °C for simplicity.12 
3.4.1 Reproducibility study of the CGA partial combustion process 
In order to understand and quantify any variability in the toxicological and/or 
chemical analyses, it was deemed important to evaluate the precision of the CGA 
combustion method. This was assessed by comparing: (a) the phenolic content in four 
different extracts by HPLC/FL and (b) the genotoxicity and the degree of inhibition of cell 
proliferation between three of the four extracts using the IVMNT. The Cambridge filters 
were extracted with 1% (v/v) aqueous acetic acid for this study because this solution is 
known to extract phenolic compounds well (Risner et al., 1990).  
HPLC/FL showed that the concentration of hydroquinone, resorcinol, catechol and 
phenol (reported as a function of the quantity of TPM extracted per quarter filter) varied 
with an average RSD of 15.5% (and median RSD of 12.6%) (Table 3-1). p-Cresol was 
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often below the limit of quantification. The high polarity of the solvent may have 
impeded the extraction of p-cresol, thus explaining why the latter was barely detected13. To 
evaluate the relative proportion of each compound, their concentrations were normalized 
relative to hydroquinone (Table 3-2) for each experiment to eliminate the sampling error 
associated with extracting only ¼ of the filter pad. The relative (i.e. normalized) 
concentrations of the phenolic compounds resorcinol, catechol and phenol determined by 
HPLC/FL, showed an average of 11.1 % RSD (Table 3-2). This precision is in close 
agreement with the HPLC/FL determination of phenols in the particulate phase of 
mainstream cigarette smoke of the 1R5F reference cigarette reported recently by 
Moldoveanu and Kiser (Moldoveanu et al., 2007). As seen in Table 3-1, the concentration 
of phenol varied the most among the four combustions; its RSD was more than twice that 
of the other phenolic compounds. Although phenol is the most volatile of the five species, 
ineffective trapping was ruled out as a source of its high variability because the temperature 
did not exceed 45 °C at the Cambridge filter pad position14. Although the experimental 
procedure was identical for each sample, it is possible that slight differences in the 
rotavaporation step may have contributed to losses of phenol in some samples. Calibration 
using an internal standard such as 4-chlorophenol deposited on the Cambridge filter pad 
prior to extraction (Moldoveanu et al., 2007) would be necessary to confirm this.   
 The IVMNT method was chosen to measure the extracted TPM bioactivity because 
it is one of the in vitro toxicity tests recommended for tobacco smoke studies by 
                                                                                                                                                    
12 Inside a burning cigarette, temperatures range from ambient to 950 ºC (Baker, 1981) and many bioactive 
products are formed between 500-800 ºC  (Torikai et al., 2004). Below these mentioned temperatures, partial 
combustion would not be as efficient. 
13 Recovery tests not performed. 
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CORESTA and Health Canada (CORESTA, 2002, Health Canada, 2004b, OECD, 2004). 
Overall, although a variation of 11.1 % in normalized phenolic content was present 
between the extracts, this did not translate into a similar variation in bioactivity. The 
IVMNT data (Figure 3-1a and 3-1b) showed that the percentages of micronuclei and 
inhibition of cell proliferation among different extracts were not significantly different as 
per the Duncan’s multiple comparison test. Therefore, we decided to continue with this 
method of combustion using the JPTP. However, to reduce the impact of the high 
variability between combustions, we pooled the extracts from three independent 
combustions to obtain one final pooled extract, which was then divided into equal aliquots 
and stored at -80°C for subsequent toxicological and chemical assays.  
                                                                                                                                                    
14 Phenol has a boiling point of 182 °C, thus, volatility was not the major source of variation at 45 °C. 
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Table 3-1: Reproducibility of the partial combustion process of CGA: phenolic compounds identified by HPLC/FD in 1% (v/v) aqueous 
acetic acid extracts of the TPM from ¼ of each of four Cambridge filters. 
Hydroquinone Resorcinol Catechol Phenol p-Cresol
λexcitation (nm) - 285 270 270 270 270
λemission (nm) - 325 310 310 298 305
Combustion 1 27.8 16.1 0.8 32.9 10.2 0.1
Combustion 2 33.2 19.5 1.0 40.4 16.1 0.1
Combustion 3 32.9 19.2 1.0 34.1 10.4 < LOD
Combustion 4 38.2 15.1 0.9 31.2 9.1 0.1
Average 33.0 17.5 0.9 34.7 11.5 0.1
RSD (%) 12.9 12.6 10.4 11.6 27.5 N/Ca 15.5
CGA combustion 
replicates
TPM qty on ¼ 
Cambridge filter (mg)
Phenolic content (µg/mg TPM) Average
 
a N/C: not calculated.  
Table 3-2: Normalized phenolic content relative to hydroquinone (from Table 3-1). 
Hydroquinone Resorcinol Catechol Phenol p-Cresol
Combustion 1 1.00 0.052 2.042 0.633 0.006
Combustion 2 1.00 0.053 2.076 0.826 0.007
Combustion 3 1.00 0.053 1.775 0.539 0.001
Combustion 4 1.00 0.060 2.067 0.604 0.005
Average - 0.054 1.990 0.651 0.005
SD - 0.004 0.144 0.124 0.003
RSD (%) - 7.1 7.2 19.0 N/Ca 11.1
CGA combustion replicates Normalized quantity relative to hydroquinone Average
 
a N/C: not calculated.  
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Figure 3-1: The genotoxic activity (% micronuclei), (a), and inhibition of cell proliferation 
(b), induced by DMSO extracts from three independent combustions of 0.5 g of CGA, on 
V79 cells exposed for 3 h without metabolic activation. Dose refers to the quantity of TPM 
or DPM (µg) per mL of medium. The three extracts were tested in the Duncan’s test (α = 
0.05) and no statistically significant difference was found. ( ) combustion 1; 
( ) combustion 2;  combustion 3. Error bars indicate standard deviation. 
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3.4.2 Effect of extraction solvent  
Selective solvent extraction was used to initiate the chemical characterization study 
of CGA combustion products. The five solvents, used in parallel, were DMSO (polarity 
index (P)=7.2, dipole moment15 (DM)=3.96), water (P=9, DM=1.85), MeOH (P=5.1, 
DM=1.70), DCM (P=3.1, DM=1.60) and EA (P=4.4, DM=1.78), thus yielding five 
different extracts. These solvents were chosen due to their different polarity index values 
and because of the limited selectivity and high variability observed with 1% (v/v) aqueous 
acetic acid as an extraction solvent. Schlotzhauer and Chortyk showed that tobacco directly 
extracted with solvents of various polarity or “extraction strength” yielded extracts of 
different chemical composition (Schlotzhauer et al., 1981). According to their miscibility 
and polarity index, the most hydrophilic products are preferentially extracted by DMSO, 
water and MeOH, whereas less hydrophilic products are found in the DCM and EA 
extracts. Generally, the phenolic compounds have amphiphilic properties, and thus should 
be found in every extract. In a previous work (Lacasse, 2007), GC/MS analysis of the five 
extracts of CGA combustion products showed the presence of phenolic compounds such as 
catechol, phenol, hydroquinone, ethyl catechol, benzoic acid and quinic acid in most of the 
extracts.  
Based on their chemical composition and the relative amounts of each combustion 
product, certain extracts among the five tested were expected to induce a higher degree of 
genotoxicity and/or inhibit cell proliferation than others by the IVMNT. The percentage of 
micronuclei, or genotoxicity, is shown in Figure 3-2a for the five extracts. At a dose of 20 
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µg/mL, the genotoxicity induced by the DCM extract was significantly different from the 
water and MeOH extracts, but not from the DMSO and EA extracts. The inhibition of cell 
proliferation is shown in Figure 3-2b for the five extracts. At doses of 5 and 10 µg/mL 
there was no statistically significant difference in the genotoxicity induced, as evaluated by 
ANOVA. However, at doses of 15 and 20 µg/mL, the inhibition of cell proliferation 
induced by the DCM extract was significantly different from all other extracts except 
DMSO at 15 µg/mL, and except water and DMSO at 20 µg/mL. The negative values 
observed for the inhibition of cell proliferation reflect cell growth. Overall, the DMSO and 
DCM extracts induced higher biotoxicity compared to extracts obtained using water, EA 
and MeOH.  
DCM is the least polar of the solvents tested and thus would be expected to extract 
phenolic compounds, which are known to be bioactive. DMSO on the other hand possesses 
excellent solvating powers; it dissolves both polar and non-polar compounds. Furthermore, 
a low concentration of DMSO (1 % (v/v) in DMEM) has low toxicity (Vignes, 2000), 
which was why the other extraction solvents were reconstituted in DMSO for the IVMNT 
assays16. 
 
                                                                                                                                                    
15 Dipole moment is related to polarity and describes the distance of separation between charges (nature of 
bonds). Solvent-solute interactions are affected by their dipole moments. 
16 Following re-constitution in DMSO, extracts were analyzed to ensure that initial solvents were not present 
to contribute to toxic response. 
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Figure 3-2: The genotoxic activity (% micronuclei), (a), and inhibition of cell proliferation, 
(b), induced by DCM, DMSO, water, EA and MeOH extracts generated from combustions 
of 0.5 g of CGA, on V79 cells exposed for 3 h without metabolic activation. Dose refers to 
the quantity of TPM (µg) per mL of medium. n = 2 for all the condensates except DCM and 
DMSO, where n = 4. The dose/extraction solvent interactions were analyzed by the Fisher 
least significant difference multiple comparison test with a Bonferroni correction to type 1 
error to ensure that the overall risk was kept under α = 0.05. Letters A, B and AB designate 
different statistical groups. Error bars have been removed for clarity. 
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3.4.3 Reproducibility study of the extraction with DMSO and DCM  
Based on the results comparing extraction by five different solvents, the precision of 
the DMSO and DCM extraction procedures was evaluated by LC/MS to ensure a robust 
and reliable method. Four independent combustion experiments were carried out for both 
DMSO and DCM. Each extract obtained was injected in duplicate. The abundance (peak 
areas) of 13 reference compounds found in the extracts were monitored (Table 3-3). 
Retention times were highly reproducible (≤ 0.1% RSD) across the four extracts tested for 
both extraction solvents. The peak area precision of the DMSO extraction (< 10 % RSD) 
was nine times better than that of DCM (data not shown)17. This may have been due to the 
volatile nature of DCM; evaporation may have occurred during the extraction procedure 
leading to less reproducible results. Therefore, DCM extraction was not further 
investigated. In addition, DMSO was observed to extract a larger number of compounds, 
which is in keeping with its good solvating strength. With respect to biological activity, the 
DMSO extracts were not further tested by the IVMNT since the results above showed that 
variation in genotoxicity and inhibition of cell proliferation was minimal even though 
phenolic content varied greatly (15.5 % average RSD, Table 3-1). 
                                                 
17 For some compounds, the peak area precision was up to nine times better for DMSO extracts, i.e., for 
quinic acid RSD from DCM extracts was 49 %, compared to 5.6 % for DMSO. The precision may have been 
due to the volatility of DCM, thus, leading to an inefficient extraction compared to DMSO. 
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Table 3-3: Reproducibility of the extraction by DMSO (n=4), with respect to peak area 
for 13 phenolic compounds identified by LC/MSD (negative mode).    
 
Reference product name Average peak area RSD (%)
(103)
Catechol 19 ± 1 5.3
Hydroxyquinone 400 ± 30 7.5
4-Methyl catechol 29 ± 2 6.9
4-Vinyl catechol 710 ± 40 5.6
2-Hydroxybenzoic acid 160 ± 10 6.3
4-Hydroxybenzoic acid 310 ± 20 6.5
4-Ethyl catechol 210 ± 20 9.5
1-(3,4-Dihydroxyphenyl)ethanone 25 ± 2 8.0
p -Coumaric acid (isomer 1) 170 ± 10 5.9
Coumaric acid (isomer 2) 34 ± 3 8.8
Hydrocaffeic acid 120 ± 6 5.0
Quinic acid 54 ± 3 5.6
Caffeic acid methyl ester 30 ± 3 10.0  
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3.4.4 Analytical separation of the DMSO extract  
Accurate mass determination by LC/TOF-MS was used to identify the main 
components, and class of components, in the whole DMSO extract (Figure 3-3). Over 40 
compounds were identified by negative ionization mode, which was used because the 
majority of the combustion products possessed alcohol and/or acidic functional groups. 
These results guided the choice of which fractions to pool for preparative LC. 
Several phenolic compounds were present in the DMSO extract, which is consistent 
with previous studies of CGA (Sharma et al., 2002a, Schlotzhauer et al., 1992, Sakuma et 
al., 1982). Based on the complexity of the combustion products of a single tobacco 
component like CGA, we can only begin to imagine the complexity of whole tobacco 
smoke. Only techniques like LC/MS and gas chromatography–MS (Moldoveanu et al., 
2007, Vaughan et al., 2008) have the selectivity and resolution needed to provide reliable 
identification and quantification of such a large range of components. Although the DMSO 
extract was bioactive according to the IVMNT, it was difficult to identify the specific 
compounds responsible for bioactivity. Therefore, it was necessary to further simplify the 
extract. Some potential techniques to achieve this include: filtration, centrifugation, liquid–
liquid extraction, solid-phase extraction and sample fractionation, among others. 
Fractionation by preparative scale LC was chosen based on its ability to divide the sample 
into precise portions having sufficient quantity for further analysis by the IVMNT.   
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Figure 3-3: Total ion chromatogram of the DMSO extract showing the CGA combustion products, which were analyzed by LC/TOF-MS in 
negative mode. The dashed lines have been overlaid to represent the compounds isolated in the three main fractions collected. 
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3.4.5 Preparative fractionation of the DMSO extract  
The DMSO extract was fractionated by preparative LC/UV (detection at 254 nm) into 
three major fractions, as indicated by the dotted lines in Figure 3-3. This allowed for 
determination of the difference in toxicity between fractions and presumably a convergence 
on the compounds responsible for the observed toxicity. The first fraction, which was 
selected to include quinic acid-related compounds and other non UV-absorbing species, 
contained 39.5 mg of product. The second fraction (22.5 mg) included catechol and its 
derivatives while the third (7.9 mg) comprised more hydrophobic compounds. Biotoxicity 
was assessed by the IVMNT. As illustrated (Figures 3-4a and 3-4b), among the three major 
fractions tested, fraction 2 induced the highest percentages of micronuclei and inhibition of 
cell proliferation compared to fractions 1 and 3. The increased level of toxicity generated 
by fraction 2 was likely due to the presence of phenolic compounds found in that fraction. 
Figure 3-4a shows that the whole DMSO extract as well as the second fraction induced the 
highest percentage of micronuclei. However, only the (whole) DMSO extract induced a 
significantly higher percentage of micronuclei at a dose of 35 µg/mL. Figure 3-4b shows 
that fraction 2 and the (whole) DMSO extract induced a significantly higher inhibition of 
cell proliferation compared to fractions 1 and 3 at doses of 15–35 µg/mL.  
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Figure 3-4: The genotoxic activity (% micronuclei), (a), and inhibition of cell proliferation 
(b), induced by (whole) DMSO extract, fractions 1–3. All other conditions as in Fig. 3-2.  
Error bars have been removed for clarity. 
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3.4.6 Chemical characterization and separation of fraction 2 
Due to its overall higher bioactivity, the second fraction was re-analyzed by 
LC/TOF-MS with accurate mass measurement to assess its chemical composition. 
Fraction 2 was found to contain catechol and its derivatives (methyl catechol, ethyl 
catechol and vinyl catechol), phenol, hydrocaffeic acid, 1-(3,4-
dihydroxyphenol)ethanone, 3,4-dihydroxybenzoic acid, p-hydroxycinnamic acid, p-
coumaric acid, caffeic acid methyl ester, caffeic acid and hydroxybenzoic acid (Figure 
3-3). Among these, the last 8 compounds  (hydrocaffeic acid to hydroxybenzoic acid) 
have not been previously reported as carcinogens, mutagens or teratogens as opposed to 
catechol, phenol and caffeic acid (Gold et al., 1997). As previously discussed, catechol 
and its derivatives are known to be responsible for induction of micronuclei and toxicity 
in the micronuclei assay (Robertson et al., 1991) and thus could be responsible for the 
increased level of bioactivity of fraction 2.  
The analytical separation of fraction 2 was optimized with respect to peak 
resolution with the objective of sub-fractionating it for further analysis to identify the 
compounds responsible for its bioactivity. Based on the compounds identified in 
fraction 2, a test mixture of seven standard compounds was prepared and a series of 
different stationary phases and eluant compositions were evaluated on the LC/MSD 
instrument as described in Materials and Methods. The best resolution for the test 
mixture was obtained with a 15 (or 20) to 75 % MeOH in 0.1 % (v/v) aqueous formic 
acid gradient over 23 min using the Polar-RP column (data not shown). This column, 
which is composed of an ether-linked phenyl stationary phase with polar end-capping, 
most likely enabled a more selective interaction with the aromatic compounds and 
improved their resolution. Subsequently, fraction 2 was analyzed under the optimized 
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conditions by LC/TOF-MS. This enabled separation of the quite abundant and 
bioactive catechol from three isomers of hydroxybenzoic acid (data not shown).  
 
3.4.7 Preparative sub-fractionation of fraction 2 and chemical 
characterization of sub-fraction 1  
The optimized analytical separation conditions used for fraction 2 of the DMSO 
extract were transferred to a Polar-RP preparative column for sub-fractionation. Figure 
3-5 shows how we generated the four major sub-fractions of fraction 2 by preparative 
LC. The genotoxicity induced by these four sub-fractions, as well as by major fraction 2 
and by the whole DMSO extract is shown in Figure 3-6a. No statistically significant 
difference (α=0.05) was measured by ANOVA between the six samples compared at the 
lower dose range (5 and 10 μg/mL). Whereas, at the dose ranges corresponding to 15 
and 20 μg/mL there were statistically significant differences in terms of generation of 
micronuclei between sub-fraction 4, the DMSO extract and sub-fraction 2. The 
inhibition of cell proliferation induced by the four sub-fractions, by fraction 2 and by 
the whole DMSO extract is compared in Figure 3-6b. Sub-fraction 1 and the DMSO 
extract induced a higher percentage of inhibition of cell proliferation but were only 
significantly higher compared to sub-fractions 2 and 3 at doses of 15 and 20 µg/mL. 
Overall, the IVMNT showed that sub-fraction 1 induced the highest degree of 
genotoxicity and inhibition of cell proliferation compared to the other sub-fractions. 
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Figure 3-5: Preparative LC chromatogram (254 nm UV trace) of fraction 2 of the 
DMSO extract showing the sub-fractions collected. The dotted lines have been overlaid 
to represent the four main sub-fractions collected. 
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Figure 3-6: The genotoxic activity (% micronuclei), (a), and inhibition of cell 
proliferation (b), induced by DMSO extract, fraction 2 and sub-fractions 1–4. All other 
conditions as in Fig. 3-2. Error bars have been removed for clarity. 
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Subsequently, sub-fraction 1 was analyzed by LC/TOF-MS (Figure 3-7) and 
found to contain catechol as the major component, 3,4-dihydroxybenzoic acid and a 
third, less abundant compound with the empirical formula C6H8O2. Based on this 
formula, some logical structures were deduced. One possible compound is 1,2-
cyclohexanedione, for which no toxicology information was found in the literature  A 
set of standards of 1,2-cyclohexanedione were prepared, but they were inactive in terms 
of toxicological response in the dose range of 5-20 μg/mL. A second possibility may be 
one of the isomers of dihydroxycyclohexadiene. Unfortunately, no standards were 
commercially available to test biotoxicity by the IVMNT. To the best of our knowledge, 
toxicological data is also not available for any of these isomers. Further structural 
analysis of the C6H8O2 compound was beyond the scope of this study.   
The second compound identified, 3,4-dihydroxybenzoic acid, is not known to be 
either genotoxic or an inhibitor of cell proliferation (Gold et al., 1997). Catechol, on the 
other hand, which was ca. 10-fold more abundant than 3,4-dihydroxybenzoic acid 
(Figure 3-7), was confirmed to be genotoxic and inhibit cell proliferation as seen in 
Figures 3-8a and 3-8b for catechol standards (5-20 μg/mL dose range) assessed by the 
IVMNT. These results support previous findings in terms of the toxicological response 
(Chouchane et al., 2006) and in terms of catechol being a product of the combustion of 
CGA (Gopalakrishna et al., 1994, Schlotzhauer et al., 1992, Robertson et al., 1991, 
Hoffmann et al., 1983, Schlotzhauer et al., 1982). Vaughan et al. recently reported that 
mainstream smoke from the 1R4F reference cigarette contained essentially the same 
quantity of catechol as hydroquinone per cigarette, whereas flue-cured tobacco 
cigarettes delivered an amount of catechol twice that of hydroquinone (Vaughan et al., 
2008). We also obtained a 2-to-1 ratio of catechol to hydroquinone in the extracted 
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particulate matter after partial combustion of CGA (Table 3-2). This suggests that 
CGA is one of the major sources of phenolic components in flue-cured tobacco 
(Vaughan et al., 2008), thus demonstrating that our choice to investigate the burning of 
the single tobacco component CGA is a simpler yet valid alternative to using whole 
tobacco smoke to study the relationship between toxicity and fractional chemical 
composition. 
  
93
 
 
Figure 3-7: Base peak LC/TOF-MS chromatogram (upper most trace) and extracted ion chromatograms (lower traces) of sub-fraction 1 of fraction 2 
of the DMSO extract of CGA combustion products. Separation conditions are given in Section 2. 
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Figure 3-8: The genotoxic activity (% micronuclei), (a), and inhibition of cell proliferation 
(b), induced by DMSO extract and catechol standards. All other conditions as in Fig. 3-1.  
( ) DMSO; ( ) catechol standard.  Error bars indicate standard deviation. 
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3.5 Conclusion 
A multidisciplinary study comprising solvent extraction, fractionation, bioassay and 
state-of-the-art LC/MS allowed us to systematically narrow in on the biotoxic components 
in the particulate matter produced from the incomplete combustion (i.e. burning) of 
chlorogenic acid (CGA). Extraction with DMSO followed by successive chromatographic 
fractionation combined with accurate mass identification and use of the IVMNT for 
bioactivity identified catechol, 3,4-dihydroxybenzoic acid and a minor, unidentified 
constituent (C6H8O2) as being components of the most bioactive sub-fraction of CGA 
combustion products. 3,4-Dihydroxybenzoic acid has not been reported to be genotoxic or 
an inhibitor of cell proliferation. Catechol, on the other hand, was the major component 
present in the most toxic sub-fraction and is known to be toxic. By testing catechol 
standards alone, we were able to confirm that catechol is indeed genotoxic and blocks cell 
proliferation in the dose working range. We suspect that catechol is therefore the major 
component responsible for the bioactivity resulting from the whole DMSO extract. 
Furthermore, a positive correlation was established between CGA (compared to other 
polyphenolic compounds) found in tobacco and catechol and ethyl-catechol found in smoke 
(Schlotzhauer et al., 1992, Schlotzhauer et al., 1982). This demonstrates that in terms of 
chemistry, our approach of studying a single component is not only valid but is also 
relevant. The relationship between CGA and catechol would support the reduction of CGA 
in tobacco in order to reduce catechol. 
Our research carried out on the combustion products of CGA may not be directly 
correlated to the smoke from all cigarette types due to the fact that the combustion of a 
single tobacco component does not take into account possible interactions between multiple 
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components during combustion. Also, the conditions of tobacco combustion, such as 
heating rate and atmospheric gas concentration have been shown to influence the relative 
proportions of the products (Baker, 1981). However, our methodology allows for the 
analysis of a simpler product mixture. Also, we cannot directly relate the toxicological 
results from the in vitro assays to in vivo toxicity since there are detoxification pathways 
involved in the latter. Finally, only the compounds detected by LC/MS in negative mode 
were accounted for. Nonetheless, our approach combining toxicology with chemical 
identification has contributed to a better understanding of the toxicity of a single tobacco 
component, CGA.  
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4.1 Abstract  
 The Borgwaldt RM20S® smoking machine enables the generation, dilution 
and transfer of fresh cigarette smoke to cell exposure chambers, for in vitro analyses. We 
present a study determining 18the precision (repeatability r, reproducibility R)19 and 
accuracy of smoke dose generated by the Borgwaldt RM20S® system and delivery to 
exposure chambers. Due to the aerosol nature of cigarette smoke, the repeatability of the 
dilution of the vapor phase in air was assessed by quantifying two reference standard gases 
methane (CH4, r between 29.0-37.0 and RSD between 2.2-4.5%) and carbon monoxide 
(CO, r between 166.8 -235.8 and RSD between 0.7-3.7%). The accuracy of dilution 
(percent error) for CH4 and CO was between 6.4-19.5% and between 5.8-6.4%, 
respectively, over a 10-1000-fold dilution range. To corroborate our findings, a small inter-
laboratory study was carried out for CH4 measurements. The combined dilution 
repeatability had an r between 21.3-46.4, R between 52.9-88.4, RSD between 6.3-17.3% 
and error between 4.3-13.1%. Based on the particulate component of cigarette smoke 
(3R4F), the repeatability (RSD = 12%) of the undiluted smoke generated by the Borgwaldt 
RM20S® was assessed by quantifying solanesol using high performance liquid 
chromatography with ultraviolet detection (HPLC/UV). Finally, the repeatability (r 
between 0.98-4.53 and RSD between 8.8-12%) of the dilution of generated smoke 
particulate phase was assessed by quantifying solanesol following various dilutions of 
                                                 
18 Originally published as “confirming the precision” and amended as “determining the precision” in the 
thesis.  
19 Repeatability measurements correspond to the agreement of individual results obtained from testing the 
same sample, in the same laboratory, having a difference in one of the following: analyst, apparatus or the day 
(Centre d’expertise en analyse environnementale du Québec, 2007). Reproducibility measurements 
correspond to the agreement of individual results obtained from testing one sample, in different laboratories, 
by a different analyst, on a different apparatus, on a different day (Centre d’expertise en analyse 
environnementale du Québec, 2007). 
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cigarette smoke.  The findings in this study suggest the Borgwaldt RM20S® smoking 
machine is a reliable tool to generate and deliver repeatable and reproducible doses of 
whole smoke to in vitro cultures. 
4.2 Introduction 
 Cigarette smoke is a complex aerosol mixture composed of over 5000 compounds 
(Rodgman et al., 2009b, Rodgman et al., 2009a) distributed between the particulate and the 
vapor phases. There are a number of different methods that have been used to investigate 
and assess the biological effects of cigarette smoke. These range from the design of an 
inhalation machine  for studies involving rodent in vivo whole smoke exposure 
(Baumgartner et al., 1980) to the use of skin painting carcinogenesis experiments using 
cigarette smoke condensates (Walaszek et al., 2007). A number of in vitro techniques have 
been reported that involve the exposure of submerged cellular cultures to either total 
particulate matter (TPM) or to aqueous cigarette smoke extracts (Cantral et al., 1995, 
Lannan et al., 1994, Nakayama et al., 1985).  
 These above methods may not be representative of the whole smoke exposure and 
toxicity. In addition, many in vivo studies involve direct animal exposure to cigarette 
smoke, often resulting in “forced inhalation” which may give rise to artifacts, considering 
that the animal is under distress throughout the exposure process. With respect to skin 
painting carcinogenesis studies, the test material is not identical to smoke inhaled by a 
smoker and is thus not representative of the major route of potential human exposure 
(Walaszek et al., 2007). For toxicological assessment of TPM, the use of dimethylsulfoxide 
(DMSO) as the TPM extraction solvent from a Cambridge filter pad (CFP) (Health Canada, 
2004b), may not be desirable for certain biological assay endpoints because DMSO is 
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known to act as an antioxidant, is a potent scavenger of free radicals and may possibly 
interfere with assays measuring oxidative stress (Kishioka et al., 2007, Misra et al., 2010). 
Another limitation of most in vitro studies is the incompatibility for simultaneous 
assessment of the vapor and particulate phase of cigarette smoke. Recent studies indicate 
that the vapor phase of cigarette smoke plays a major role in the toxicological responses 
(Bombick et al., 1997c, Bombick et al., 1997b, Phillips et al., 2004, Wieczorek et al., 2006, 
CORESTA, 2005). Thus, exposure to whole cigarette smoke (including both phases) 
should give a comprehensive description of cigarette smoke toxicity.  
   To study the toxicity of whole cigarette smoke, accurate and precise generation, 
dilution and delivery of the smoke would be desirable. Recent advancements have led to 
the development of advanced smoke generation systems, such as the Borgwaldt RM20S® 
smoking machine (Phillips et al., 2005), Burghart Mimic Smoker-01® (Scian et al., 2009a) 
, the Vitrocell Smoking Robot VC 10® (Aufderheide et al., 2000). Also this has led to the 
development of novel in vitro exposure systems such as British American Tobacco’s 
(BAT) exposure chamber (Phillips et al., 2005) and the CULTEX system (Aufderheide et 
al., 2000). These exposure systems have been designed to ‘minimize the loss of smoke 
components and to mimic the events occurring in the smoker’s respiratory tract’ according 
to Scian et al. (Scian et al., 2009a). They are direct exposure methods and thus are more 
representative of human inhalation than indirect methods using impingers (Lestari et al., 
2006) . These systems also allow for the generation of fresh cigarette smoke in various 
dilutions (or doses) and direct delivery to cell cultures. The ability to introduce smoke 
diluted over a wide range is required for in vitro cell culture investigations because of the 
high sensitivity of these biological systems. The Borgwaldt RM20S® smoking machine in 
combination with BAT’s exposure chamber using Transwell® inserts, enables direct 
 101
exposure of in vitro  cellular cultures to whole cigarette smoke at the air-liquid interface 
(Fig. 4-1) (Massey et al., 1998, Phillips et al., 2005). This smoking machine, first 
commercialized in 2005, can smoke up to eight cigarettes simultaneously with the smoke 
collected into eight independent syringes. Each syringe can dilute the cigarette smoke with 
air in ratios ranging from 1:1.14 to 1:4000 (smoke volume: air volume), which corresponds 
to a range of 87- 0.025 % (v/v) cigarette smoke in air. For biological exposures, doses tend 
to be in the range of 0.4- 5% (v/v) cigarette smoke in air (Phillips et al., 2005). The dose at 
this range of whole smoke dilution has been correlated to the quantity of TPM deposited on 
a CFP and on the Transwell® inserts within BAT’s exposure chamber (Massey et al., 1998, 
Phillips et al., 2005). However, the accuracy, precision and linearity of the smoke dose 
delivered to the exposure chamber by the Borgwaldt RM20S® smoking machine were not 
reported and therefore are the subject of the current study.  
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Figure 4-1:  Schematic of the exposure of cell or tissue culture to whole cigarette smoke or vapor phase using 
the Borgwaldt RM20S® in combination with BAT’s exposure chamber. The RM20S® can smoke up to eight 
cigarettes simultaneously, which correspond to a specific port, syringe and exposure chamber (A-D). The 
machine smokes the cigarettes, dilutes the smoke and delivers it into the exposure chambers (chambers were 
not used in this study). Exposure chambers A & B exposed to whole smoke versus C & D exposed to vapor 
phase only. 
 
 This study reports the repeatability, reproducibility and accuracy of whole smoke 
generation and dilution from the Borgwaldt RM20S® smoking machine using two gases 
(CH4 and CO) and a cigarette smoke particulate matter marker (solanesol). The two 
reference gases were chosen based on their presence in the vapor phase of cigarette smoke 
and facile quantification of CH4 by flame ionization detection (FID) and CO by infrared 
spectroscopy. To corroborate our findings, the CH4 reproducibility measurements were 
compared between two different laboratories (Montreal, Canada and Southampton, UK) 
using the same method. Secondly, for the particulate component of cigarette smoke, the 
repeatability of the smoke generated by the Borgwaldt RM20S® was assessed by high 
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performance liquid chromatography coupled to an ultraviolet absorbance detector 
(HPLC/UV) for solanesol (C45H74O) extracted from the cigarette filter tip of a reference 
cigarette (3R4F). Solanesol naturally occurs in tobacco leaves and has been used as a direct 
marker of the amount of cigarette smoke particulate phase generated during combustion 
(Armitage et al., 2004). Finally, the repeatability and reproducibility of the dilution of 
generated particulate phase were assessed based on extracted solanesol quantification for 
various dilutions of cigarette smoke. The precision and accuracy results obtained from this 
study will provide a reliable tool for dose delivery from the Borgwaldt RM20S® smoking 
machine, in combination with BAT’s exposure chamber and Transwell® inserts, for future 
studies of exposure of cells and tissue cultures to whole cigarette smoke. 
 
4.3 Materials and Methods 
4.3.1 Whole Smoke Exposure System: the Borgwaldt RM20S® Smoking 
Machine and BAT’s Exposure Chamber  
The Borgwaldt RM20S® (Borgwaldt KC GmbH, Hamburg, Germany) is an 
automatic smoking machine that generates and dilutes cigarette smoke for in vitro cell 
culture investigations (Borgwaldt KC, 2010). It has a rotary based engine that can 
simultaneously smoke four types of cigarettes for several hours, depending on the smoking 
regime used. The instrument has an incorporated anemometer allowing for correct air flow, 
as well as electrical lighter, butt detector and butt extractor. The Borgwaldt RM20S® was 
designed in collaboration with BAT (Southampton, UK) and can be used with BAT’s 
exposure chamber to enable cells or tissues to be exposed to the diluted smoke generated 
by the Borgwaldt RM20S®. Within the chamber, the cells or tissues lie on a 24 mm 
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diameter Transwell-Clear® insert (Corning, NY, USA) which is a microscopically 
transparent porous polyester membrane, and are exposed to smoke at the air-liquid 
interface (Thorne et al., 2009, Phillips et al., 2005).  
Prior to the study, the entire instrument, including the syringes20, was thoroughly 
cleaned by repeated rinsing with 70 % (v/v) ethanol in water until all residues were visibly 
removed. The cleaning solvent was allowed to evaporate thoroughly before conducting 
experiments At the beginning of each day, the instrument was tested as follows: the air 
velocity was verified to be 20 ± 3 cm/sec; checks were performed for air leaks (acceptable 
range of pressure between 2750-3000 Pa); and the puff volumes were adjusted to 35 mL. In 
between trials on the same day, clearing puffs were performed to reduce the potential effect 
of carry over. Following usage, the smoking ring, cigarette holders, butt length detector, 
airflow lid and ashtray were cleaned using the same ethanol-water mixture described above 
to ensure that all tar, ashes and loose pieces of tobacco did not build up and hinder the 
operation of the instrument. This cleaning procedure was done within 12 h before the next 
usage, always permitting sufficient time for the solvent to evaporate afterwards. 
4.3.2 Vapor Phase Measurements-General Procedure  
Two reference gas standards, CH4 and CO, were chosen to assess the precision and 
accuracy of the smoke diluted by the Borgwaldt RM20S® instrument using a recovery-
based study at several dilution levels. The general procedure was as follows: a sealed bag 
was filled with one of the two standard gases and placed at the inlet of the Borgwaldt 
RM20s® smoking machine (cigarette smoking position). The gas was then diluted in 
                                                 
20 Syringes were calibrated with a similar technique as described below for CH4 measurements and pistons 
were manually adjusted in order for the syringes to produce given predicted values of CH4. 
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compliance with the International Standard Organization (ISO) puffing profile, 
consisting of a 35 mL puff volume, 2 s puff duration and 60 s puff interval (International 
Organization for Standardization, 1999) for a total of 10 or 15 min. A clean, pre-evacuated 
gas bag was connected to the exhaust position to collect the diluted standard gas. All four 
syringes (A-D) were assessed. The CH4 measurements were compared between the two 
laboratories. 
4.3.3 CH4 Measurements in the Canadian Laboratory 
The methane reference standard, comprised of 10% CH4 in argon (Praxair, Danbury 
CT, USA), was used to assess dilutions corresponding to reference standard gas 
concentrations in air of 0.1, 0.2 and 0.52% (v/v) (i.e., dilution factors of 1000-, 500- and 
193-fold, respectively). Quantification of CH4 for each syringe (A-D) was made with a 
3010 MINIFID portable heated flame ionization detector (FID) total hydrocarbon analyzer 
(Signal Instruments, Willow Grove, PA, USA). This FID has a stated accuracy of better 
than ±0.2 ppm (or ±1%, whichever is greater) with linearity better than ±0.05 ppm (0.5%) 
for an analyte range of 0-100 000 ppm hydrocarbon, which was thus well suited for this 
study because the measured CH4 concentrations ranged from 100 to 520 ppm. Triplicate 
runs were performed for each syringe at each dilution level, which took a period of three 
days to complete. The FID was calibrated each day using hydrocarbon-free air and a 500 
ppm span gas (external reference, CH4 in air (Praxair)). Given the specifications for the 
detector, it was presumed that 520 ppm CH4 was still within the linear dynamic range even 
though it lies slightly above the external calibration point. The FID was fueled by a mixture 
of hydrogen with helium (40/60) (Praxair).  
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4.3.4 CH4 Measurements in the UK Laboratory   
The procedure in the UK laboratory was the same as that carried out in Canada with 
the following exceptions: the modified Borgwaldt RM20S® instrument contained eight 
syringes (syringes 1-8); the reference standard was 10% CH4 in nitrogen (Air Products 
PLC, Cheshire, UK); runs were performed in quadruplicate; the 3010 MINIFID portable 
heated FID (same as above) used for quantification was from Signal Group Ltd, Surrey, 
UK. 
4.3.5 CO Measurements  
The carbon monoxide reference standard, comprised of 9.98% CO (Praxair), was 
used to assess dilutions corresponding to reference standard gas concentrations in air of 1, 
2, 5 and 10% (v/v) (i.e., dilution factors of 100-, 50-, 20- and 10-fold, respectively). 
Quantification of CO for syringes A-D (n=3/syringe) was made using a COA 205 infrared 
CO analyzer (Cerulean, Milton Keynes, UK). According to the manufacturer, the infrared 
analyzer has an accuracy of better than ±0.1 ppm (or ±1%) for a 0-100 000 ppm dynamic 
range. The general procedure described above was changed slightly to improve the method. 
The first modification included sending off the first puff to waste and collecting the second 
to sixteenth puff (15 puffs total). This was implemented to exhaust the air in the tubing to 
obtain a more accurate measurement of CO. Secondly, the connectors used for the gas bags 
were changed to reduce the dead volume. The infrared analyzer was calibrated each day 
using air and a 0.5% CO span gas (external reference, Praxair), which was deemed 
adequate for the targeted CO concentration range (i.e., 0.1 to 1%) and given the 
instrument’s wide dynamic range.  
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4.3.6 Particulate Phase Measurements-General Procedure 
The cigarettes used in this study were Kentucky reference cigarettes (3R4F, 
University of Kentucky, USA) and were conditioned at 22°C and 60% relative humidity for 
48 h prior to smoking. Cigarettes were smoked with compliance to ISO puffing profiles as 
described above. Cigarettes were smoked simultaneously (corresponding to syringes A-D) 
for 30 min for a total of 30 puffs/port (1 puff/min). For individual ports, this corresponded 
to four cigarettes being smoked per port. The cigarette smoke was evaluated directly in the 
filter tips (n=10/syringe) and also after dilution in air to concentrations of 1, 2 and 5% (v/v) 
(i.e., dilution factors of 100-, 50- and 20-fold, respectively and n=3/syringe/dilution). Three 
runs were performed daily and the order in which dilutions were made was changed over 
the days to reduce potential bias. All four syringes were assessed.  
Quantitation of solanesol, a cigarette smoke particulate phase marker, was used to 
assess the precision of smoke delivery in the Borgwaldt RM20S® instrument before and 
after smoke dilution. Standard solutions of solanesol (Sigma-Aldrich, St. Louis, MO; ≥ 
95%) were prepared to construct a calibration curve consisting of concentrations ranging 
from 0.45 to 150 μg/mL in methanol (Thermo Fisher Scientific, Whitby, Canada, 99.9%). 
Solanesol was quantified by liquid chromatography with absorbance detection (at 210 nm) 
using an Agilent 1200 HPLC/UV system equipped with ChemStation software version 
B.03.02, (Agilent Technologies, Waldbronn, Germany). Separations were made on a Luna 
C18 analytical column (3 µm, 50 mm x 2.0 mm) with C18 guard column (Phenomenex, 
Torrance, CA, U.S.A.) under isocratic elution conditions in methanol:acetonitrile (70:30 
(v/v)) at a flow rate of 0.3 mL/min. The total run time was 10 min. The column temperature 
was set to 30 °C and the autosampler cooler was set to 5 °C. Injections of 10 μL of all 
standards and samples were performed in duplicate. Peak areas were used for quantitation 
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and the extraction solvent was used as a blank. The instrumental detection limit (LOD) 
was determined using the standard deviation (σ) in the background noise of the solvent 
blank and the slope of the external calibration curve (i.e., LOD = (3σ)/slope), whereas the 
method detection limit was determined using the peak height for solanesol at 1% (v/v) 
smoke dilution and the corresponding baseline noise to calculate 3σ.    
4.3.7 Solanesol Measurements Prior to Dilution 
The solanesol content in the cigarette filter tips was used to assess the smoke 
delivery precision prior to (i.e., up-stream of) the dilution. From the individual filter tips 
(butts), 10 mm portions were cut from the mouth end and the four butts for a given port- 
corresponding to a 30 min smoking duration- were pooled to represent one sample and 
stored at -20 °C until analysis. The TPM from each pooled sample was extracted in 16 mL 
methanol with agitation using a flat bed shaker at 200 rpm for 20 min. Ten smoke samples 
were generated for each port (A-D) and analyzed for solanesol content by HPLC in order to 
evaluate the repeatability of smoke generation prior to the dilution step. 
4.3.8 Solanesol Measurements Following Dilutions 
To assess the repeatability and reproducibility of smoke delivery following dilution 
by the instrument, solanesol was quantified after its collection on a 44 mm diameter 
Cambridge filter pad (CFP) inserted after the dilution syringe (i.e., in place of the exposure 
chamber, (Fig. 4-1). Each CFP was transferred to a 125 mL Erlenmeyer flask for 
extraction. To prevent any residue loss, the filter holder was wiped down with a quarter of a 
clean CFP, which was added to the Erlenmeyer flask. The “diluted” TPM on the CFP was 
extracted with 8 mL of the following solvent mixture under agitation for 20 min: 1% (v/v) 
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anethol (Acros Organics, Geel, Belgium, 99%), 0.25% (v/v) ethanol (Les Alcools de 
Commerce, Boucherville, Canada, 95%) and 0.1% (v/v) methanol in isopropanol (Thermo 
Fisher Scientific, 99.9%).  
4.3.9 Statistical Analysis  
Statistical analyses were carried out using MINITAB® v. 15.1.30 statistical 
software. The precision figures of merit calculated were relative standard deviation (RSD) 
across syringes at each dilution level, repeatability (r) and/or reproducibility (R). Linear 
regression was used to compute predictive equations and correlation coefficients for CO, 
CH4 and solanesol. For gas phase measurements of CO dilutions, RSD and repeatability 
within the Canadian laboratory only were calculated. The repeatability limit, r, in this case 
is defined as the difference that can be expected between two individual measurements 
carried out on the same syringe with a probability of 0.95.  
The inter-laboratory study was carried out for CH4 dilution measurements only. In 
the case of CH4, r is defined as the difference that can be expected between two individual 
measurements carried out within either laboratory with a probability of 0.95. 
Reproducibility, R, is the difference that can be expected between two measurements 
carried out between the two laboratories, two operators and two instruments, with a 
probability of 0.95. For this study, r and R were calculated by taking into account all of the 
results obtained from both Canada and UK laboratories. 
For particulate phase measurements, repeatability, r, was calculated for solanesol 
dilutions in the same way as for CO for the Canadian laboratory only. In addition, a control 
chart (Shewhart chart) was used to visually compare the smoke delivery from the four ports 
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measured using solanesol. This tool also allowed assessment of the stability for smoke 
delivery from each port over time.  
 
4.4 Results 
4.4.1 Vapor Phase Measurements 
The accuracy of dilution by the instrument’s syringes was estimated by introducing 
a known, fixed concentration of CH4 at the smoking port (10% CH4 in argon gas reference 
standard) and then measuring the CH4 concentration in the gas collected in each syringe for 
the three levels of dilution tested: 0.1, 0.2 and 0.52% (v/v) in air. For 100% accuracy21 at 
each dilution level, the expected concentrations of collected methane should be 0.01% (100 
ppm), 0.02% (200 ppm) and 0.052% (520 ppm). The precision of dilution was estimated 
based on triplicate CH4 measurements for each syringe at each dilution level. The overall 
accuracy (reported as percent error) for the Canadian laboratory CH4 measurements across 
the three dilution levels and four syringes (A-D) was between 6.4-19.5%, of which only 1% 
or less is attributed to error in the FID instrument used for the measurements, and the 
precision (reported as RSD) was between 2.2-4.5% (Table 4-1). The correlation between 
the selected CH4 dilution level and measured CH4 concentrations after dilution was 
evaluated by linear regression, giving an equation of CCH4 = 35.54 + 0.86·Dilution and 
correlation coefficient of >0.98, which indicated good linearity across the dilution range 
studied (Fig. 4-2). According to the instrument specifications, error in the linearity for this 
analyte range due to the FID alone is ±0.5 % and is thus not a significant contribution. The 
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accuracy and precision were best in the middle range of dilutions (Table 4-1, last two 
columns). There was a positive bias at lower measurements and underestimation of the 
highest selected CH4 concentration since the y-intercept was greater than zero and the slope 
was 14 % less than the predicted value of 1.0022.  
 
Table 4-1: Summary of the Borgwaldt RM20S®’s dilution precision: r, RSD and error values from measured 
CH4  for selected levels of dilution for syringes A-D used in the Canadian laboratory (n=3). 
 
Dilution CH4 Target Mean CH4 Repeatability RSD Error
(%) (ppm) (ppm) r (%) (%)
0.52 520 480.0 29.0 4.5 8.0
0.2 200 208.8 22.5 2.2 6.4
0.1 100 119.5 37.0 3.5 19.5  
                                                                                                                                                    
21  Originally published as “For a recovery of 100% (i.e., an accuracy approaching 0% error)“ and amended as 
“For 100% accuracy”  in the thesis. 
22 The achieved data values (y axis) should be as close to the predicted data values (x axis), thus, ideally 
attaining 1.00. 
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Figure 4-2:  Assessment of the Borgwaldt RM20S® dilution precision and accuracy: correlation between the 
FID-based quantification of collected CH4 as a function of the selected level of dilution for syringes A-D for a 
10% CH4 standard reference gas (Canadian laboratory), i.e., CH4 doses of 0.1, 0.2 and 0.52 % (v/v) in air. 
Data were acquired in triplicate for all dilution levels (n=3). Linear fit analysis: y = 35.5 + 0.8557x (R2 = 
0.987) with upper and lower confidence intervals (dotted lines) and predicted intervals (dashed lines) 
calculated at 95% probability. 
 
 
The CH4 dilution measurements taken in the Canadian laboratory were compared to 
those taken in the laboratory located in the UK with a similar instrument having 8 syringes 
(syringes 1-8) for the same dilution levels (n=4/syringe) (Table 4-2). Contrary to results for 
the Canadian laboratory alone, accuracy was marginally better at the highest selected 
dilution level for the combined laboratories (Table 4-2, last column), even when taking into 
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consideration up to ±1% measurement error in the FID. The combined accuracy and 
precision data for all 12 syringes-four in the Canadian laboratory instrument (syringes A-D) 
and the eight in the UK laboratory instrument (syringes 1-8) were plotted (Fig. 4-3). The 
slopes, which reflect the accuracy of CH4 measurements across the dilution range, were 
0.86 and 0.93 for the Canadian and UK laboratories, respectively, and 0.91 for the pooled 
data (Fig. 4-3). By plotting the accuracy and precision of dilution of CH4 for the 12 
individual syringes (in the two laboratories) and the individual dilution levels, syringe bias 
depending on dilution level was observed (Fig. 4-4). At the target level of 100ppm, or 
dilution of 0.1% selected (top panel, Fig. 4-4), the variability between syringes is lower in 
the Canadian than in the UK laboratory. On the contrary, at the target level of 520ppm for 
dilution of 0.52% (bottom panel, Fig. 4-4), the variability between syringes is lower in the 
UK than in the Canadian laboratory. Despite these differences, the data are still consistent 
across groups; the combined repeatability and linearity of the dilution range studied had an 
RSD between 6.3-17.3% with R2 >0.98 and accuracy between 4.3-13.1% (in percent error). 
From the RSD values, the lowest target dilution level gave the least favorable precision 
(Table 4-2). However, based on the r and R values calculated, the inter-lab variability was 
low and similar to inter-run variability for only the 0.1% (v/v) sample.  
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Table 4-2: Overall precision figures of merit of r, R, RSD and error values from measured CH4  for three 
dilution levels for syringes A-D used in the Canadian laboratory (n=3), syringes 1-8 used in the UK 
laboratory (n=4). 
 
Dilution CH4 Target Mean CH4 Repeatability Reproducibility RSD Error
(%) (ppm) (ppm) r R (%) (%)
0.52 520 497.8 45.8 88.4 6.3 4.3
0.2 200 210.2 21.3 52.9 9.0 5.1
0.1 100 113.1 46.4 54.7 17.3 13.1
 
 
 
Figure 4-3:  Assessment of the Borgwaldt RM20S® dilution precision and accuracy: correlation between the 
FID-based quantification of collected CH4 as a function of the selected level of dilution by any given syringe 
for a 10% CH4 reference standard. Data were acquired for all dilution levels and 12 syringes, i.e., for syringes 
A-D used in the Canadian laboratory (n = 3/syringe/dilution) and syringes 1-8 used in the UK laboratory (n = 
4/syringe/dilution). Calculated slopes were for each laboratory and combined measurements. 
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Figure 4-4: Dilution precision for individual syringes as a function of the desired level of dilution. Graphs showing the concentration of CH4 collected after dilution of a 
10% CH4 gas standard by the syringes in both Borgwaldt RM20S® instruments (used in laboratories in Canada and the UK). Top, middle and bottom panels represent 
dilutions to 0.1%, 0.2% and 0.52%, respectively. Mean CH4 concentrations are plotted with standard deviations (n=3) for each syringe. 
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 Similar to the methane experiments, quantification of carbon monoxide (9.98% CO 
gas reference standard) collected at each syringe in the Canadian laboratory instrument, but 
for four dilution levels (1, 2, 5 and 10%), was also used to asses the accuracy and precision 
of dilution. For 100% accuracy23 at each dilution level, the expected concentrations of 
collected CO would be 0.0998% (998 ppm), 0.1996% (1996 ppm), 0.499% (4990 ppm) and 
0.998% (9980 ppm). Based on triplicate runs at each dilution level, the overall precision 
was determined to be between 0.7-3.7% RSD, of which 1% error can be attributed to the 
measurement system according to the manufacturer, and accuracy was between 5.8-6.4% 
relative error (Table 4-3). A good correlation between the targeted and the measured CO 
concentration across the 4 levels of dilution was observed (Fig. 4-5). The slope was 
0.913724 compared to the predicted value of 0.998—an absolute error of 8.4%—but 
linearity was good with R2 = 0.99. The CO detection system contributes only 1% to the 
total error. Having attained values within acceptable criteria (RSD < 10% and R2 >0.95) for 
both reference gases studied indicates that the equipment reliably generates and delivers 
accurate doses of whole smoke. 
 
 
 
 
                                                 
23 Originally published as “For 100% recovery (i.e., 100% accuracy)“ and amended as “For 100% accuracy”  
in the thesis. 
24 Originally published as “913.7 compared to the predicted value of 998” but amended as “0.9137 compared 
to the predictied value of 0.998”. 
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Table 4-3: Summary of the Borgwaldt RM20S®’s dilution precision: r, RSD and error values from 
measured CO for selected levels of dilutions for syringes A-D used in the Canadian laboratory (n=3). 
 
Dilution CO Target Mean CO Repeatability RSD Error
(%) (ppm) (ppm) r (%) (%)
10 9980 9341.7 204.26 0.7 6.4
5 4990 4691.7 235.84 1.7 6.0
2 1996 2100.0 166.77 2.8 5.9
1 998 1058.3 166.77 3.7 5.8  
 
Figure 4-5:  Assessment of the Borgwaldt RM20S® dilution precision and accuracy: correlation between the 
non-dispersive infrared (NDIR) based quantification of collected CO as a function of the selected level of 
dilution for syringes A-D for a 9.98% CO standard reference gas, i.e., CO doses of 1, 2, 5 and 10 % (v/v) in 
air. Data were acquired in triplicate for all dilution levels (n=3). Linear fit analysis: y = 186.3 + 0.9137x (R2 = 
0.999) with upper and lower confidence intervals (dotted lines) and predicted intervals (dashed lines) 
calculated at 95% probability. 
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4.4.2 Particulate Phase Measurements 
Solanesol was quantified by HPLC/UV in cigarette filter tips prior to dilution as 
well as on CFPs placed after the dilution syringe (Fig. 4-1) to evaluate the repeatability of 
smoke delivery in the Borgwaldt RM20S®. First, ten cigarette smoke samples, each 
corresponding to 30 min smoking periods (4 tips pooled/port), were analyzed for solanesol 
content in the filter tips for each syringe port (A-D). The results are presented in the form 
of a Shewhart control chart for each port (Fig. 4-6). Shewhart charts are used for 
monitoring the stability of measurement systems. Their utility lies in predicting the 
temporal variation in precision based on short term variations, which can be easily 
measured. Individual concentrations of solanesol for the 40 samples (10 per port) ranged 
from 6.8 μg/mL (sample 3, syringe A) to 11.9 μg/mL (sample 8, syringe D) and the mean 
solanesol concentration across the four syringe ports was 9.5 ± 1.2 μg/mL between samples 
(n=40) for pooled samples (top panel Fig. 4-6). Upper (UCL) and lower (LCL) control 
limits, represented by a solid line, correspond to 3σ and indicate the threshold above which 
data points are statistically unlikely to exceed. The stability of the variation between 
successive samples, is represented by the moving range (MR), i.e., the mathematical 
difference between successive samples for a given port (middle panel Fig. 4-6). The 
average MR is calculated for the 9 differences; the smaller this value, the lower the 
temporal variation. The difference (absolute value) between injection replicates related to 
HPLC performance was plotted as the range (R) within a measurement (bottom panel Fig. 
4-6). Ideally, the range should approach 0, which is the default LCL. The worst value in the 
range chart was for sample 2, syringe port B, where duplicate HPLC injections resulted in a 
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difference of 1.25 μg/mL solanesol. The UCL and LCL bands tend to be the narrowest 
for syringe C data for all three charts (Fig. 4-6), indicating  that syringe port C was the most 
stable and reliable at delivering the same dose of smoke. The overall precision associated 
with the smoke generated by the Borgwaldt RM20S® corresponded to an RSD of 12%, 
which is slightly above the expected precision tolerance of 10%. However, random errors 
associated with the extraction and analysis steps were expected to contribute to the overall 
precision of the method and thus 12% RSD was deemed acceptable for operation of the 
Borgwaldt RM20S®.  
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Figure 4-6:  Assessment of the smoke delivery of the Borgwaldt RM20S®: Shewhart control charts showing the HPLC-based quantification of collected solanesol from 
cigarette filter tips. Data were acquired for the smoke delivery at all syringe ports: A-D (n=10 samples each) for a 30 min period (4 tips were pooled/port/sample). The 
top panel represents the mean solanesol concentrations (µg/mL) from replicates (n=2 injections) obtained for each pooled sample. The combined mean is shown as a 
solid line for each port (A-D). The middle panel represents the moving range (MR), or differences between successive samples. The bottom panel represents the range 
(R) within a measurement and is the difference between replicates with respect to HPLC determinations. Upper (UCL) and lower (LCL) control limits, represented by 
dotted lines, correspond to 3σ. The LCL label in the bottom panel was removed for clarity as it corresponds to 0.  
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Secondly, to assess the dilution reliability of each syringe, a CFP was used to 
collect the TPM of cigarette smoke following dilution and solanesol in the TPM was 
quantified. The cigarette smoke was diluted in air to concentrations of 1, 2 and 5% (v/v) 
(n=3/syringe), which would correspond to the dose when cells or tissue culture are placed 
in the exposure chambers (Fig. 4-1). The overall precision across the four syringes 
associated with the smoke generated and diluted by the Borgwaldt RM20S® was between 
8.8-12% RSD (Table 4-4). The effect of run day and run order on the precision of dilutions 
showed no statistically significant difference. However, there was a borderline syringe 
effect (p=0.047 for the Bartlett’s test for equality of variances). The solanesol concentration 
(μg per mL of extraction solvent) was plotted as a function of the selected dilution level (% 
of whole smoke) (Fig. 4-7) and linearity of the solanesol content was R2 >0.95 across the 
dilution range. The instrumental and method LODs were determined to be 3.4×10-4 and 
1.4×10-2 µg/mL, respectively. Therefore, the solanesol concentrations investigated were at 
least 100 times higher than the quantitation limit (3.3⋅LOD) and thus free of errors 
associated with measurements at trace levels.   
  
122
Table 4-4: Summary of the Borgwaldt RM20S®’s smoke dilution precision: r and RSD values for 
measured solanesol for selected dilutions for syringes A-D used in the Canadian laboratory (n=3).  
 
Dilution Mean Solanesol Repeatability RSD
(%) (µg/mL) r (%)
5 19.8 4.53 12
2 8.66 1.69 9.0
1 4.34 0.98 8.8  
 
Figure 4-7:  Assessment of the dilution precision of whole smoke in the Borgwaldt RM20S®: LC/MS based 
quantification of solanesol collected on a CFP as a function of the selected level of dilution of smoke for 
syringes A-D, i.e., whole smoke doses of 1, 2 and 5% (v/v) in air. Data were acquired in triplicate for all 
dilution levels (n=3). Linear fit analysis: y = 0.742 + 3.816x (R2 = 0.954) with upper and lower confidence 
intervals (dotted lines) and predicted intervals (dashed lines) calculated at 95% probability. 
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4.5 Discussion  
A rigorous evaluation of the precision and accuracy of smoke generation and dilution 
by the Borgwaldt RM20S® smoking machine is an essential step before any cell culture 
studies can be carried out because of the importance of dosimetry. We used the standard 
reference gases CH4 and CO, as well as quantification of solanesol in the particulate  phase 
of diluted and undiluted cigarette smoke, to carry out a detailed evaluation of the 
Borgwaldt RM20S®. In addition, inter-laboratory variation was assessed using the CH4 
data.  
The use of two different standard reference gases used “as is” allowed us to assess 
the dilution repeatability of the instrument over a wide range of dilution levels: 0.1 to 10% 
(v/v) in air. Precision values ranged from 0.7 to 4.5% RSD for measurements carried out on 
the Canadian laboratory instrument only (Tables 4-1 and 4-3) and linearity of the measured 
standard gases after dilution versus the target dilution levels was better than R2 = 0.98 
(Figs. 4-2 and 4-5). Accuracy of the eight target dilution levels tested ranged from 5.8 to 
19.5% relative error (Tables 4-1 and 4-3), where the latter value corresponded to dilution to 
0.1% of the methane standard, in other words a 1000-fold dilution of the CH4 introduced at 
the syringe port. It is important to note that this error value was more than twice that of any 
of the other dilution levels investigated. Given the good accuracy and precision expected 
for detection of CH4 at 100ppm by the MINIFID system and the positive bias observed at 
this selected level (Table 4-1), it seems the syringes in the Canadian laboratory machine 
may not fully reach 1000-fold dilution. This explains the observed lower slope versus the 
predicted value of 1.00 (Fig. 4-2). Nonetheless, for dilutions between 0.2-10% (v/v) in air, 
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the accuracy of dilution of the Borgwaldt RM20S® was excellent, particularly 
considering that the FID alone contributed up to 1% of the total relative error.   
As described in the Materials and Methods section, the procedure for CO standard 
gas experiments was slightly different than that for CH4; improved connectors for gas bags 
were used and the first puff was directed towards the waste to reduce the effects of the first 
puff being diluted by air in the tubing. These modifications may have contributed slightly 
to the lower RSD values for CO (Table 4-3) and lower relative error.  
The effect of  syringe number was monitored in the inter-laboratory CH4 study, 
where both precision and accuracy varied visibly, depending on the dilution level (Fig. 4-
4). In the UK laboratory instrument, precision and accuracy were superior for the highest 
standard gas concentration tested, 0.52% (equivalent to 520 ppm CH4, 1:193 whole smoke 
dilution)(Fig. 4-4c, syringes 1-8). The RSD values between laboratories for targeted CH4 
dilutions in air of 0.1, 0.2 and 0.52% (v/v) were 17.3, 9.0 and 6.3%, respectively. Between 
laboratories, no statistically significant differences (p>0.05) were observed between 
standard deviations for target values of 100ppm and 200ppm (dilution to 0.1% and 0.2% of 
the CH4 standard, respectively). However, at the target value of 520ppm CH4 reference gas, 
significant differences (p = 0.025) were observed between the Canadian and UK 
laboratories. The variation within syringes in the Canadian lab was observed to increase at 
the lowest standard gas concentration tested, 0.1% (equivalent to 100ppm CH4, 1:1000 
whole smoke dilution (v/v)), which is not commonly used for in vitro cell culture analyses.  
Achieving an overall precision of between 2.2-4.5% RSD for the standard reference 
gases (Tables 4-1 and 4-3), which includes the inherent errors in the CH4 and CO detectors, 
was deemed satisfactory in terms of repeatability for further use of the Borgwaldt RM20S® 
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instrument. Moreover, the reproducibility between labs for dilutions down to 0.2 and 
0.52% CH4 standard in air (v/v) was 6.3 and 9.0% RSD, which indicated a comparable 
reproducibility between laboratories for these commonly used dilutions for dosing cells and 
tissue cultures.  
Measuring solanesol in the filter tips of the cigarettes allowed for the assessment of 
the precision of the smoke generation prior to dilution (based on particulate phase 
measurements), which was 12% RSD on average across 4 syringes. The measurements 
were found to be within upper and lower confidence levels for each port, within their 
respectable limits (middle panel Fig. 4-6). The RSD of the solanesol quantification 
following dilution (i.e., from TPM collected on the Cambridge filter pad) was between 8-
12% (Table 4-4) and the relationship between quantity and dilution level was linear (R2 
>0.95) for the dilution range selected (Fig. 4-7). Although the solanesol data yielded a 
poorer repeatability than CH4 and CO, as well as a slight syringe effect, it was still 
considered acceptable when taking into account the accuracy of the smoke generation 
(potential deposition on tubing and syringe surfaces or inherent variability of cigarettes25), 
the additional sample handling (e.g., extractions) compared to gas phase measurements and 
error involved in the analytical measurement by HPLC. The syringe effect could possibly 
be reduced by improving the piston adjustment of the syringes, or by planning the 
experimental design to include alternating syringes, or by applying a weighting factor. On 
the other hand, the residual plots (data not shown) and percent error for CO data indicated 
                                                 
25 The variability for 3R4F cigarettes is 1.5 % (n=11), based on TPM measurements (University of Kentucky, 
2010b).  
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that the points were random i.e., no effect of syringes, which is likely because 
particulate phase deposition was not a factor for the gas standard measurements.26 
The precision figures obtained for solanesol measurements following dilution were 
similar to those obtained from the standard gas measurements and demonstrate that the 
particulate marker values were within acceptable limits in the measurement system, 
indicating the equipment is suitable for cell exposure studies. 
 
Table 4-5: Summary of the Borgwaldt RM20S®’s smoke dilution precision: r and RSD values for measured 
solanesol for selected dilutions for syringes A-D used in the Canadian laboratory (n=3).  
 
Dilution Mean Solanesol Repeatability RSD
(%) (µg/mL) r (%)
5 19.8 4.53 12
2 8.66 1.69 9.0
1 4.34 0.98 8.8  
4.6 Conclusions 
Overall, the values obtained from CH4, CO and solanesol repeatability experiments 
were within acceptable limits in measurement systems (RSD < 10% and R2 >0.95) 
indicating the equipment  can reliably generate accurate doses of cigarette smoke suitable 
for cell exposure and dosimetry studies. Furthermore, having assessed the precision of the 
smoking machine with CH4 from two different laboratories and with different operators 
provides us with even greater confidence in the reliability of dose. 
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These results suggest the Borgwaldt RM20S® system provides a reliable and 
repeatable method for generating and delivering whole smoke to in vitro cell cultures using 
exposure systems, which to our knowledge, has never been assessed or specified by the 
supplier. We propose to further characterize the dose within the chamber following 
exposure to whole smoke as a function of dilution factor, in terms of specific smoke 
constituents. This system could also be used for evaluation of cigarette design 
modifications intended to potentially reduce the harmful effects of smoke.     
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26 Another factor that may have contributed to the variability in gas and particulate measurements was the 
instrumental air velocity having up to 15% RSD (20 ± 3 cm/sec). 
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5.1 Abstract 
 Advanced smoke generation systems, such as the Borgwaldt RM20S® smoking 
machine used in combination with the BAT exposure chamber, allow for the generation, 
dilution and delivery of fresh cigarette smoke to cell or tissue cultures for in vitro cell 
culture analyses. Recently, our group confirmed that the Borgwaldt RM20S® is a reliable 
tool to generate and deliver repeatable and reproducible exposure concentrations of whole 
smoke to in vitro cultures (Kaur et al., 2010).  However, the relationship between dose and 
diluted smoke components found within the exposure chamber has not been characterized. 
The current study focused on the development of a headspace stir bar sorptive extraction 
(HSSE) method to chemically characterize some of the vapor phase components of 
cigarette smoke generated by the Borgwaldt RM20S® and collected within a cell culture 
exposure chamber. The method was based on passive sampling within the chamber by 
HSSE using a TwisterTM stir bar. Following exposure, sorbed analytes were recovered 
using a thermal desorption unit and a cooled injection system coupled to gas 
chromatography/mass spectrometry for identification and quantification. Using the HSSE 
method, sixteen compounds were identified. The desorption parameters were assessed 
using ten reference compounds and the following conditions led to the maximal response: 
desorption temperature of 200 °C for 2 min with cryofocussing temperature of -75 °C. 
During transfer of the stir bars to the thermal desorption system, significant losses of 
analytes were observed as a function of time27; therefore, the exposure-to-desorption time 
interval was kept at the minimum of 10 ± 0.5 min. Repeatability of the HSSE method was 
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assessed by monitoring five reference compounds present in the vapor phase (10.1 - 
12.9 % RSD) and n-butyl acetate, the internal standard (18.5 % RSD).  The smoke dilution 
precision was found to be 17.2, 6.2 and 11.7 % RSD for exposure concentrations of 1, 2 
and 5 % (v/v) cigarette vapor phase in air, respectively. A linear response of analyte 
abundance was observed as a function of dilution.  Extrapolation to 100 % (v/v) cigarette 
vapor phase, i.e., undiluted smoke, gave yields for the five compounds ranging from 6 to 
450 ng for 10 min exposure. 
5.2 Introduction 
 Recent advancements have led to the development of several smoke generation 
systems such as the Borgwaldt RM20S® (Phillips et al., 2005), the Burghart Mimic 
Smoker-01® (Scian et al., 2009a, Scian et al., 2009b) and the Vitrocell Smoking Robot VC 
10® (Aufderheide et al., 2000). Also, this has led to the development of novel in vitro 
exposure systems such as British American Tobacco’s (BAT) exposure chamber (Phillips 
et al., 2005) and the CULTEX system (Aufderheide et al., 2000). These systems generate 
fresh cigarette smoke over a wide range of dilutions (i.e., exposure concentrations) required 
for in vitro cell culture investigations. 
 The Borgwaldt RM20S® in combination with BAT’s exposure chamber 
using Transwell® inserts enables direct exposure of in vitro cellular cultures to whole 
cigarette smoke at the air-liquid interface (Fig. 5-1) (Massey et al., 1998, Phillips et al., 
2005, Thorne et al., 2009). This smoking machine, first commercialized in 2005, can 
smoke up to four cigarettes simultaneously with the smoke collected into four independent 
                                                                                                                                                    
27 Losses of 19-31 % were observed for the 5 reference compounds. 
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syringes. Each syringe can dilute the cigarette smoke with air in ratios ranging from 
1:1.14 to 1:4000 (smoke volume : air volume), which corresponds to a range of 87 - 0.025 
% (v/v) cigarette smoke in air. For biological exposures, doses tend to be in the range of 0.4 
- 5% (v/v) cigarette smoke in air (Phillips et al., 2005). The dose at this range of whole 
smoke dilution has only been correlated to the mass of total particulate matter (TPM) 
deposited on a Cambridge filter pad (CFP) placed either before the exposure chamber or 
within it, on a Transwell® insert (Massey et al., 1998, Phillips et al., 2005).  
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Figure 5-1: a) Schematic of the Borgwaldt RM20S® in combination with the BAT exposure chamber 
showing one of the four smoking ports connected to a dilution syringe. The machine smokes the cigarette, 
dilutes the smoke and delivers it to the exposure chamber (Thorne et al., 2009). Insertion of a CFP to trap 
particulate matter downstream of the syringe allows exposure of cell or tissue culture to the diluted vapor 
phase only. b) Cross-section of the exposure chamber (Thorne et al., 2009) showing the location for the 
TwisterTM stir bar for HSSE experiments. For in vitro cell culture assays, medium flows in and out of the 
chamber. In this work, no cells and no culture medium were used 
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 Our group recently carried out a study to determine the precision and accuracy 
of dilution of the smoke dose generated by the Borgwaldt RM20S® and delivered to the 
exposure chamber by measuring two reference standard gases (CH4 and CO) introduced at 
the smoking port and a cigarette particulate phase marker (solanesol) from whole smoke 
(Kaur et al., 2010). The repeatability of vapor phase dilution was ≤ 4.5 % RSD for dilutions 
of 0.1 - 0.52% (v/v) CH4 in air and was ≤ 3.7 % RSD for dilutions in air of 1 - 10% (v/v) 
CO. The accuracy of CO measurements was 5.8 – 6.4 % error for the dilution range 
studied. The repeatability of dilution of the particulate phase in air ranged from 8.8 – 12 % 
RSD when quantifying solanesol. Overall, the findings suggested that the Borgwaldt 
RM20S® is a reliable tool to generate and deliver repeatable and reproducible doses of 
whole smoke to in vitro cultures (Kaur et al., 2010). Scian et al. (Scian et al., 2009b) 
measured in detail the chemical constituents of the particulate phase and reported 
recoveries at the exposure chamber of < 40 % in the Burghart smoking system for most of 
the compounds monitored, with repeatability of the measurements reaching over 35 % RSD 
for smoke diluted to 50% (v/v) in air. To date, no studies have reported the chemical 
characterization of the vapor phase smoke components within the exposure chamber itself. 
Evaluation of the dosimetry linearity of gaseous compounds present in the cigarette smoke 
following dilution and transfer to the exposure chamber is important to complete the 
characterization of this type of in vitro cell system.  
 Cigarette smoke is an extremely complex aerosol mixture composed of over 5000 
chemical compounds (Rodgman et al., 2009a, Rodgman et al., 2009b) found distributed 
between the particulate and vapor phases. The vapor phase of cigarette smoke contains 
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volatiles and semivolatiles that play a major role in the in vitro toxicological responses 
(Bombick et al., 1997b, CORESTA, 2005, Phillips et al., 2004, Wieczorek et al., 2006, 
Bombick et al., 1997c). In this study, only the vapor phase of cigarette smoke was targeted. 
Techniques used for the collection and extraction of vapor phase constituents include 
vapor-liquid extraction, simultaneous distillation extraction (SDE), solid phase 
microextraction (SPME) and stir bar sorptive extraction (SBSE). The first two techniques 
tend to be time consuming and has resulted in poor repeatability (Zhong et al., 2005) 
compared to SPME and SBSE. SPME using poly(dimethylsiloxane) (PDMS) as the 
absorptive phase has been used for the analysis of the volatile phase of tobacco flavors 
(Zhong et al., 2005). Among other problems with SPME. is the reduced sensitivity due to 
limiting volumes of PDMS that can be used. SBSE, which also relies on PDMS as the 
sorptive phase, may resolve some of the issues faced when using SPME. 
 SBSE, which was introduced in 1999 (Baltussen et al., 1999), is based on the theory 
of SPME and has been used extensively for environmental, food and biological 
applications (Bicchi et al., 2009). SBSE was explored for extraction of cigarette vapor 
phase components due to its higher mass loading compared to traditional SPME, as it uses 
a thicker film of adsorbent together with an increased surface area (Ochiai et al., 2008). For 
the moment, PDMS is the only commercially available SBSE coating. It provides low 
detection limits; in the sub-ppb level (Baltussen et al., 1999, Benijts et al., 2001). Typical 
SBSE devices, such as the TwisterTM from Gerstel, consist of a magnetic stir bar encased in 
glass and coated with a ≤ 1 mm film of PDMS, which can contain between 55-219 µL of 
PDMS (compared to ≤ 0.5 µL in SPME) depending on the length of the stir bar. SBSE used 
to sample the vapor phase is referred to as headspace stir bar sorptive extraction (HSSE) 
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(Tienpont et al., 2000, Bicchi et al., 2000, Hou et al., 2006, Bicchi et al., 2002). 
Following exposure to a liquid or gaseous sample, the stir bar is placed within a thermal 
desorption unit coupled to a GC for separation and analysis. Advantages of HSSE and 
SBSE include robustness, ease of handling volatile compounds, automation, stability, good 
reproducibility and application to many types of analytes, heterogeneous samples and 
vapor, liquid and solid samples. A major drawback associated with both techniques is the 
difficulty to perform true quantitation even when using an internal standard, particularly in 
HSSE when only liquid phase standards are available. 
 The objective of the current study was to develop a solvent-free method to 
chemically characterize the vapor phase components (volatiles and semivolatiles) of diluted 
3R4F cigarette smoke, generated by the Borgwaldt RM20S® and collected within an 
exposure chamber. The method chosen is based on passive sampling within the chamber 
(where cells or tissue cultures would be placed) by HSSE using a TwisterTM stir bar. 
Following exposure to diluted cigarette smoke, sorbed analytes are recovered using a 
thermal desorption unit (TDS) and a cooled injection system (CIS) coupled to GC/MS for 
identification and quantification. A central composite experimental design based on three 
factors was proposed to determine the optimal desorption temperature, desorption time and 
CIS cryofocussing temperature needed to maximize the peak areas of ten selected reference 
compounds. Each factor was assessed at three levels. Using the experimental center-point, 
the repeatability of the HSSE method for diluted cigarette smoke was assessed for five of 
the vapor phase reference compounds. Recovery of the vapor phase components was 
measured as a function of time. Lastly, the dilution precision was measured for a range of 
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smoke dilutions typically used for cell culture assays (range of 1 - 5 % (v/v) cigarette 
smoke in air). 
 
5.3 Materials and Methods 
5.3.1 Whole Smoke Exposure System: the Borgwaldt RM20S® Smoking 
Machine and BAT’s Exposure Chamber  
The Borgwaldt RM20S® (Borgwaldt KC GmbH, Hamburg, Germany) is an 
automatic smoking machine that generates and dilutes cigarette smoke for in vitro cell 
culture investigations (Borgwaldt KC, 2010). It has a rotary based engine that can 
simultaneously smoke four types of cigarettes for several hours, depending on the smoking 
regime used. The instrument has an incorporated anemometer allowing for correct air flow, 
as well as electrical lighter, butt detector and butt extractor. The Borgwaldt RM20S® was 
designed in collaboration with BAT (Southampton, UK) and can be used with BAT’s 
exposure chamber to enable cells or tissues to be exposed to the diluted smoke generated 
by the Borgwaldt RM20S® (Fig. 5-1a). Within the chamber, the cells or tissues lie on a 24 
mm diameter Transwell® clear insert (Corning, NY, USA), which is a microscopically 
transparent porous polyester membrane, and are exposed to smoke at the air-liquid 
interface (Thorne et al., 2009, Phillips et al., 2005). However, no cells/tissues were used in 
the current study. At the beginning of each day and following each usage, the machine was 
run through a thorough maintenance routine, as this can affect the performance of the 
instrument (Kaur et al., 2010). The cigarettes used in this study were Kentucky Reference 
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cigarettes (3R4F) (University of Kentucky, USA) and were conditioned at 22°C and 60 
% relative humidity for 48 hours prior to smoking. Cigarettes were smoked in compliance 
to International Standard Organization (ISO) puffing profiles, consisting of 35mL puff 
volume over a 2 sec puff duration and 60 sec puff interval (International Organization for 
Standardization, 1999) for a total of 10 min unless otherwise indicated. Despite having four 
dilution syringes available for use, the same syringe (syringe C) was used throughout this 
study to eliminate any potential bias that could have been generated by the effect of a given 
syringe (Kaur et al., 2010). Cigarette smoke was generated with the Borgwaldt RM20S® 
and a 44 mm diameter CFP was placed at the inlet of the exposure chamber to capture the 
particulate phase allowing only the vapor phase of the smoke to enter the exposure 
chamber. Some semi-volatiles are distributed between both the particulate and vapor phases 
(i.e., phenols), and a portion of these compounds can be retained on the CFP (Baker, 1999, 
Adam et al., 2006). Within the chamber, the PDMS-coated TwisterTM stir bar was placed 
on a 24 mm diameter TranswellTM plate (Corning, NY, USA) for the duration of the smoke 
run (Fig. 5-1b). During exposure, no liquid/medium was used within the exposure chamber, 
where it would normally be if cells were present. Following exposure to the diluted smoke 
vapor phase (ranging from 1 to 10 % (v/v) in air), the stir bar was removed and transferred 
to the TDS. 
5.3.2 HSSE Sampling and Collection  
Commercially available TwisterTM stir bars from Gerstel (Mülheim an der Ruhr, 
Germany) were 2 cm in length coated with a 0.5 mm thick PDMS film, which corresponds 
to 47 µL of PDMS. Conditioning was carried out according to the manufacturer;s direction 
  
138
as follows: stir bars were placed in HPLC grade acetonitrile (Fisher Scientific, Whitby, 
Ontario, Canada) for 2 days and transferred into a specialized thermal conditioning unit for 
stir bars (Gerstel) at 280 °C for 4 h with a helium flow rate of 40 mL/min. This procedure 
provided for removal of residual acetonitrile and other impurities present in the PDMS 
phase. After conditioning, then cooling to room temperature, the stir bars were either 
exposed to a sample or stored in sealed glass tubes to prevent contamination from the 
surrounding environment. Following exposure, the stir bar was removed using a piece of 
stainless steel wire and transferred into an empty glass thermal tube of 4 mm ID and 177 
mm length, blocked at both ends (Gerstel). The minimum transfer time between the end of 
smoke exposure and insertion into the TDS was 10 ± 0.5 min. Using the optimized 
desorption method, the stir bar was immediately ready for the next extraction. According to 
the manufacturer, stir bars may be used for hundreds of extractions with little or no 
deterioration, as long as temperatures are below 325 °C and solvents are not used for 
extraction of compounds. Multiple carry-over tests were performed to confirm that stir bars 
would not contribute to carry-over if re-used. During the experiments involving the use of 
higher than normal thermal desorption temperatures, stir bars were not re-used if 
deterioration of the PDMS phase was observed; e.g., if siloxane background peaks were 
seen in the chromatogram, corresponding to  hexamethylcyclotrisiloxane (m/z 207), 
octamethylcyclotetrasiloxane (m/z 281) or decamethylcyclopentasiloxane (m/z 73, 267 
and/or 355). 
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5.3.3 Thermal Desorption and GC/MS Analysis 
Analyte determination by GC/MS was carried out with an Agilent 6890N/5973N 
System (Agilent technologies, Waldbronn, Germany) equipped with a TDS (Gerstel) 
connected to a programmable temperature vaporization cooled injection system (CIS-4 
model, Gerstel) using a transfer line heated at 300 °C. Desorption was carried out at 200, 
250 or 300 °C for 1, 2 or 3 min under a helium flow of 60 mL/min. On the CIS-4 injector, 
the cryofocussing temperature was set to -100, -75 or -50 °C using liquid nitrogen (Praxair, 
Danbury, CT, USA). Following cryofocussing, the temperature of the CIS-4 was ramped 
up to 300 °C at 10 °C /min and held for 2 min during which time the analytes were 
transferred to the GC column with a split ratio of 37.3:1, unless otherwise indicated. 
Deactivated quartz wool liners were used (Gerstel). Separation was carried out in a DB-
5MS column (60 m × 0.25 mm ID, 0.25 µm film thickness, from Agilent Technologies) 
with a constant column head pressure of 25 psi helium as the carrier gas. The oven 
temperature was set to 60 °C for 0 min and increased by 2 °C/min to 108 °C, then held for 
1 min, for a total run time of 25 min. Finally, the analytes were detected by the mass 
selective detector (MSD) in scan mode from 41 to 300 m/z at 5.29 scans/sec, in positive ion 
mode. For all quantitative work, peak areas were obtained from integration of peaks in the 
extracted ion chromatograms (XICs).  
5.3.4 Reference Compounds 
 From the compounds identified in the vapor phase of cigarette smoke using the 
methods described above, five were chosen for use as reference compounds based on their 
abundances, their wide distribution across the chromatographic elution window and their 
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peak resolution: benzene, 2,5-dimethyl furan, toluene, ethyl benzene and limonene 
(Thermo Fisher Scientific, ≥ 95 %).  
5.3.5 Preparation of n-Butyl Acetate Internal Standard (IS) 
A 7.6 µM standard solution of n-butyl acetate (Thermo Fisher Scientific) was prepared 
in HPLC grade methanol (Thermo Fisher Scientific). The IS concentration was selected 
based on the abundance range of the analyte ions in our sample run. The standard solution 
was aliquotted into amber GC vials with crimped aluminum caps (Chromatographic 
Specialties, Brockville, ON, Canada) for single use and stored at 4 °C until use.  
In each case, 1 µL of the IS was transferred directly onto the 2 cm stir bar using a 
micropipette and left in a closed dish for 15 min to partition into the bulk PDMS. To assess 
the repeatability of the internal standardization procedure, the stir bar was placed in the 
center of a TDS tube and transferred to the TD system using the center point  conditions 
(i.e., desorption at 250 °C for 2 min and cryofocussing at -75 °C) of the experimental 
design as described in the next section. The repeatability was calculated as the percent 
relative standard deviation (RSD) obtained for the mean XIC peak area of the IS (n=12, 
using twelve different stir bars) by GC/MS analysis.  
For smoke exposure experiments, stir bars spiked with IS were exposed to diluted 
vapor phase (10% (v/v) cigarette smoke in air). Following exposure, the stir bar was 
transferred to the TDS within 10 ± 0.5 min. Repeatability was calculated as the percent 
RSD (n=6, using six different stir bars) in mean XIC peak areas of the IS, of each of the 
five reference compounds listed above, as well as for the ratio reference peak-to-IS. 
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5.3.6  Optimization of Desorption Parameters and Statistical Analysis 
Three factors (TDS desorption temperature, desorption time and CIS-4 
cryofocussing temperature) were selected for maximization of the GC/MS peak area 
response using a face-centered composite experimental design. Three different levels of 
each factor were selected: desorption temperatures of 200, 250 and 300 °C; desorption 
times of 1, 2 and 3 min; cryofocussing temperatures of -50, -75 and -100 °C. Other than 
these parameters, all other conditions were the same as those previously described for 
exposure of the stir bar to 5 % (v/v) vapor phase in air for HSSE-GC/MS experiments. The 
XIC peak areas from the five reference compounds and an additional five analytes (2-
methyl-1,3-butadiene, 3-methyl-2-butanone, p-xylene, styrene and 1-methyl-4-(1-
methylethylidene)cyclohexane), were analyzed using a quadratic regression with second 
order interactions to determine the maximal response for the three experimental factors.  
5.3.7 Stability of Sorbed Compounds on the Stir Bar 
Following exposure to 5 % (v/v) vapor phase in air, the stir bar (i.e., with sorbed 
sample) was transferred to the TDS at various time intervals to assess the effect of the delay 
time between vapor phase exposure and thermal desorption on recovery of the sorbed 
analytes. The times selected for this study were 10, 40, 160 and 1440 min (24 hours), where 
10 min represented the fastest possible transfer from the exposure chamber to the TDS due 
to instrumental constraints. For stir bars not immediately analyzed, the desorption tubes 
were placed in individual plastic containers with caps (having inert inserts), wrapped in foil 
and stored at 4 °C. Using the optimized TDS and cryofocussing parameters, the XIC peak 
areas of the five reference compounds were used to assess their sorption persistence on the 
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stir bar after exposure. Each time point was analyzed in triplicate (i.e., n=3, using three 
different stir bars). 
5.3.8 Measurement of Dilution Precision 
Stir bars were exposed to various smoke dilution levels typically used for cell 
culture assays (1, 2 and 5% (v/v) cigarette vapor phase in air) for a 10 min smoking period. 
The optimized HSSE method and TDS parameters were used for GC/MS measurement of 
the XIC peak areas of the five reference compounds for each dilution level. Each dilution 
was analyzed in triplicate (i.e., n=3, using three different stir bars). 
5.3.9 Semi-Quantitative Analysis of Diluted Smoke Vapor Phase 
Standard solutions of the five reference compounds were prepared in HPLC grade 
hexane (Thermo Fisher Scientific) and calibration curves comprising 4 to 7 points covering 
the following ranges were prepared: benzene, 0 – 250 µM; 2,5-dimethyl furan, 0 – 50 µM; 
toluene, 0 – 100 µM; ethylbenzene, 0 – 10 µM; limonene, 0 – 10 µM. These concentration 
ranges were selected to match the XIC peak areas obtained in the smoke vapor samples. In 
each case, 1 µL of diluted standard was directly transferred onto the 2 cm stir bar using a 
micropipette and left in a closed dish for 10 min (same duration as smoke exposure). 
Following exposure, the stir bar was transferred to the TDS within 10 ± 0.5 min. This 
quantification procedure was used so that the sorption/desorption processes were taken into 
account. The optimized HSSE method and TDS parameters were used for GC/MS 
measurement of the XIC peak areas of each standard. Each concentration was analyzed 
once (i.e., n=1). The linear equations obtained from the calibration curves (Table 5-3) were 
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used to estimate the minimum quantities of each reference compound present after 
exposure to 1, 2 and 5% (v/v) cigarette vapor phase in air (Table 5-3). 
 
5.4 Results and Discussion 
5.4.1 Vapor Phase Characterization using HSSE, Thermal Desorption 
and GC/MS Analysis 
Our long term goal is to correlate the chemical composition with the toxicological 
response of cells or tissue exposed to diluted whole cigarette smoke. These experiments 
complement previous work carried out on the reliability of the smoke generation and 
dilution in the Borgwaldt RM20S® where repeatability, reproducibility and accuracy for 
solanesol, a particulate phase marker, and the standard reference gases CH4 and CO were 
determined (Kaur et al., 2010).  
Following a 30 min exposure of the stir bar to 10 % (v/v) vapor phase in air, 16 
compounds were identified by thermal desorption-GC/MS using the NIST Scientific and 
Technical Database Library with a match criterion of ≥80 % (Fig. 5-2). All were confirmed 
to be present in cigarette smoke based on open literature (Rodgman et al., 2009b, Adam et 
al., 2006, Chen et al., 2003, Polzin et al., 2007, Dong et al., 2000, Darrall et al., 1998, 
Bartle et al., 1969, Baggett et al., 1974, Stedman, 1968, Mauldin, 1976). Of the compounds 
identified, which included primarily esters, ketones, aldehydes or hydrocarbons, five were 
chosen as reference compounds for further study and method optimization (benzene, 2,5-
dimethyl furan, toluene, ethyl benzene and limonene) based on their distribution across the 
  
144
elution window. The remaining eleven compounds detected in the sample are identified 
in the GC/MS chromatogram (Fig. 5-2).  
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Figure 5-2: HSSE-GC/MS chromatogram showing the identification of 16 compounds found in the vapor 
phase sample. Sorption was carried out using a 2 cm PDMS-coated stir bar (Twister™) exposed to 10% (v/v) 
smoke vapor phase dilution in air for a smoking period of 30 min. The five compounds chosen for reference 
purposes, shown in bold type, were benzene, 2,5-dimethyl furan, toluene, ethyl benzene and limonene. 
 
Prior to assessing the repeatability28 of the method, the use of an IS was explored. 
Ideally, the IS should be a volatile species exposed in a similar way as the vapor phase to 
                                                 
28 Recall, repeatability measurements correspond to the agreement of individual results obtained from testing 
the same sample, in the same laboratory, having a difference in one of the following: analyst, apparatus or the 
day whereas, reproducibility measurements correspond to the agreement of individual results obtained from 
testing one sample, in different laboratories, by a different analyst, on a different apparatus, on a different day 
(Centre d’expertise en analyse environnementale du Québec, 2007). The combination of repeatability and 
reproducibility data adds to the robustness of the method. 
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the stir bar during the smoke exposure process and should not interfere with the 
analytes in the chromatogram. However, due to limitations of the sample type, smoking 
machine and health and safety concerns, the IS had to be applied directly to the stir bar as a 
liquid prior to exposure. n-Butyl acetate was chosen for its volatility, which was similar to 
the reference compounds, its absence in the cigarette vapor phase sample and its elution 
time, which was well separated from the most abundant analytes. Its purpose was to 
eliminate response variability due to the thermal desorption-GC/MS analysis steps, but not 
due to the smoke generation, dilution, or volatile sorption processes. The IS peak areas 
obtained from XICs were compared following a 15 min sorption period in a closed vessel. 
The peak area repeatability for the IS was 25.8 % RSD (n=12)29. Despite its poor precision, 
the IS was used during collection of data following smoke vapor phase exposure. Sources 
of precision error associated with the use of the IS may include pipetting and transferring at 
the 1 µL level, volatility of the IS over the sorption period, variability in the stir bar 
retention capacity and/or TDS and GCMS steps. 
The repeatability of the HSSE method was assessed by comparing the peak areas of 
the five reference compounds and the spiked IS after exposure to 5 % (v/v) cigarette vapor 
phase in air. The repeatability of the IS following exposure improved30 to 18.5 % RSD 
(n=6) (Table 5-1), which was surprising because it included additional handling steps and a 
longer total exposure period compared to the closed vessel experiment. The repeatability of 
the five reference compounds varied from 10.1 - 12.9 % RSD (n=6) (Table 5-1, column 4), 
                                                 
29 Q test was performed on internal standard repeatability data values and indicated that all points should be  
retained (no outliers).  
30 F test performed on both data sets (IS repeatability), variances were not significantly different because Fcalc 
(1.62) < Fcritical (4.70) at α = 0.05. 
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which represents errors associated with the combined steps of smoke generation, smoke 
dilution, sorption by the stir bar, desorption by the TDS, cryofocussing and analysis by 
GC/MS31. The poorer precision for the IS compared to the five reference compounds could 
be due to it not having been sorbed in the same way (i.e., applied to the stir bar from the 
liquid versus vapor phase) as well as due to errors associated with pipetting only 1 µL at 
each replicate. Application of the IS to correction of analyte peak areas resulted in higher 
RSDs (Table 5-1, column 6) than for the analytes alone and thus was not used for 
quantitative purposes. As a result, peak areas for the reference compounds without IS 
correction were compared in subsequent studies. Due to the complexity of the sample, 
XICs were used for integration of the peak areas to avoid measurement of co-eluting peaks 
and for accurate quantification.   
 
                                                 
31 The RSDs obtained in our study were comparable to those obtained from similar studies: 5-20 % RSD 
(Darrall et al., 1998), 10.2-37.1 % RSD (Polzin et al., 2007). 
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Table 5-1 : Repeatability data for exposure of a PDMS-coated stir bar (Twister™) to 5% (v/v) vapor 
phase in air from 3R4F cigarettes for a 10 min smoking period. Integration results were obtained from the 
peak areas of the 5 reference compounds and the IS by GC/MS using the XICs. 
 
Peak  
# 
Peak ID 
Mean Peak 
Area 
RSD (%) 
(n=6) 
Ratio 
Aanalyte/AIS 
RSD (%) 
of Ratio   
1 Benzene 56816.0 11.2 0.939 17.6 
2 
2,5-Dimethyl 
furan 20759.7 12.9 0.342 17.3 
3 Toluene 235373.8 12.2 3.900 19.7 
4 Ethylbenzene 35956.2 10.1 0.596 19.1 
5 Limonene 34796.5 12.2 0.578 20.9 
IS n-Butyl acetate 61921.2 18.5 - - 
 
 
5.4.2 Optimization of Desorption Parameters and Statistical Analysis 
A face-centered composite experimental design was used to obtain the maximal 
response for 10 analytes as a function of three desorption parameters. The 3-factor, face-
centered design can be visualized as a cube with a star centered inside having its six points 
at the center of each face of the cube. Fifteen combinations of the three levels of each 
factor—desorption temperature, desorption time and cryofocussing temperature—were 
used, corresponding to those at the 8 “corners” of the cube, at the centers of the 6 faces 
(i.e., the star points) and at the single, center point. The order of the runs was randomized to 
  
148
reduce bias and the center point condition (desorption at 250°C for 2 min, 
cryofocussing at -75°C) was repeated at the beginning, the end and throughout the series of 
runs (e.g., runs 1, 9, 11, 15, 16 and 20), which is typical in face-centered composite design. 
Quadratic regression analysis of the XIC peak area responses for each analyte did not yield 
any significant factor effects or interactions in the parameters assessed for the measured 
analytes. Low precision—in excess of 10 % RSD in peak areas (Table 5-1)—may have 
been responsible for this result. However, a slight trend in two of the factors could be seen 
graphically for the five main reference compounds (Fig. 5-3 b and c) with the best 
responses occurring at a desorption temperature of 250 °C for 2 min with a cryofocussing 
temperature of -75 °C32. It is important to note that at higher desorption temperatures 
(> 250°C), deterioration of the PDMS phase was observed by the presence of siloxane 
background peaks. Therefore, 200 °C was deemed the best desorption temperature to avoid 
damage to the stir bar.  
 
                                                 
32 The trend observed for peak area as a function of desorption time (Fig. 5-3b) does not follow the expected 
trend predicted, increasing over time, and thus remains unclear. 
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Figure 5-3: Effect of the three optimization factors on the abundances of five reference compounds exposed 
to 5 % (v/v) vapor phase in air. a) Peak area as a function of stir bar desorption temperature for a 2 min 
desorption time and cryofocussing at -75°C; b) Peak area as a function of stir bar desorption time for 
desorption at 250°C and cryofocussing at -75°C; c) Peak area as a function of cryofocussing temperature 
when desorption was held at 250°C for 2 min. Integrated peak areas of the reference compounds were 
obtained from the GC/MS XICs: Benzene, ; 2,5-Dimethyl furan, ; Toluene (peak area /10 to aid 
plotting), ; Ethyl benzene, ; Limonene,  . Each data point represents an average of three 
individual runs using three different stir bars and error bars indicate relative standard deviation. 
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Arrangement of the runs in decreasing order of cryofocussing temperature followed 
by increasing desorption time (Table 5-2) also showed that the highest peak area responses 
for six of the ten analytes occurred at the desorption temperature of 200 °C for a 2 min 
desorption time and cryofocussing at -75 °C, and thus these maximal conditions were used 
for all further studies. These desorption conditions are similar to those used in another 
tobacco flavor study of volatile and semi-volatile components (Hou et al., 2006). Some 
analytes were not efficiently cryofocussed, and thus absent, when using -50 °C (Table 5-2).  
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Table 5-2: Optimization of the HSSE desorption parameters representing 10 vapor phase components found on a stir bar following exposure to 5 % (v/v) cigarette vapor 
phase in air. The 10 compounds identified by GC/MS are listed in order of retention time, tr. Relative peak areas were calculated from the XIC peak areas for each 
analyte 
 
2-Methyl-1,3-
butadiene
3-Methyl-2-
butanone Benzene
2,5-Dimethyl 
furan Toluene
Ethyl-
benzene p-Xylene Styrene
1-Methyl-4-(1- methyl-
ethylidene) 
cyclohexane
Limonene
tr   3.77 min 4.72 min 4.78 min 5.27 min 6.42 min 9.06 min  9.36 min 10.20 min 16.80 min 17.14 min
b.p. 34 °C 94 °C 80 °C 93 °C 110 °C 136 °C 138 °C 145 °C ~172 °C b 176 °C
12 200 1 -50 0 0 0 0.80 0.70 0.75 0.66 0.63 0.54 0.58
8 300 1 -50 0.04 0 0.09 0.88 0.90 0.96 0.94 0.95 0.88 0.80
5 250 2 -50 0.02 0 0.01 0.76 0.72 0.88 0.84 0.77 0.50 0.52
19 200 3 -50 0 0 0 0.69 0.68 0.77 0.29 0.70 0.78 0.84
6 300 3 -50 0 0 0.06 0.92 0.94 0.91 0.92 1.00 1.00 1.00
4 250 1 -75 0.74 0.73 0.57 0.57 0.57 0.53 0.54 0.54 0.35 0.47
7 200 2 -75 0.94 1.00 1.00 1.00 1.00 1.00 1.00 0.90 0.74 0.78
Mean b 250 2 -75 0.90 0.86 0.91 0.79 0.73 0.80 0.70 0.74 0.63 0.67
10 300 2 -75 0.91 0.76 0.86 0.79 0.82 0.90 0.87 0.75 0.58 0.70
14 250 3 -75 0.82 0.75 0.78 0.70 0.68 0.65 0.30 0.62 0.60 0.63
3 200 1 -100 0.82 0.68 0.82 0.65 0.56 0.73 0.74 0.77 0.60 0.62
2 300 1 -100 1.00 0.81 0.86 0.72 0.65 0.68 0.67 0.69 0.57 0.62
13 250 2 -100 0.86 0.74 0.75 0.74 0.72 0.83 0.37 0.77 0.62 0.70
17 200 3 -100 0.88 0.87 0.82 0.62 0.64 0.84 0.39 0.78 0.71 0.67
18 300 3 -100 0.76 0.65 0.56 0.63 0.55 0.61 0.59 0.58 0.47 0.50
a  Per compound, i.e., data were normalized vertically with respect to the highest abundance (peak area) in a given column.
b  Boiling point estimated based on relative retention time.
c Mean response of six center point runs: 1, 9, 11, 15, 16 and 20. 
Desorption Parameters
Run # Desorption Temp (°C)
Desorption 
Time (min)
Cryofocussing 
Temp (°C)
Relative Peak Areaa
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5.4.3 Stability of Sorbed Compounds on the Stir Bar  
Using the optimized desorption conditions, the stability of the vapor phase 
components sorbed on the stir bar (i.e., their resistance to spontaneous desorption) was 
studied. Four time intervals representing transfer of the stir bar from the exposure chamber 
to the TDS were assessed: 10 min, which was the minimum transfer time, 40, 160 and 1440 
min (24 hours). The stability was estimated by comparing the peak areas of the five 
reference compounds as a function of transfer time following exposure to 5 % (v/v) 
cigarette vapor phase in air (Fig. 5-4). A 19 - 31 % loss in the reference compounds was 
observed within 40 min followed by only a 0 - 9 % loss over the next two hours. The losses 
were independent of the compounds’ volatility33. As predicted, these results indicate the 
importance of considering the volatile, or semi-volatile, nature of the sample in such 
studies. Therefore, for all further studies, stir bars were consistently transferred to the TD 
system as soon as possible (e.g., 10 ± 0.5 min) to maintain consistency between runs and to 
maximize sensitivity. This study did not take into account potential degradation of vapor 
phase compounds, or reactions and interactions between various smoke components 
(Rodgman, 2000).  
 
                                                 
33 The desorption rates were not similar for all compounds, but a function of their respective partition 
coefficients with the PDMS phase and concentration gradients. Log Ko/w and losses were for; benzene (2.13 
and 19%); 2,5-dimethyl furan (2.24 and 27%); toluene (2.73 and 31%); ethylbenzene (3.15 and 24%) and D-
limonene (4.38 and 31%), respectively. The only reference compound that did not follow this trend was 
ethylbenzene. Based on error bars (SDs) for the measurements, losses between 19-31 % do not indicate 
significant losses and are most likely related to error on measurements. 
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Figure 5-4: Stability measurements of five vapor phase reference compounds desorbed from a Twister™ stir 
bar, following exposure to 5 % (v/v) cigarette vapor phase in air for HSSE experiments. The transfer time 
intervals (i.e., between exposure and desorption) selected for the analysis were 10, 40, 160 and 1440 min (24 
hours). Integration results were obtained from the XIC peak areas of the 5 reference compounds by GC/MS: 
Benzene, ; 2,5-Dimethyl furan, ; Toluene, ; Ethylbenzene, ; Limonene,  . Each 
data point represents an average of 3 individual runs using 3 different stir bars and error bars indicate standard 
deviation. 
 
5.4.4 Measurement of Dilution Precision 
Using the optimized HSSE-GC/MS method, the dilution precision of the vapor 
phase was measured by monitoring the peak areas of the five reference compounds as a 
function of the exposure concentration (i.e., dose equivalent): 1, 2 and 5 % (v/v) cigarette 
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vapor phase in air (Fig. 5-5). The average RSDs associated with the vapor phase 
generated and diluted by the Borgwaldt RM20S® were 17.2, 6.2 and 11.7 % (n=3) at 1, 2 
and 5 % (v/v) smoke, respectively. The linearity was good with correlation coefficients (r2) 
of >0.99 for each compound. Previous work in our laboratory indicated that the 
repeatability of the dilution of reference standard gases (CH4 and CO) was between 0.7 - 
4.5 % RSD with r2 >0.99 for a similar dilution range (Kaur et al., 2010). From the same 
study, it was also shown that the precision of the smoke generation itself was only 12 % 
RSD based on measuring solanesol in the particulate phase over the same smoke dilution 
range: 1 – 5 % (v/v) in air. The lower precision seen in the current study at 1 % smoke 
dilution (i.e., 17.2 % average RSD for 5 compounds) is likely due to high variability in the 
minute quantities of analyte sorbed on the stir bar at this dilution level since all other 
factors affecting the mass sorbed, i.e., PDMS film thickness, sample volume, partition 
coefficient, etc., were unchanged. Taking this into account, the results obtained in the 
current study corroborate the conclusion that the Borgwaldt RM20S® presents acceptable 
limits for repeatability measurements across dilutions.   
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Figure 5-5: Dilution precision data representing the vapor phase components found on a PDMS coated stir 
bar (Twister™), following exposure to 1, 2 and 5 % (v/v) cigarette vapor phase in air from 3R4F cigarettes 
for HSSE experiments. Integration results were obtained from the peak areas of the 5 reference compounds by 
GC/MS using the XICs: Benzene, ; 2,5-Dimethyl furan, ; Toluene,  (abundance shown on 
right vertical axis); Ethylbenzene, ; Limonene,  . Each data point represents an average of 3 
individual runs using 3 different stir bars and error bars indicate standard deviation. 
 
5.4.5 Semi-Quantitative Analysis of Diluted Smoke Vapor Phase 
 
External calibration was achieved using standard solutions in hexane applied to the stir 
bar. The same TDS-GC/MS parameters as with the vapor phase measurements were used. 
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Relative response factors calculated from the XIC peak areas for each standard at 10 
µM showed that ethylbenzene and limonene gave large responses (Table 5-3), presumably 
because of their stronger partition into the PDMS phase on the stir bar. Based on the smoke 
vapor phase peak areas at each dilution level (e.g., Fig. 5-5 data), yields ranging from 0.1 to 
22 ng were estimated (Table 5-3). It should be noted that the values in Table 5-3 represent 
minimum amounts as it is unlikely that equilibrium was reached for each puff. Quantitative 
HSSE is typically carried out in a closed system whereas in this experiment, each puff 
remained in the exposure chamber for 1 min and was then pushed out by a subsequent puff 
of fresh cigarette vapor phase. In addition, 100 % recovery was likely not attained for the 
sorption/desorption process with the PDMS phase, which is compound dependent. 
Extrapolation to 100% vapor phase, i.e., undiluted smoke, gives estimated yields in the 
range of 6 to 450 ng for the reference compounds (Table 5-3), which is 2 – 3 orders of 
magnitude less than reported amounts per cigarette (one full cigarette = 7 – 10 puffs). Other 
studies on the vapor phase components of cigarette smoke have reported quantities of 
benzene ranging from 23 to < 70 µg/cig (Darrall et al., 1998, Adam et al., 2006, Chen et 
al., 2003, Baggett et al., 1974, Polzin et al., 2007), 2,5-dimethylfuran at 58 µg/cig (Baggett 
et al., 1974), toluene ranging from 57 to < 200 µg/cig (Darrall et al., 1998, Adam et al., 
2006, Chen et al., 2003, Baggett et al., 1974, Polzin et al., 2007), ethylbenzene ranging 
from 4.4 – 5.5 µg/cig (Darrall et al., 1998, Polzin et al., 2007) and D-limonene at 64 µg/cig 
(Baggett et al., 1974). The fact that previous studies were carried out on different tobacco 
blends (e.g., 1R4F, 2R4F reference cigarettes, etc.) with different smoking apparatuses and 
assessed using different sampling methods (e.g., cold or cryo traps (Darrall et al., 1998, 
Baggett et al., 1974, Polzin et al., 2007); collection bags (Darrall et al., 1998, Polzin et al., 
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2007); solvent trap (Darrall et al., 1998); on-line analysis (Baggett et al., 1974, Adam et 
al., 2006) does not fully account for the large differences in quantities obtained compared 
to the present study. Besides the HSSE factors mentioned above, underestimation of the 
yields may also result from the procedure used to introduce the liquid-phase standards (i.e., 
error in pipetting 1 µL; differences between the PDMS/liquid versus PDMS/gas phase 
sorption processes), the known dilution error of up to 6.4% for the smoking machine (Kaur 
et al., 2010) and the large error in the calibration curve intercept values (Table 5-3).  
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Table 5-3: Semi-quantitative analysis of the five reference vapor phase 1 compounds found on a stir bar following 10 min exposure to 1, 2 and 5 % (v/v) cigarette vapor 
phase in air for HSSE experiments. 
 
Reference 
compound 
tr  of 
standard 
(min) 
tr  of 
sample 
(min) 
Relative 
response 
factora 
Calibration  
curveb 
Estimated minimum amount  
for 10 min exposure to diluted 
smoke vapor phase 
(ng)c 
Extrapolation to 
undiluted smoke 
vapor phase  
(ng) 
     1 % 2 % 5 % (100 %) 
Benzene 4.79 4.78 1.0 
y = (189 ± 30)x + (3401 ± 4013) 
r2 = 0.9529 
3.7 8.9 22.0 450 
2,5-Dimethyl 
furan 
5.26 5.27 1.9 
y = (364 ± 65)x + (1626 ± 1660) 
r2 = 0.9405 
0.76 1.5 5.1 110 
Toluene 6.41 6.42 8.5 
y = (2257 ± 121)x + (1300 ± 5145) 
r2 = 0.9858 
2.1 3.4 9.6 190 
Ethylbenzene 9.03 9.06 27 
y = (11896 ± 634)x - (3712 ± 3252) 
r2 = 0.9915 
0.11 0.19 0.35 6 
Limonene 17.1 17.1 15 
y = (48004 ± 2200)x - (1006 ± 1538) 
r2 = 0.9937 
0.21 0.38 0.75 13 
a  Based on XIC peak areas for standards at 10 µM. 
b  Linear regression curves have slope units of Peak area/µM;  r2: correlation coefficient. 
c  Calculated from average peak areas (Fig. 5) then converted to ng based on 1 µL standard applied to stir bar. Exposure of 10 min = 10 puffs.  
Error is estimated to be on the order of 18 – 25 % RSD based on results for the IS, n-butyl acetate. 
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5.5 Conclusions 
The HSSE method was successfully applied to the characterization of the vapor 
phase of diluted cigarette smoke collected in an exposure chamber. This procedure allowed 
for the components sorbed on the stir bar to be desorbed, re-focused and analyzed in one 
integrated/automated experimental step, without the use of extraction solvents. This 
technique, when coupled to GC/MS, allowed for the rapid and direct quantitative analysis 
of volatile and semi-volatile smoke vapor phase components in the exposure chamber of 
the Borgwaldt RM20S® and provided a linear response across smoke dilutions. The IS, n-
butyl acetate, did not prove useful for improving precision associated with the method. 
Semi-quantitative analysis of five smoke vapor phase components showed systematic 
underestimation of the yields compared to previously published values. Improvements in 
quantification and precision might be achieved by using deuterated standards or a gas-
phase internal standard (i.e., hexane) introduced at each puff via a switching valve inserted 
before the dilution syringe. Nonetheless, the results obtained in this study were within 
acceptable limits for repeatability measurements between dilutions.34  
The HSSE technique is simple, cost effective, can be easily implemented in most 
laboratories and can be applied to a wide range of analyses, e.g., environmental, food and 
automotive. Moreover, these results show that although there are a wide range of volatiles 
and semi-volatiles with different physical properties, dilution and delivery in the Borgwaldt 
RM20S® is achieved through a non-selective manner. In addition, this study provided 
                                                 
34 A linear response was observed for dilutions of 1- 10 % smoke vapour phase in air, and thus, was 
considered acceptable. 
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additional knowledge about a whole smoke exposure system to give us a more 
complete picture of the exposure concentration applied to cell cultures for future toxicology 
studies.  
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6 Conclusion 
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6.1 General Remarks: Summary of Principle Results 
Tobacco smoke is one of the most challenging mixtures to analyze based on its 
complexity, from the number and types of constituents to its aerosol nature involving a 
wide range of particles mixed with the vapor phase.  Our work was based on the 
development of reliable and robust tobacco smoke fractionation methods to allow for the 
comparisons of toxicological effects. Specific analytical separation and detection 
techniques in combination with in vitro toxicological assays were used for these types of 
analyses. The uniqueness of our approach lies in the union of chemical identification in 
parallel with toxicological characterization. Our approach began with designing the 
methodology to work with an individual tobacco component, which could then be applied 
to a more complex sample, e.g., the vapor phase of cigarette smoke.  
Our first objective was to chemically characterize the most bioactive fractions 
associated with the particulate phase combustion products of a single tobacco constituent, 
chlorogenic acid. By combining analytical techniques in parallel with in vitro toxicological 
testing, specifically the IVMNT, we developed a method to fractionate and identify the 
groups of compounds responsible for the cytotoxicity observed by the IVMNT. Catechol, a 
co-carcinogen and known product of the combustion of chlorogenic acid, was identified to 
be the major component in the most bioactive fraction assessed by the IVMNT.  
The practical complexity of assessing tobacco smoke and vapor phase toxicity was 
simplified by using the Borgwaldt RM20S® whole smoke generation instrument and BAT 
in vitro exposure chamber, which became available in our laboratory in 2007. In previous 
reports using the same system, cell culture studies had been carried out and a positive dose 
  
163
response relationship was observed for cells exposed to cigarette whole smoke and cell 
viability measured by the NRU assay (Phillips et al., 2004). In vitro biological assays have 
a high degree of variability associated with the use of heterogeneous cell samples, thus, all 
other sources of variability must be reduced or accounted to accurately assess toxicological 
endpoints. However, to our knowledge, there was no manufacturer’s specifications or data 
generated on the reliability of the cigarette smoke dose generated and delivered within the 
exposure chamber. Our second objective was to assess the reliability of the dose delivery 
from this type of instrumentation. Using reference gas standards (CO and CH4, introduced 
at the smoking port) as well as a particulate phase marker (solanesol, in actual cigarette 
smoke), we were able to assess the machine’s reliability for smoke generation and dilution 
in terms of repeatability, reproducibility and accuracy; the delivery system was deemed 
reliable for cell exposure studies based on our results in Chapter 4. Moreover, our results 
were comparable to those obtained from another laboratory for a similar study (i.e. for CH4 
repeatability studies, our laboratory gave an overall precision of 2.2-4.5% and combined 
precision from both labs, gave a RSD of  6.3-17.3%). 
Our third objective was to chemically characterize the vapor phase constituents 
delivered to the exposure chamber using HSSE (Chapter 5). HSSE has been used for the 
collection of volatiles in the environment/air, food and flavors (Hou et al., 2006, Bicchi et 
al., 2002, Koester, 2003, Bicchi et al., 2009) and to our knowledge has not been 
specifically used for the enrichment of tobacco smoke components generated by a smoking 
machine. Thus, we developed a sensitive HSSE technique to extract the vapor phase 
components present in the chamber during cigarette smoke exposure, at a dilution or dose 
commonly used in cell culture exposures. The major components were identified by mass 
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spectrometry to evaluate the dosimetry of gaseous compounds present in the exposure 
chamber.  
Recently Scian et al., carried out similar types of characterization studies for another 
type of smoke exposure system, the Burghart Mimic Smoker-01 (Scian et al., 2009a, Scian 
et al., 2009b). Their study was solely based on particulate phase measurements to assess 
the reproducibility of the dose delivered to the exposure chamber and the deposition (i.e. 
loss) between undiluted and diluted smoke (50 ± 10 % loss observed). The authors 
concluded that significant changes occur between smoke generation and delivery to the 
exposure chamber based on the analysis of the particulate phase. Overall, their study 
confirms the importance of chemical characterization for these types of systems in order to 
accurately assess toxicological endpoints. Other than these mentioned studies, only 
biological studies have been carried out with whole smoke exposure systems. 
Traditionally, the approach used by the tobacco industry targeted the solvent extracts 
of the particulate phase or vapor phase using indirect methods (Lestari et al., 2006). The 
general trend is now heading towards generation and subsequent analysis of whole cigarette 
smoke, as a holistic and more direct way to approach smoke (Phillips et al., 2005, Scian et 
al., 2009a, Scian et al., 2009b, Thorne et al., 2009, Aufderheide et al., 2000, Massey et al., 
1998). More specifically, the new techniques developed can be used to assess relative 
toxicities between different types of cigarettes and perhaps to the assessment of a harm-
reduced product. The techniques developed in this work can also be applied to other 
industries that face similar problems based on the complexity of samples and the 
combination of sophisticated type of instrumentation required for biologically active 
samples, including, environmental/air quality, diesel exhaust, food, fragrance.  
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6.2 Successes and Drawbacks of the Project  
In the field of tobacco science, it is rare to find multi-disciplinary research tying 
together refined analytical chemistry techniques with toxicological assays. Our objectives 
of being able to analyze a biologically relevant complex mixture in a reliable way were 
met. From our study on chlorogenic acid combustion products (Chapter 3), the most toxic 
sub-fraction was identified and contained catechol, 3,4-dihydroxybenzoic acid and an 
isomer of cis-benzeneglycol (structure unconfirmed). Catechol and 3,4-dihydroxybenzoic 
acid have been identified as tobacco smoke constituents. Catechol is a “Hoffmann analyte” 
(Rodgman et al., 2009b), genotoxic and blocks cell proliferation (Kaur et al., 2009). 3,4-
Dihydroxybenzoic acid has not been reported to be genotoxic or an inhibitor of cell 
proliferation. The characterization of the cigarette smoke vapor phase components 
presented in Chapter 5, involved the use of 5 reference markers: benzene, 2,5-dimethyl 
furan, ethylbenzene, toluene and D-limonene. These markers have also been identified in 
tobacco smoke (Rodgman et al., 2009b). Benzene and toluene are both “Hoffmann 
analytes” (Rodgman et al., 2009b); benzene, toluene and ethylbenzene are commonly used 
as markers for smoke volatile organic compounds (Hinwood et al., 2006, Sanchez et al., 
2006); and 2,5-dimethyl furan has been used as an effective tobacco smoke biomarker in 
human breath and as an environmental tobacco smoke marker (Gordon et al., 2002, Bi et 
al., 2005). Our objectives were not to identify all of the compounds present in our samples, 
but, to develop the analytical methods to characterize tobacco smoke components at 
biologically relevant concentrations. By confirming the presence of the compounds listed 
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above, we can conclude that the methodology developed is viable for analysis of 
complex mixtures, such as tobacco smoke.  
Although simplification of the sample matrix is required for the analysis of tobacco 
smoke, it is important to note that synergistic/additive effects may have been disrupted 
and/or not accounted for (Chapter 3).  
The method used for quantitation (Chapter 5) underestimated product yields and 
had many sources of error. In addition, some of the non-volatiles and semi-volatiles not 
being extracted/enriched using the HSSE method; assessment of both the particulate and 
vapor phases can not be carried out simultaneously using this method. In terms of the semi-
quantitative analysis performed on the cigarette smoke vapor phase components (Chapter 
5), the method of analysis can largely influence the results obtained because of the many 
variables involved. Despite the use of reference cigarettes, collection and extraction 
techniques for vapor and particulate phases are not consistent throughout the literature and 
standardization is quite challenging. Sorptive phases and solvents preferentially extract 
compounds that have high respective selectivity to “get what you select for”. The 
methodology developed (Chapters 4-5) can potentially serve as standardized methods for 
the assessment of instrumentation (Chapter 4) or screening of tobacco products (Chapter 3, 
5) for the Tobacco Industry.   
6.3 Future Challenges  
In Chapter 5, we used n-butyl acetate as our internal standard for the analysis of 
vapor phase components in cigarette smoke by HSSE. Subsequent to publication, an F test 
  
167
was performed on the internal standard data (18.5 -25.8 % RSD) to assess variances; 
variances were not significantly different because Fcalc (1.62) < Fcritical (4.70) at α = 0.05. 
Future work to improve quantitation, could include investigating the use of a internal 
standard (i.e., deuterated benzene or a hexane gas phase standard) introduced at each puff 
via a switching valve inserted before the dilution syringe. This could eliminate the high 
variability associated with pipetting low volumes of 1μL. It is important to consider that 
fresh smoke analytes were present in the exposure chamber, sent to the exhaust while 
subsequent puffs were generated and not allowed to equilibrate. Further studies could 
include allowing for the extraction by HSSE following exposure in a closed vessel for a 
fixed period of time.  
Furthermore, other work could include, simultaneous chemical characterization of the 
particulate and vapor phases in the chamber during cell culture exposure and also working 
towards an online method to monitor the particulate and vapor phase components in real 
time or puff-by-puff, to reduce losses, increase sensitivity and to monitor the smoke as it 
changes over time (i.e. aging process and generation of artifacts) (Borgerding et al., 2005, 
Adam et al., 2006).  
  
168
7 Bibliography 
Adam T, Mitschke S & Baker R, R. 2009. Investigation of tobacco pyrolysis gases and 
puff-by-puff resolved cigarette smoke by single photon ionisation (SPI)-time-of-
flight mass spectrometry (TOFMS). Contrib Tob Res, 203-226. 
Adam T, Mitschke S, Streibel T, Baker RR & Zimmermann R 2006. Quantitative puff-by-
puff-resolved characterization of selected toxic compounds in cigarette mainstream 
smoke. Chem Res Toxicol, 19, 511-520. 
Armitage AK, Dixon M, Frost BE, Mariner DC & Sinclair NM 2004. The effect of 
inhalation volume and breath-hold duration on the retention of nicotine and 
solanesol in the human respiratory tract and on subsequent plasma nicotine 
concentrations during cigarette smoking. Contrib Tob Res, 21, 240-249. 
Aufderheide M & Mohr U 2000. CULTEX- an alternative technique for cultivation and 
exposure of cells of the respiratory tract to airborne pollutants at the air/liquid 
interface. Exp Toxicol Pathol, 52, 265-270. 
Baggett MS, Morie GP, Simmons MW & Lewis JS 1974. Quantitative determination of 
semivolatile compounds in cigarette smoke. J Chromatogr, 97, 79-82. 
Baker R, R. 1999. Smoke Chemistry. In: DAVIS, L. & NIELSEN, M. (eds.) Tobacco 
Production, Chemistry and Technology. Oxford: Blackwell Science Ltd. 
Baker RR 1981. Product formation mechanisms inside a burning cigarette. Prog Energy 
Combust Sci, 7, 135-153. 
Baker RR & Bishop LJ 2003. The pyrolysis of tobacco ingredients. J Anal Appl Pyrolysis, 
71, 223-311. 
Baltussen E, Sandra P, David F & Cramers C 1999. Stir bar sorptive extraction (SBSE), a 
novel extraction technique for aqueous samples: Theory and principles. J Microcol 
Sep, 11, 737-747. 
Bartle KD, Bergstedt L, Novotny M & Widmark G 1969. Tobacco chemistry. II. Analysis 
of the gas phase of tobacco smoke by gas chromatography-mass spectrometry. J 
Chromatogr, 45, 256-63. 
Baumgartner H & Coggins CR 1980. Description of a continuous-smoking inhalation 
machine for exposing small animals to tobacco smoke. Contrib Tob Res, 10, 169-
174. 
Benijts T, Vercammen J, Dams R, Tuan HP, Lambert W & Sandra P 2001. Stir bar sorptive 
extraction-thermal desorption-capillary gas chromatography-mass spectrometry 
applied to the analysis of polychlorinated biphenyls in human sperm. J Chromatogr 
B, 755 137-142. 
Bi X, Sheng G, Feng Y, Fu J & Xie J 2005. Gas- and particulate-phase specific tracer and 
toxic organic compounds in environmental tobacco smoke. Chemosphere, 51, 1512-
1522. 
Bicchi C, Cordero C, Iori C, Rubiolo P & Sandra P 2000. Headspace sorptive extraction 
(HSSE) in the headspace analysis of aromatic and medicinal plants J High Resolut 
Chromatogr, 23, 539-546  
  
169
Bicchi C, Iori C, Rubiolo P & Sandra P 2002. Headspace sorptive extraction (HSSE), 
stir bar sorptive extraction (SBSE) and solid phase microextraction (SPME) applied 
to the analysis of roasted arabica coffee and coffee brew. J Agr Food Chem, 50, 
449-459. 
Bicchi C, Liberto E, Cordero C, Sgorbini B & Rubiolo P 2009. Stir-bar sorptive extraction 
and headspace sorptive extraction: An overview. LCGC North America, 27, 376-
390. 
Bombick BR, Murli H, Avalos JT, Bombick DW, Morgan WT, Putnam KP & Doolittle DJ 
1997a. Chemical and biological studies of a new cigarette that primarily heats 
tobacco - Part 2 - In vitro toxicity of mainstream smoke condensate. Food Chem 
Toxicol, 36, 183-190. 
Bombick DW, Ayres PH & Doolittle DJ 1997b. Cytotoxicity assessment of whole smoke 
and vapor phase of mainstream and sidestream cigarette smoke from three kentucky 
reference cigarettes Toxicol Meth, 7, 177-190. 
Bombick DW, Bombick BR, Ayres PH, Putnam K, Avalos J, Borgerding MF & Doolittle 
DJ 1997c. Evaluation of the genotoxic and cytotoxic potential of mainstream whole 
smoke and smoke condensate from a cigarette containing a novel carbon filter. 
Fundam Appl Toxicol, 39, 11-7. 
Borgerding M & Klus H 2005. Analysis of complex mixtures – cigarette smoke. Exp 
Toxicol Pathol, 57, 43-73. 
Borgwaldt KC. 2010. Borgwaldt KC:Smoking Machine RM20S. (available at: 
http://www.borgwaldt.de/cms/borgwaldt-
kc/produkte/rauchmaschinen/rotierende/rauchmaschine-brrm20s.html) [Last 
accessed on 30-Aug-2010]. 
Bratberg M. 2006. Maximization of the HPLC-MS separation of a standard mixture of 
seven compounds found in the combustion of chlorogenic acid: internship report. 
Buszewski B, Ulanowska A, Ligor T, Denderz N & Amann A 2009. Analysis of exhaled 
breath from smokers, passive smokers and non-smokers by solid-phase 
microextraction gas chromatography/mass spectrometry. Biomed Chromatogr, 23, 
551-556. 
Byrd GD, Fowler KW, Hicks RD, Lovette ME & Borgerding MF 1990. Isotope dilution 
gas chromatography-mass spectrometry in the determination of benzene, toluene, 
styrene and acrylonitrile in mainstream cigarette smoke. J Chromatogr, 503. 
Cantral DE, Sisson JH, Veys T, Rennard SI & Spurzem JR 1995. Effects of cigarette 
smoke extract on bovine bronchial epithelial cell attachment and migration. Am J 
Physiol Lung Cell Mol Physiol, 268, L723-L728. 
Centre d’expertise en analyse environnementale du Québec. 2007. Protocole pour la 
validation d’une méthode d’analyse en chimie:DR-12-VMC. (Available at: 
www.ceaeq.gouv.qc.ca/accreditation/.../DR12VMC_protocole_val_chimie.pdf). 
[Last accessed on 29-11-2010]. 
Chen P 2004. Chemistry of cigarette burning processes. Contrib Tob Res, 21, 105-110. 
Chen PX & Moldoveanu SC 2003. Mainstream Smoke Chemical Analyses for 2R4F 
Kentucky Reference Cigarette. Contrib Tob Res, 20, 448-458. 
  
170
Chouchane S, Wooten JB, Tewes FJ, Wittig A, Muller BP, Veltel D & Diekmann J 
2006. Involvement of semiquinone radicals in the in vitro cytotoxicity of cigarette 
mainstream smoke. Chem Res Toxicol, 19, 1602-1610. 
CORESTA. 2002. The rationale and strategy for conducting in vitro toxicology testing of 
tobacco smoke. Paris. (Available at http://www.coresta.org/) [Last accessed, 30-
Aug-2010]. 
CORESTA. 2005. In vitro exposure of cells to smoke at the air liquid interface. CORESTA 
(Available at 
www.coresta.org/Reports/IVT_TF_Report_Smoke_Air_Liquid_Interface.pdf) [Last 
accessed 30-Aug-10]. 
Côté F, Létourneau C, Mullard G & Voisine R 2010. Estimation of nicotine and tar yields 
from human-smoked cigarettes before and after the implementation of the cigarette 
ignition propensity regulations in Canada. Regul Toxicol Pharmacol, Epub ahead of 
print November 1; PMID:20303374. 
Darrall KG, Figgins JA, Brown RD & Phillips GF 1998. Determination of benzene and 
associated volatile compounds in mainstream cigarette smoke. Analyst, 123, 1095-
101. 
DeMarini DM 2004. Genotoxicity of tobacco smoke and tobacco smoke condensate: A 
review. Mutat Res, 567, 447-474. 
Dong JZ, Glass JN & Moldoveanu SC 2000. A simple GC-MS technique for the analysis of 
vapor phase mainstream cigarette smoke. J Microcol Sep, 12, 142-152. 
Dube MF & Green CR 1982. Methods of collection of smoke for analytical purposes. Rec 
Adv Tob Sci, 8, 42-102. 
Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S & Zeiger E 2003. HUMN 
project: detailed description of the scoring criteria for the cytokinesis-block 
micronucleus assay using isolated human lymphocyte cultures. Mutat Res, 534, 65-
75. 
Frenesius RE 1985. Analysis of tobacco smoke condensate. J Anal Appl Pyrol, 8, 561-575. 
Frieauff W, Potter-Locher F, Cordier A & Suter W 1998. Automatic analysis of the in vitro 
micronucleus test on V79 cells. Mutat Res, 413, 57-68. 
Gold LS & Zeiger E 1997. Handbook of carcinogenic potency and genotoxicity databases, 
Florida, CRC Press Inc., 754  
Gopalakrishna R, Chen ZH & Gundimeda U 1994. Tobacco smoke tumor promoters, 
catechol and hydroquinone, induce oxidative regulation of protein kinase C and 
influence invasion and metastasis of lung carcinoma cells. Proc Natl Acad Sci, 91, 
12233-12237. 
Gordon SM, Wallace LA, Brinkman MC, Callahan PJ & Kenny DV 2002. Volatile organic 
compounds as breath biomarkers for active and passive smoking. Environ Health 
Perspect, 110, 689-98. 
Harris DC 2006. Quantitative chemical analysis China Lake, W. H. Freeman, pp 663. 
Health Canada 1999. Determination of phenolic compounds in mainstream tobacco smoke. 
Official method T-114. 
Health Canada 2004a. Bacterial reverse mutation assay for mainstream tobacco smoke. 
Official method T-501 version 1.1. 
  
171
Health Canada 2004b. In vitro micronucleus assay for mainstream tobacco smoke. 
Official method T-503. 
Health Canada 2004c. Neutral red uptake assay for mainstream tobacco smoke. Official 
method T-502 version 1.1. 
Heddle JA, Fenech M, Hayashi M & Macgregor JT 2010. Reflections on the development 
of micronucleus assays. Mutag. 
Hinwood AL, Berko HN, Farrar D, Galbally IE & Weeks IA 2006. Volatile organic 
compounds in selected micro-environments. Chemosphere, 63, 421-9. 
Hoffmann D. 1993. Analysis of toxic smoke constituents. In: Toxicity testing plan, Vol. 5. 
(Available at  http://www.cpsc.gov/LIBRARY/FOIA/foia00/os/testing2.pdf) [Last 
accesssed 30-Aug-10]. 
Hoffmann D & Hecht SS 1990. Advances in tobacco carcinogenesis. In: COOPER, C. S. & 
GROVER, P. L. (eds.) Chemical Carcinogenesis and Mutagenesis. London, UK: 
Springer-Verlag. 
Hoffmann D, Hecht SS & Wynder EL 1983. Tumor promoters and carcinogens in tobacco 
carcinogenesis. Environ Health Perspect 50, 247-257. 
Hoffmann D & Hoffmann I 1997. The changing cigarette, 1950-1995. J Toxicol Environ 
Health, 50, 307-364. 
Hoffmann D & Hoffmann I 1998a. Chemistry and toxicology: The cigar. Smoking and 
Tobacco Control Monograph, 9. 
Hoffmann D & Hoffmann I 1998b. Tobacco smoke components. Contrib Tob Res, 18, 49-
52. 
Hoffmann D & Hoffmann I 2001a. The changing cigarette: Chemical studies and 
bioassays. In: BURNS, D. M. & BENOWITZ, N. L. (eds.) Risks associated with 
smoking cigarettes with low-machine-measured yields of tar and nicotine. 
Bethesda, MD: NCI Smoking and tobacco Control. 
Hoffmann D, Hoffmann I & El-Bayoumy K 2001b. The less harmful cigarette: A 
controversial issue. A tribute to Ernst L. Wynder. Chem Res Toxicol, 14, 767-90. 
Hou Y, Yang L, Wang B, Xu J, Yang Y, Yang Y, Cao Q & Xie X 2006. Analysis of 
chemical components in tobacco flavors using stir bar sorptive extraction and 
thermal desorption coupled with gas chromatography-mass spectrometry. Chin J 
Chromatogr, 24, 601-605. 
Huber GL 1989. Physical, chemical, and biological properties of tobacco, cigarette smoke, 
and other tobacco products. Semin Respir Med, 10, 297-332. 
IARC 1986. Chemistry and analysis of tobacco smoke. In: Monographs on the evaluation 
of the carcinogenic risk of chemicals to humans – Lyon – France, 38, 83-121. 
International Organization for Standardization. 1999. ISO 3402-Tobacco and tobacco 
products-Atmosphere for conditioning and testing. Geneva. (Available at 
http://www.iso.org/iso/catalogue_detail.htm?csnumber=28324) [Last accessed 30-
Aug-10]. 
Jansson T, Curvall M, Hedin A & Enzell CR 1986. In vitro studies of biological effects of 
cigarette smoke condensate II. Induction of sister-chromatid exchanges in human 
lymphocytes by weakly acidic semivolatile constituents. . Mutat Res, 169, 129-139. 
  
172
Kaur N, Lacasse M, Fürtös A, Waldron KC & Morin A 2009. Sequential fractionation 
with concurrent chemical and toxicological characterization of the combustion 
products of chlorogenic acid. J Chromatogr A, 1216, 4703-4712. 
Kaur N, Lacasse M, Roy J-P, Cabral J-L, Adamson J, Errington G, Waldron KC, Gaca M 
& Morin A 2010. Evaluation of precision and accuracy of the Borgwaldt RM20S® 
smoking machine designed for in vitro exposure. Inhal Toxicol, (Accepted for 
publication). 
Kishioka T, Iida C, Fujii K, Nagae R, Onishi Y, Ichi I & Kojo S 2007. Effect of dimethyl 
sulphoxide on oxidative stress, activation of mitogen activated protein kinase and 
necrosis caused by thioacetamide in the rat liver. Eur J Pharmacol, 564, 190-195. 
Koester CJ 2003. Environmental analysis. Anal Chem, 75, 2813-2829. 
Lacasse M. 2007. Caractérisation toxicologique et chimique des produits de combustion 
d’un composé pur du tabac: l’acide chlorogénique INRS- IAF M.Sc. Thesis. 
Lannan S, Donaldson K, Brown D & MacNee W 1994. Effect of cigarette smoke and its 
condensates on alveolar epithelial cell injury in vitro. Am J Physiol, 266, L92-L100. 
Leffingwell JC 1999. Leaf chemistry: Basic chemical constituents of tobacco leaf and 
differences among tobacco types In: DAVIS, L. & NIELSEN, M. (eds.) Tobacco 
Production, Chemistry and Technology. Oxford: Blackwell Science Ltd. 
Lestari F, Markovic B, Green A, R., Chattopadhyay G & Hayes A, J. 2006. Comparative 
assessment of three in vitro exposure methods for combustion toxicity. J Appl 
Toxicol, 26, 99-114. 
Li Q, Aubrey MT, Christian T & Freed BM 1997. Differential inhibition of DNA synthesis 
in human T cells by the cigarette tar components hydroquinone and catechol. 
Fundam Appl Toxicol, 38, 158-165. 
Li Q, Geiselhart L, Mittler JN, Mudzinski SP, Lawrence DA & Freed BM 1996. Inhibition 
of human T lymphoblast proliferation by hydroquinone. Toxicol Appl Pharmacol, 
139, 317-323. 
Lickint F 1929. Tabak und Tabakrauch als ätiologischer Faktor des Carcinoms J Canc Res 
Clin Oncol, 30, 349-365. 
Massey E, Aufderheide M, Koch W, Lodding H, Pohlmann G, Windt H, Jarck P & Knebel 
JW 1998. Micronucleus induction in V79 cells after direct exposure to whole 
cigarette smoke. Mutag, 13, 145-149. 
Mauldin RK 1976. The characterization of cigarette smoke from CytrelAA® smoking 
products and its comparison to smoke from flue-cured tobacco: II. semi-volatile 
phase analysis Contrib Tob Res, 8, 422-429. 
McCue JM, Lazis S, Cohen JJ, Modiano JF & Freed BM 2003. Hydroquinone and catechol 
interfere with T cell cycle entry and progression through the G1 phase. Mol 
Immunol, 39, 995-1001. 
Misra M, Leverette RD, Hamm JT & Vulimiri SV 2010. In vitro toxicological evaluation 
of cigarette smoke particulate phase matter: Effect of dimethyl sulfoxide (DMSO) 
as solvent. Contrib Tob Res, 24, 1-9. 
Moldoveanu SC & Kiser M 2007. Gas chromatography/mass spectrometry versus liquid 
chromatography/fluorescence detection in the analysis of phenols in mainstream 
cigarette smoke. J Chromatogr A, 1141, 90-7. 
  
173
Nakayama T, Kaneko M, Kodama M & Nagata C 1985. Cigarette smoke induces DNA 
single-strand breaks in human cells. Nature, 314, 462 - 464 
 
Nanni EJ, Lovette ME, Hicks RD, Fowler KW & Borgerding MF 1990. Separation and 
quantitation of phenolic compounds in mainstream cigarette smoke by capillary gas 
chromatography with mass spectrometry in the selected-ion mode. J Chromatogr A, 
505, 365-374. 
Ochiai N, Sasamoto K & Kanda H. 2008. A novel extraction procedure for stir bar sorptive 
extraction (SBSE): Sequential SBSE for uniform enrichment of organic pollutant in 
water samples. (Available at http://www.gerstel.de/en/apps-twister-sbse.htm) [Last 
accessed 30-Aug-10]. 
OECD. 2004. Draft proposal for a new guideline 487: In vitro micronucleus test, OECD 
guideline for the testing of chemicals, adopted: 14th June 2004, version 1. OECD 
Publications, Paris. 
Omori F, Higashi N, Chida M, Sone Y & Suhara S 1999. Internal standard-based analytical 
method for tobacco smoke vapor phase components Contrib Tob Res, 18, 131-146. 
Palmer GK & Pearce RC 1999. Production practices: Light air-cured tobacco. In: DAVIS, 
L. & NIELSEN, M. (eds.) Tobacco Production, Chemistry and Technology. 
Oxford: Blackwell Science Ltd. 
Paschke T, Scherer G & Heller WD 2002. Effects of ingredients on cigarette smoke 
composition and biological activity: A literature overview. Contrib Tob Res, 20, 
107-247. 
Peedin GF 1999. Production practices: Flue-cured tobacco. In: DAVIS, L. & NIELSEN, M. 
(eds.) Tobacco Production, Chemistry and Technology. Oxford: Blackwell Science 
Ltd. 
Phillips J, Kluss B, Richter A & Massey E 2005. Exposure of bronchial epithelial cells to 
whole cigarette smoke: Assessment of cellular responses. Altern Lab Anim, 33, 
239-248. 
Phillips J, Richter A & Massey ED. 2004. Determination of the cytotoxicity of whole 
cigarette smoke (poster presentation). In:  The Annual Congress of the British 
Toxicological Society, April 21-24 2004, UK.(A link to the poster can be found at 
http://www.bat-
science.com/groupms/sites/BAT_7AWFH3.nsf/vwPagesWebLive/DO7AXGRG?op
endocument&SKN=1) 
Poirier M, Fournier M, Brousseau P & Morin A 2001. Effects of volatile aromatics, 
aldehydes, and phenols in tobacco smoke on viability and proliferation of mouse 
lymphocytes. J Toxicol Environ Health A, 65, 1437-1451. 
Polzin GM, Kosa-Maines RE, Ashley DL & Watson CH 2007. Analysis of volatile organic 
compounds in mainstream cigarette smoke. Environ Sci Technol, 41, 1297-302. 
Préfontaine D, Morin A, Jumarie C & Porter A 2006. In vitro bioactivity of combustion 
products from 12 tobacco constituents. Food Chem Toxicol, 44, 724-738. 
Risner CH & Cash S, L. 1990. A high performance liquid chromatographic determination 
of major phenolic compounds in tobacco smoke. J Chromatogr Sci, 28, 2-7. 
  
174
Robertson ML, Eastmond DA & Smith MT 1991. Two benzene metabolites, catechol 
and hydroquinone, produce a synergistic induction of micronuclei and toxicity in 
cultured human lymphocytes. Mutat Res, 249, 201-209. 
Rodgman A 2000. Smoke pH: A review. Contrib Tob Res, 19, 117-139. 
Rodgman A 2003. The composition of cigarette smoke: Problems with lists of tumorigens. 
Contrib Tob Res, 20, 402-437. 
Rodgman A & Green CR 2003. Toxic chemicals in cigarette mainstream smoke – hazards 
and hoopla. Contrib Tob Res, 20, 481-545. 
Rodgman A & Perfetti TA 2009a. The chemical components identified in tobacco and 
tobacco smoke prior to 1954: A chronology of classical chemistry. Contrib Tob 
Res, 23, 277-333. 
Rodgman A & Perfetti TA 2009b. The chemical components of tobacco and tobacco 
smoke, Boca Raton, FL, CRC Press, pp 928. 
Runeckles VC 1963. Tobacco polyphenols II. On the biosysthesis of chlorogenic acid. . 
Can J Biochem Physiol, , 2249-2258. 
Sakuma H, Matsushima S, Munakata S & Sugawara S 1982. Pyrolysis of chlorogenic acid 
and rutin. Agric Biol Chem, 46, 1311-1317. 
Sanchez JM & Sacks RD 2006. Development of a multibed sorption trap, comprehensive 
two-dimensional gas chromatography, and time-of-flight mass spectrometry system 
for the analysis of volatile organic compounds in human breath. Anal Chem, 78, 
3046-54. 
Schlotzhauer WS & Chortyk OT 1981. Pyrolytic studies on the origin of phenolic 
compounds in tobacco smoke. Tob Sci, 25, 6-10. 
Schlotzhauer WS, Martin RM, Snook ME & Williamson RE 1982. Pyrolytic studies on the 
contribution of tobacco leaf constituents to the formation of smoke catechols. J 
Agric Food Chem, 30, 372-374. 
Schlotzhauer WS, Snook ME, Chortyk OT & Wilson RL 1992. Pyrolytic evaluation of low 
chlorogenic acid in tobaccos in the formation of the smoke co-carcinogen catechol. 
J Anal Appl Pyrol, 22, 231-238. 
Scian MJ, Oldham MJ, Kane DB, Edmiston JS & McKinney WJ 2009a. Characterization 
of a whole smoke in vitro exposure system (Burghart Mimic Smoker-01). Inhal 
Toxicol, 21, 234-243. 
Scian MJ, Oldham MJ, Miller JH, Kane DB, Edmiston JS & McKinney BC 2009b. 
Chemical analysis of cigarettes smoke particulate generated in the MSB-01 in vitro 
whole smoke exposure system. Inhal Toxicol, 21, 1040-1052. 
Sharma RK, Fisher TS & Hajaligol MR 2002a. Effect of reaction conditions on pyrolysis of 
chlorogenic acid. J Anal Appl Pyrol, 62, 281-296. 
Sharma RK, Wooten JB, Baliga VL, Martoglio S, P A & Haljaligol MR 2002b. 
Characterization of char from the pyrolysis of tobacco. J Agric Food Chem, 50, 
771-783. 
Snyder R, Witz G & Goldstein BD 1993. The toxicology of benzene. Environ Health 
Perspect, 100, 293-306. 
Stedman RL 1968. The chemical composition of tobacco and tobacco smoke. Chem Rev, 
68, 153-207. 
  
175
Stich HF, Rosin MP, Wu CH & Powrie WD 1981. A comparative genotoxicity study of 
chlorogenic acid (3-O-caffeoylquinic acid). Mutat Res, 90, 201-212. 
Swain AP, Cooper JE & Stedman RL 1969. Large-scale fractionation of cigarette smoke 
condensate for chemical and biologic investigations. Cancer Res, 29, 579-83. 
Takanami Y, Chida M, Hasebe H, Sone Y & Suhara S 2003. Analysis of cigarette smoke 
by an online thermal desorption system and multidimensional GC-MS. J 
Chromatogr Sci, 41, 317-22. 
Thorne D, Wilson J, Kumaravel TS, Massey ED & McEwan M 2009. Measurement of 
oxidative DNA damage induced by mainstream cigarette smoke in cultured NCI-
H292 cells. Mutat Res, 673, 3-8. 
Tienpont B, David F, Bicchi C & Sandra P 2000. High capacity headspace sorptive 
extraction. J Microcol Sep, 12, 577-584 
Torikai K, Yoshida S & Takahashi H 2004. Effects of temperature, atmosphere and pH on 
the generation of smoke compounds during tobacco pyrolysis. Food Chem Toxicol, 
42, 1409-17. 
Torikaiu K, Uwano Y, Nakamori T, Tarora W & Takahashi H 2005. Study on tobacco 
components involved in the pyrolytic generation of selected smoke constituents. 
Food Chem Toxicol, 43, 559-568. 
Tso TC 1999. Seed to Smoke. In: DAVIS, L. & NIELSEN, M. (eds.) Tobacco Production 
and Technology. Oxford: Blackwell Science Ltd. 
U.S. Department of Health and Human Services. 1989. Reducing the health consequences 
of smoking, 25 years of progress. A report of the Surgeon General. 
University of Kentucky. 2010a. Reference Cigarette Program: 3R4F Preliminary Analysis. 
(available at: http://www.ca.uky.edu/refcig/) [(Last accessed on 08/25/2010)]. 
University of Kentucky. 2010b. Reference cigarette program: 3R4F preliminary analysis. 
(Available at: http://www.ca.uky.edu/refcig/) [Last accessed on 08/25/2010]. 
US Surgeon General. 1964. Smoking and health  
US Surgeon General. 1982. The health consequences of smoking: Cancer: A report of the 
surgeon general. 
Vaughan C, Stanfill SB, Polzin GM, Ashley DL & Watson CH 2008. Automated 
determination of seven phenolic compounds in mainstream tobacco smoke. 
Nicotine Tob. Res., 10, 1261-1268. 
Vignes R. 2000. Dimethyl sulfoxide (DMSO) a "new" clean, unique superior solvent. In:  
American Chemical Society Annual Meeting, August 20-24 2000, Washington. 20 
Walaszek Z, Hanausek M & Slaga TJ 2007. The role of skin painting in predicting lung 
cancer. Int J Toxicol, 26, 345-351. 
Weeks WW 1999. Leaf chemistry: Relationshipp between leaf chemistry and organoleptic 
properties of tobacco smoke. In: DAVIS, L. & NIELSEN, M. (eds.) Tobacco 
Production, Chemistry and Technology. Oxford: Blackwell Science Ltd. 
Wieczorek R & Röper W. 2006. Effect of vapour phase on whole cigarette mainstream 
smoke in vitro cytotoxicity. In:  CORESTA Congress, October 15-20 2006, Paris, 
France.Personal communication (a link to abstract SS28 can be found at 
http://www.coresta.org/Past_Abstracts/Paris2006-SmokeTech-Oct06.pdf). 
Wynder EL & Hoffmann D 1967. Tobacco and tobacco smoke, studies in experimental 
carcinogenesis, New York, Academic Press, 730. 
  
176
Wynder EL & Hoffmann D 1969. A study of tobacco carcinogenesis. X. Tumor 
promoting activity. Cancer, 24, 289-301. 
Ye Q 2008. Development of solid-phase microextraction followed by gas chromatography-
mass spectrometry for rapid analysis of volatile organic chemicals in mainstream 
cigarette smoke. J Chromatogr A, 1213, 239-44. 
Zhong K-J, Wei W-Z, Guo F-Q & Huang L-F 2005. Comparison of simultaneous 
distillation extraction and solid-phase microextraction for determination of volatile 
constituents in tobacco flavor. J Cent South Univ Technol, 12, 547-551. 
 
 
 
 
 
i
8 Appendix A - Experimental Flow Chart 
 
Figure 8-1: Experimental flow chart of the chlorogenic acid combustion product study. 
1Corresponds to LC/UV reversed-phase experimental conditions described in section 3.3.9 
2Corresponds to LC/UV reversed-phase experimental conditions described in section 3.3.11 
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9 Appendix B - Maximization of the HPLC-MS 
Separation of a Standard Mixture of Seven 
Compounds found in the Combustion of Chlorogenic 
Acid  
The DMSO extract of the combustion products of chlorogenic acid was separated and 
collected in three major fractions by preparative LC/UV. The second fraction was 
identified as the most bioactive fraction by the IVMNT. Many compounds were identified 
within this fraction by HPLC-MS. The objective of this set of experiments was to 
maximize the analytical separation of this second fraction using seven standard reference 
compounds to represent this fraction. This appendix is based on work done and reported by 
a summer student, Mari Bratberg, that I co-supervised with Karen C. Waldron (Bratberg, 
2006).  
In total, four different stationary phases (Table 9-1) and nine different mobile phase 
compositions (Fig. 9-1 and 9-2) were tested. Table 9-1: Description of HPLC separation 
columns used (Phenomenex, Torrance ,CA) 
Column 
number
Name Phase Description Particle 
size/ μm
Pore 
size/Å
Diamete
r (mm)
Length 
(mm)
1 Synergi Polar-RP Ether-linked phenyl with polar end-capping 4 80 4,6 150
2 Gemini C6-Phenyl R=C6-phenyl (no endcapping) 5 110 4,6 150
3 Synergi Hydro-RP C18 with polar end-capping 4 80 4,6 150
4 Gemini C18 R=C18 (no endcapping) 5 110 4,6 150  
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Figure 9-1: Representation of the nine types of mobile phase gradient elutions used. The 
solvent consisted of MeOH in 0.1% aqueous formic acid (pH 3-4), with concentrations of 
MeOH of 10-50 to 75% increasing over 24 min. 
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Figure 9-2: Total Ion Chromatograms (m/z 50-1000) of the comparison of the nine types 
of mobile phase gradient elutions used MeOH of 10-50 to 75% in 0.1 % aqueous formic 
acid, increasing over 24 min. 
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 All columns run with mobile phase gradient of 20 to 75% MeOH were well 
separated (Fig. 9-3), and the best resolution was obtained with the Synergi Polar-RP and 
the Gemini C6-Phenyl column.  
 
 
Figure 9-3: Total Ion Chromatograms (m/z 50-1000) representing the separations of 
the standard mixture using a gradient of 20-75% MeOH in 1% aqueous formic acid. 
Mixture contained: 2,5-dihydroxybenzoic Acid (1), p-hydroxybenzoic acid (2), caffeic 
acid (3), p-coumaric acid (4), 4-hydroxy-3-methoxycinnamic acid (5), benzoic acid (6) 
and trans-cinnamic acid (7).  
 
In terms of elution order, the same relative elution order was obtained using the four 
columns except for one of the standard reference compounds, 2,5-dihydroxybenzoic acid. 
2,5-dihydroxybenzoic acid should be the most polar compound thus the least retained on all 
columns. Instead, 2,5-dihydroxybenzoic acid was the first compound to elute  in the more 
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polar columns, Synergi Polar-RP and Hydro-RP, third to elute in the Gemini C18 and fifth 
in the Gemini C6-Phenyl column. The interaction of this compounds with the stationary 
phase of the Gemini C6-Phenyl column could be explained by interactions between benzene 
ring and the stationary phase phenyl groups, since the analyte contains OH groups in ortho- 
and meta-positions to the carboxylic group, making the benzene ring more accessible for 
interactions with column (compared to benzene rings with their constituents in para-
position)  
Considering gradient elution conditions, the larger the initial amount MeOH used, the 
higher eluent strength. This led to shorter time of analysis and dramatic loss of resolution. 
Using inital conditions of 20% MeOH (gradient #3), with an ether-linked phenyl stationary 
phase with polar end-capping (Synergi Polar-RP) resulted in a good compromise between 
time of analysis and resolution. These conditions were used for subsequent separations of 
the second fraction of the combustion products of chlorogenic acid.  
Finally, to evaluate the repeatability of the LC/MS separation, the RSD was calculated 
from 10 identical runs on one column (Gemini C18) was determined and the repeatability 
was assessed for retention time, 0.11 % RSD, and peak area, 1.28 % RSD. The overall RSD 
of the LC/MS system was determined to have excellent repeatability at 1.28%. 
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